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Due to various social, environmental, and technological issues associated with petro-based 
chemical processes, bio-based production using microbial cell factories has been recognized as a 
modern biotechnology for more renewable, sustainable, and clean manufacturing of chemical 
compounds. With respect to conventional chemical transformation, such in vivo biotransformation 
offers a substantial processing simplicity and technological leverage, particularly for the 
production of structurally complex compounds, by carrying out intricate and multi-step reactions 
with high specificity via one-pot reaction. Among numerous microbial cell factories, bacterium 
Escherichia coli is the most popular and user-friendly workhorse primarily due to its genetic 
amenability and well-developed bioprocessing strategies. While wild-type E. coli is not a native 
producer for many chemical products, technological advances in synthetic biology, genetic 
engineering, protein engineering, and metabolic engineering have offered a promise for extensive 
tailoring of E. coli strains with virtually any types of biosynthetic capacity. In this thesis study, we 
integrate several strain and bioprocess engineering strategies for rewiring of carbon flux around 
one of tightly-regulated central metabolic branch-points (i.e., node of succinyl-CoA) to enhance 
precursor supply for effective biosynthesis of three particular value-added chemicals, i.e., 
propionate, 3-hydroxyvalerate (3-HV), and 5-aminolevulinate (5-ALA), in E. coli host strains.  
 In our initial study, we use our previously-derived propanologenic (i.e., 1-propanol-
producing) bacterium E. coli strain with an activated genomic Sleeping beauty mutase (Sbm) 
operon for heterologous propionate production. Note that activated Sbm pathway branches out of 
the tricarboxylic acid (TCA) cycle at the succinyl-CoA node to form propionyl-CoA and its 
derived metabolites of 1-propanol and propionate. We first investigate the sensitivity around 




contributing to carbon flux toward this node. These particular reactions are from three TCA cycle 
routes, i.e., i.e., oxidative TCA cycle, reductive TCA branch, and glyoxylate shunt. Effective 
blocking of oxidative TCA cycle and deregulating glyoxylate shunt has led to the secretion of 
roughly 30.9 g l-1 of propionate with minimal byproduct formation upon fed-batch cultivation our 
engineered strain under aerobic conditions. To best of our knowledge, the propionate titer reached 
in this study is the highest reported in E. coli from single structurally-unrelated carbon source (i.e., 
glycerol).  
 For the subsequent part of our thesis, we further engineer our Sbm-activated E. coli strain 
by constructing a 3-hydroxyacid pathway for the production of heterologous long (odd)-chain 3-
HV. The development of this particular strain involved modular construction of 3-HV biosynthetic 
pathway by establishing efficient Claisen condensation, reduction reaction, and CoA removing 
capabilities. In addition to strain engineering, various biochemical strategies (i.e., cultivation 
temperature, carbon sources, and aeration) were investigated for high secretion of approximately 
3.71 g l-1 3-HV under vent-cap shake-flask cultivation.  
 We used the information obtained from previous sections to scale-up our 3-HV production 
under batch and fed-batch bioreactor system. Herein, we used bioprocess engineering approach to 
enable more carbon flux toward succinyl-CoA node (and ultimately propionyl-CoA) by 
simultaneously inhibiting oxidative TCA cycle and deregulating glyoxylate shunt. With these 
developed strategies, we demonstrated effective cell growth, minimum secretion of byproducts, 
and high 3-HV production (up to 10.6 g l-1) in aerobic fed-batch culture. As far as we are aware, 
the level of 3-HV reached in this study is the highest reported for any microbial strain thus far.  
 In our final study, we investigate the feasibility of our developed TCA cycle engineering 




manipulated the non-native Shemin part of heme biosynthetic pathway by downregulating 
essential 5-ALA-consuming reaction using Clustered Regularly Interspersed Short Palindromic 
Repeats interference (CRISPRi), thus considerably preserving intracellular pool of this target 
metabolite. As Shemin pathway synthesized 5-ALA in a one-step reaction catalyzed by molecular 
fusion of succinyl-CoA and glycine, formation of 5-ALA was further improved by channeling 
more carbon toward succinyl-CoA precursor in TCA cycle, reaching high titer of 6.93 g l-1 under 
aerobiosis. To best of our knowledge, the consolidated strain and bioprocess engineering strategy 
reported in this study represents one of the most effective and economical bio-based production of 
5-ALA in E. coli from single carbon source.  
 Collectively, this thesis attempts to highlight the importance and applicability of integrated 
strain engineering and bioprocessing strategies for enhanced bio-based production of industrially 
valuable products. Harnessing this enhanced carbon flux toward succinyl-CoA node and 
employing various modular chain elongation and pathway enzymes can open the avenue for the 
controlled production of various other valuable succinyl-CoA-derived chemicals.  
 
Keywords: Escherichia coli, succinyl-CoA, TCA cycle, glycerol, propionyl-CoA, sleeping beauty 
mutase, propionate, 3-hydroxyvalerate, 5-aminolevulinate, CRISPRi, metabolic engineering, 
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The global demand for renewable energy to meet human social and economic development has 
been increasing at an unprecedented pace. Rapidly emerging technologies surrounding bio-based 
production, which adopts whole-cell biocatalysts to drive chemical conversions, are gaining 
recognition as sustainable and environmentally friendly tools for manufacturing (Weiss et al. 
2012). The use of biocatalysts for chemical production has many advantages, particularly in terms 
of selectivity (i.e., regio-, chemo-, diastereo-, and enantioselectivity) and ability to perform multi-
step reactions which can regenerate cofactors under mild operational conditions (Lin and Tao 
2017). However, the applicability of biological systems is often limited as a consequence of 
inherent nature of cells in general. Cells have evolved vast transcriptional regulations and 
complicated inter-pathway interactions in order to maintain metabolic homeostasis, thus 
considerably restricting carbon flux to desired target metabolites (Nielsen and Keasling 2016). 
Novel biotechnologies such as synthetic biology, genetic engineering, metabolic engineering, and 
systems biology serve as tools to tweak these rigid lines of communication in endogenous 
pathways and allow for more flexible carbon flux aversion. Hence, by improving strain 
performance either through deregulation of natural metabolism or through introduction of 
heterologous pathways, industrial production of value-added chemicals can be significantly 
enhanced. In addition, bio-based production of chemicals permits the use of raw/cheap materials, 
i.e., lignocellulosic or waste substrates, generating a more sustainable and economical conversion 
process. To date, several chemicals have been biologically produced on an industrial scale, 




2010) and even bulk ones such as succinate, 1, 3-propanediol, ethanol, and polyhydroxyalkanoates 
(PHAs) (Hermann et al. 2007).  
 Central metabolism is one of the most conserved features of all living organisms and it can 
be generalized into set of 12 major precursor metabolites (Noor et al. 2010). At each particular 
branch-point node, several other complex pathways are extended for assembling virtually all 
cellular components (i.e., biomass) and natural products. As a result of this high carbon flux 
encompassing large number of reactions, cells have developed many levels of tight regulation for 
governing production of essential products (i.e., amino acids, fatty acids, nucleotides, and 
carbohydrates), making redirection of carbon in central metabolism a rather difficult task (Nielsen 
and Keasling 2016). Consequently, the primary focus of this thesis study is to manipulate carbon 
flux around one of these 12 major precursor metabolites of central metabolism, i.e., succinyl-CoA, 
for biomanufacturing of several value-added chemicals.      
 Succinyl-CoA is an intermediate of tricarboxylic acid (TCA) cycle and it plays an 
important role in the metabolism of fatty and amino acids. In addition to acting as a major 
metabolic branch-point, node of succinyl-CoA is also one of the sites for anaplerotic reactions 
(Lennarz and Lane 2013), which are known to recycle drained intermediates allowing TCA cycle 
flux to proceed without disruption and to facilitate energy production. In Escherichia coli and most 
other bacterial strains, succinyl-CoA can be derived via three oxygen-dependent pathways in the 
TCA cycle, i.e., (i) reductive TCA branch, (ii) oxidative TCA cycle, and (iii) glyoxylate shunt (see 
Chapters 3-6) (Cheng et al. 2013). Under low oxygenic conditions, succinate is synthesized as an 
end-product of mixed acid fermentation via the reductive TCA branch (Thakker et al. 2012), which 
is often metabolically unfavorable due to the restricted availability of reducing equivalents 




accumulate as it is readily consumed in the active oxidative TCA cycle, except for the conditions 
of oxidative stress and/or acetate/fatty-acid consumption under which succinate can be aerobically 
derived via the operational glyoxylate shunt (Thakker et al. 2012). 
 Herein, we implement various strain and bioprocess engineering strategies to build-up 
intracellular production of succinyl-CoA for enhanced production of three distinct industrially 
valuable products, i.e., propionate, 3-hydroxyvalerate (3-HV), and 5-aminolevulinate (5-ALA), in 
genetically tractable E. coli host. The first two products, propionate and 3-HV, were derived from 
common non-native propionyl-CoA precursor, which was synthesized as a result of reactivation 
of dormant endogenous Sleeping beauty mutase (Sbm) pathway by manipulating Sbm operon 
genes (i.e., sbm-ygfD-ygfG-ygfH). The formation of third product, 5-ALA, was made possible via 
implementation of heterologous Shemin or also known as C4 pathway (part of larger heme 
biosynthetic pathway) in E. coli host strain.   
1.1 Research objectives  
 
The primary objectives of this research can be described as follows: 
 
1. Establish a platform for redirecting carbon flux in TCA cycle toward succinyl-CoA and 
Sbm pathway for enhanced biosynthesis of propionate in E. coli 
2. Implement a heterologous 3-HV biosynthetic pathway in E. coli and test the effects of 
biochemical and genetic manipulations on 3-HV production under shake-flask cultivation 
3. Scale-up the production of 3-HV in E. coli using bioprocess engineering strategies under 
batch and fed-batch bioreactor cultivation 
4. Activate non-native Shemin pathway in E. coli and integrate metabolic engineering and  





1.2 Thesis organization 
 
This thesis is comprised of six technical manuscripts corresponding to Chapters 2-6.   
Chapter 2 provides a comprehensive literature summary on current energy problems, 
biomass conversion technologies, specialty chemical production, strain engineering, relevant 
heterologous pathways used in this study, and a brief discussion on glycerol as valuable feedstock.  
Chapter 3 outlines the metabolic and bioprocess engineering strategies for production of 
first value-added chemical (i.e., propionate) of this thesis. In this study, we demonstrate the 
efficacy of TCA cycle engineering in our previously-derived Sbm-activated E. coli host strain. In 
addition to redirecting more carbon toward succinyl-CoA, we also investigate the effects of 
multiple TCA cycle mutants and their ability to secrete propionate. This chaper serves as a proof-
of-concept for carbon flux redistribution toward succinyl-CoA from which all our subsequent 
experimentations are based on.  
Chapter 4 and Chapter 5 are both focused on production of 3-HV in numerous Sbm-
activated E. coli strains. Chapter 4 deals with verifying, constructing, and optimizing 3-HV 
production under different shake-flask conditions. After modular construction of 3-HV 
biosynthetic pathway by establishing efficient Claisen condensation, reduction reaction, and CoA 
removing capabilities, various cultivation conditions were investigated in an attempt to further 
improve 3-HV biosynthesis. Chapter 5, on the other hand, explores various 
biochemical/bioprocessing methods for large-scale 3-HV production in batch and fed-batch 
bioreactor systems. This chapter discusses the effects of integrating TCA cycle engineering and 
aeration conditions in more detail.  
Chapter 6 demonstrates the effects of consolidating strain engineering (i.e., gene silencing 




high-level 5-ALA production using glycerol as the single main structurally-unrelated carbon 
source. This study highlights the advantages of using Clustered Regularly Interspersed Short 
Palindromic Repeats interference (CRISPRi) for repressing essential reactions, such those found 
in heme biosynthetic pathway.  
Chapter 7 concludes the thesis by providing an overview and major findings/results 
obtained throughout the entirety of this thesis work. Different recommendations and future 
prospects are also discussed as means of further engineering microbial cell factories for not only 
improving products from Sbm and heme biosynthetic pathways, but also those derived from 





























2.1 Energy problem  
 
Since the dawn of the Industrial Revolution, large quantities of fossil fuels have been readily 
consumed in effort to power economies and provide unprecedented prosperity to people all across 
the world. Currently, it is estimated that more than 88% of the world’s energy demand is met by 
conventional fuels (i.e., petroleum, coal, and natural gas) (Weiland 2010). Despite the continued 
discovery of global fossil fuel reserves (Abas et al. 2015), these sources of energy are finite and 
non-renewable. At the same time, the steady increase in world population and diminishing levels 
of absolute poverty in developing countries (Cazzuffi et al. 2017; de Janvry and Sadoulet 2010) 
are predicted to evoke a 35% increase in energy demand by the year 2040 (Snow 2013). Similarly, 
another study predicts that, by the year 2035, the energy demand in developing countries is 
expected to increase by 84% (Graham-Rowe 2011). In addition, as a result of unfortunate geo-
political instabilities materializing across the globe, the price of oil has been known to abruptly 
and aggressively fluctuate, further highlighting the dependency of this particular market on 
unpredictable international events.  
In light of ever-increasing demand for fossil fuels, concentrations of greenhouse gases 
(GHG) in the atmosphere are on the rise, with petro-derived carbon dioxide (CO2) being a 
significant contributor (Weiland 2010). While recent technological efforts have been implemented 
to capture certain GHG, i.e., adsorbing by chemicals (e.g., amines and carbonates) (Darunte et al. 
2016) and pre-combustion methods (e.g., chemical looping) (Alalwan et al. 2017), these advances 
are generally regarded as insufficient as the rate of GHG release via fossil fuel combustion will 




nuclear power has been gaining popularity, there are many leading problems associated with its 
use, i.e., no solution for long-term radioactive waste storage or destruction (Lior 2008), and 
proliferation of hazardous nuclear material has become a growing concern over the past decade.  
It is thus evident the world needs to adapt to rapidly changing energy landscape and that 
transitioning to low-carbon energy/net-zero emission system is required for a more economically, 
politically, and environmentally-sustainable future. However, in order to effectively implement 
the production of renewable and sustainable energy, considerable advances have to be made in 
essential engineering materials to overcome the associated economic cost barriers (Swenson 
2008). 
2.2 Biofuel production from biomass 
 
To date, there are many renewable energy sources that are considered to be alternatives to fossil 
fuels, including (but are not limited to) wind or solar power, hydroelectricity, geothermal power, 
and biomass. While many alternatives energy sources are available, biofuels generated from 
biomass are generally more sustainable, have the ability to be stored for transportation, and 
contains nearly zero carbon footprint (Trembly et al. 2010). Biomass is defined as any organic, 
non-fossil material with biological origin, such as plants, agricultural residues, forest/municipal 
wastes, and microbial cells, all of which can potentially serve as sustainable energy sources 
(Abdeshahian et al. 2010).  A recent emerging strategy is to expand biorefinery and 
biotransformation technologies to convert renewable biomass feedstock into clean energy fuels 
and other value-added chemicals (An et al. 2011). Note that biomass represents the largest 
renewable energy source by accounting for more than two-thirds of the green energy supply 




The term biofuel refers to mainly liquid fuels and various blending components that are 
synthesized from biomass substrates (Stöcker 2008). The nature of biofuels are categorized on the 
basis of raw material type and transformation processes, and their features are compared in Table 
2.1. First generation biofuels are type of biofuels that extract energy from edible feedstocks, i.e., 
sugarcane, sugarbeet, maize, wheat, soybean, and soyflower (Scragg 2009). Major challenge 
facing first generation biofuels are their dependency on large areas of land for cultivation purposes. 
It has been extensively reported that first generation biofuels are generally considered undesirable 
sources of energy as growth of food-crop feedstocks can highly conflict with food-security (Singh 
et al. 2011). While second generation biofuels will not directly compete with the food market as 
they are generated from non-edible lignocellulosic biomass, i.e., switchgrass and 
agricultural/forest residues, their production requires harsh physical conditions and extensive land 
usage, reducing their economic feasibility (Singh et al. 2011). Other sources of energy for second 
generation biofuel production include municipal and industrial waste products (i.e., wastewater, 
food waste, crude glycerol, and biomethanol). In spite of significantly reduced costs associated 
with production of organic waste feedstocks, their subsequent biofuel transformation is limited 
due to inconsistencies regarding size/content of the particular feedstock. Alternatively, third 
generation biofuels circumvent major challenges found in first and second generation biofuels, 
namely food competition and land usage, and are produced using algal biomass for photosynthetic 
capture of CO2 and subsequent intracellular synthesis of biofuels (i.e., biodiesel) (Huang et al. 
2009; Saladini et al. 2016; Singh et al. 2011).  Albeit, the production of third generation biofuels 





 Table 2.1: Major characteristics of globally available biomass feedstock 
Feedstock type 
 
Example(s) Advantage(s) Limitation(s) 
Share of total 
biomass energy in 
the world (%) 
Share of total 





Sugarcane, maize High energy content 
Requires arable land, 









Non-competitive with food 
industries 






Microalgae cells Devoid of farming and land 
inputs 







Relatively high PFCE 
potential 






Consequently, the emerging fields of metabolic engineering and synthetic biology have spawn the 
development of fourth generation biofuels which seek to enhance PFCE in genetically altered algea 
and cyanobacteria (Berla et al. 2013; Hays and Ducat 2015). Promising results have recently been 
observed in photosynthetic microbes with engineered metabolic pathways using solar energy and 
TCA cycle intermediates (Halfmann et al. 2014; Savakis and Hellingwerf 2015).  
2.2.1 Biomass conversion technologies and biorefineries 
Biomass-derived fuels and residues can be converted into energy carriers via two major processes, 
i.e., (i) thermo-chemical, and (ii) biochemical conversions. Thermo-chemical conversion is the 
controlled heating/oxidation of biomass which includes combustion pyrolysis (e.g., thermal 
decomposition of biomass), and gasification (e.g., exothermic partial oxidation of biomass) 
technologies (Tanger et al. 2013). Biochemical conversions of biomass involves the use of 
enzymes (e.g., hydrolysis of cellulosic materials), and whole-cell transformation systems using 
microorganisms (e.g., anaerobic digestion and fermentation) for the production of liquid fuels 
(Sharma et al. 2014). Note that due to complex and recalcitrant nature of particular feedstocks, 
primarily lignocellulosic substrates, biorefineries require the implementation of extensive 
pretreatments methods.  
A biorefinery is a facility that integrates conversion processes and equipment to generate 
fuels, power, and chemicals from biomass, and can be classified into three phase groups, i.e., phase 
I, phase II, and phase III  (Fernando et al. 2006). Phase I biorefinery plant has limited processing 
capabilities as it utilizes only one type of feedstock for the production of a single product (e.g., dry 
mill ethanol plant). Phase II biorefinery plant also uses one type of feedstock but, unlike phase I, 
it has the ability to produce multiple end products with more processing flexibilities (e.g., wet 




since it uses a selection of feedstocks to generate an array of products by employing wide-range 
of conversion technologies (e.g., whole-crop biorefineries). Nonetheless, biorefinery concept is 
still in its infancy and requires rigorous research and development in order to improve current 
performance and transformation capabilities (Kamm and Kamm 2004). Note that it is plausible 
that the future direction of biorefineries may be geared toward the production of precursors of only 
high value chemicals or production of raw starting materials that can be used by current chemical 
plants (Fernando et al. 2006).  
2.3 Specialty and fine chemical production 
 
Specialty chemicals are formulations of chemicals that contain one or more fine chemicals as 
active ingredients. Fine chemicals, as opposed to bulk, are of high value and can only be produced 
in small, limited quantities via chemical or biotechnological processes. In comparison to bulk 
chemical structures, fine chemicals are generally complex (i.e., containing aromatic compounds, 
organic amines, and proteogenic/non-proteogenic amino acid groups) and are used in 
pharmaceutical, agricultural, and cosmeceutical industries (Pollak 2011; Saxena 2015). While 
many types of fine chemicals exist in natural environment, only a handful of these chemicals are 
available commercially as their extraction process is considered rather difficult and expensive.  
2.4 Chemical processes 
 
Industrial chemicals are currently derived from fossilized carbon (e.g., oil, coal, and natural gas), 
which is generally regarded as a non-sustainable approach. The chemical industry is based on 
thermal cracking of volatile by-products from crude oil refining (i.e., light hydrocarbons) to form 
ethylene and propylene compounds (Nikolau et al. 2008). In addition to benzene, ethylene and 
propylene are used as major platform chemicals which are subsequently converted via oxidation, 




Vollheim 1993). For the synthesis of fine chemicals, homogenous and heterogeneous palladium 
(Pd) catalysts are typically used to facilitate transformation reactions, including (but not limited 
to) carbonylation of alkenes/dienes, chemoselective hydrogenation, debenzylation, oxidation of 
alkenes/dienes, and Suzuki coupling reactions (Blaser et al. 2001). Needless to say, due to 
hundreds of Pd-catalyzed processes in operation for fine chemical synthesis, the current industrial 
production capabilities would not be possible without this and other precious/expensive metals 
(i.e., platinum).  
2.5 Biological processes 
 
Synthesis of specialty chemicals using microbial cell factories has become a pragmatic alternative 
to conventional chemical production processes as they contain enantiomerically-strict enzymes 
capable of producing limited by-products under mild conditions (Murphy 2012; Raman et al. 
2014). The projected production target of bio-based chemicals and materials in the United States 
(US) for 2020 and 2030 is set to 18 and 25%, respectively (Thompson et al. 2015). In Europe, net 
chemical production from biomass is expected to reach 30% by 2030, up from 10% in 2013 
(Thompson et al. 2015). While functional replacement of petrochemical chemicals by bio-based 
chemicals offer an opportunity to launch novel chemical species, it can also broaden chemical 
products into new applications (Nikolau et al. 2008). The introduction of functional replacement 
of petrochemical chemicals with those that are bio-based have already been proposed, i.e., ethyl 
lactate replacing hydrocarbon solvents (Vu et al. 2006), 2,4-furandicarboxylic acid replacing 
terephthalic acid as a polyester monomer (Moore and Kelly 1978; R O et al. 2018), and glucaric 






2.6 Strain engineering perspectives 
 
The development of microbial systems that merge synthetic biology with genetic/metabolic 
engineering has been on a steady rise over the last couple of decades. Although often prompting 
ambiguous interpretations, synthetic biology, in its basic form, is a concept of reshaping biology 
into hierarchy of abstractions with an intention to integrate biological components into larger 
assemblies by modular design (Leonard et al. 2008). For instance, the hierarchical categorization 
of biological systems into “parts” (i.e., lowest/basic biological function), “devices” (i.e., able to 
carry our certain functions), and “systems” (i.e., combinations of devices that can execute specified 
tasks) are all structuralized in a “chassis” (i.e., host organism) (Figure 2.1). Basically, synthetic 
biology deals with disassembling, constructing, and rearranging of any specific or combination of 
these hierarchial abstractions to enhance programmability or robustness of cells for particular 
undertaking.  
Metabolic engineering is a scientific discipline that deals with direct modification of 
metabolic pathways and their regulatory networks for the microbial production of various target 
biomolecules or chemicals (Schempp et al. 2017; Stephanopoulos 2012). While metabolic 
engineering has a unique industrial dimension of being able to introduce heterologous genes into 
biological hosts for the synthesis of non-native metabolites, it can also be used toward optimization 
of titers and productivity for the development of economical processes (Woolston et al. 2013). 
Starting from the very first successful heterologous gene expression in bacterial host over 45 years 
ago (Cohen et al. 1973) to the more recent advances in metabolic flux analysis, global transcription 
machinery engineering, and design of pathways using computational tools (Woolston et al. 2013), 
metabolic engineering has been highly viewed as a robust tool for production of wide-ranging 




various fuels (i.e., ethanol, butanol, isobutanol, oils, and lipids), organic chemicals (i.e., succinate, 
lactate, butyrate, and isoprene), biopolymers, pharmaceuticals, and specialty chemicals. In terms 
of pragmatics, ten strategies of system metabolic engineering have been previously outlined in 
Nature Biotechnology (Lee and Kim 2015), of which major strain development approaches include 
selection of host strain, metabolic pathway reconstruction (i.e., screening of heterologous gene 
expression), removal of negative regulatory circuits (i.e., point mutations and/or gene knockouts), 
and flux rerouting for precursor optimization (i.e., gene overexpression, knockouts, 
downregulations, etc.). List of several industries that have effectively implemented metabolic 
engineering for chemical production are listed in Table 2.2.  
Improving the yield, titer, and productivity of materials synthesized by engineered 
organisms for commercialization requires further manipulation of microbial physiology and 
metabolism, with special emphasis on carbon and energy balance (Chubukov et al. 2016). 
However, a major challenge facing future research in synthetic biology/metabolic engineering is 
effectively overcoming unpredictable or unstable physiology of engineered microbes. Introducing 
novel biological pathways into host organisms can often result in poor metabolic performance or 
productivity (Wu et al. 2016), which is generally a result of kinetic bottleneck and/or metabolic 
burden on the cell. Adopting fluxomic measurements such as flux balance analysis (FBA) can 
predict cellular phenotypes and biosynthetic yields by taking into account the stoichiometry of 
biochemical reactions and measurement of uptake fluxes (Varma and Palsson 1994). In addition, 
effectively combining FBA with 13C tracing, known as 13C-metabolic flux analysis (13C-MFA) can 
be used to thoroughly measure functional pathways in all respects of metabolic network (Wu et al. 
2016). A more comprehensive understanding of metabolic burdens at different cellular levels can 
















Figure 2.1: Structural framework of synthetic biology. Adopted from (Leonard et al. 2008). 
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Chemical name Application Biological host Companies 
Lysine Feed additive Corynebacterium glutamicum Evonik, ADM, CJ, Ajinomoto 
1,3-Propanediol Chemical building block Escherichia coli Dupont and Tate & Lyle joint venture 
7-ADCA Antibiotic precursor Penicillium chrysogenum DSM 
1,4-Butanediol Chemical building blocl Escherichia coli Genomatica 
Artemisinic acid Anti-malarial drug Saccharomyces cereviciae Sanofi Aventis 
Isobutanol Advanced biofuel Saccharomyces cereviciae Gevo, Butamax 
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2.7 Tricarboxylic acid (TCA) cycle  
 
The tricarboxylic acid (TCA) cycle, also commonly known as Krebs cycle, is one of the major 
biochemical hubs in the cell and is widely recognized to play two key metabolic roles, (i) energy 
production in form of acetyl-CoA oxidation, and (ii) biosynthesis of essential precursors (i.e., 
amino acids) (Cohen 2011). The expression levels of TCA cycle are highly dependent on 
availability of oxygen (Amarasingham and Davis 1965) and carbon source (Gray et al. 1966). 
When oxygen acts as a terminal electron acceptor, the cycle operates in a cyclical manner oxidizing 
substrate to CO2 and forming NADH for respiration (Vuoristo et al. 2015), both of which are 
known to support effective growth. On the other hand, when no terminal electron acceptor is 
available (i.e., during anaerobiosis), the cyclical nature of TCA cycle is disrupted as fumarate 
reductase replaces succinate dehydrogenase to allow for activation of reductive branch, i.e., 
conversion of oxaloacetate to succinyl-CoA. Note that, a functionally complete TCA cycle can be 
formed under oxygen limitation when cells are grown on glycerol with nitrate (acting as terminal 
electron acceptor) supplementation. Growth on acetate or certain fatty acids call for transcriptional 
activation of anaplerotic pathway known as glyoxylate shunt/bypass (Kornberg 1966). Please see 
following chapters for illustrations and detailed descriptions of TCA cycle.  
2.7.1 Engineering of TCA cycle for bio-based chemical production 
As TCA cycle generates important metabolic precursors, this pathway has been readily engineered 
in various organisms for production of industrially valuable chemicals, of which major examples 
include succinic acid (Blankschien et al. 2010; Lin et al. 2005), citric acid (Papagianni 2007), L-
glutamic acid (Hermann 2003),  itaconic acid (Blazeck et al. 2014), and 1,4-butanediol (1,4-BDO) 
(Yim et al. 2011). The potential market for these particular compounds can be broadened if the 




more effective cell factories. For instance, co-expression of genes encoding fumarase (i.e., fumRs) 
from Rhizopus oryzae and fumarate reductase (i.e., Frds1) from Saccharomyces cerevisiae in 
Aspergillus niger had activated reductive TCA pathway from malate to succinate which was 
further used to produce citric acid (de Jongh and Nielsen 2008). Other studies have demonstrated 
the construction of Corynebacterium glutamicum by simultaneously overexpressing native acetyl-
CoA synthase (encoded by acs) and citrate synthase (encoded by gltA) to enhance TCA cycle for 
high titer production of succinic acid (Zhu et al. 2013b). In addition, variety of TCA cycle 
engineering approaches have also been applied in E. coli for succinate production, such as 
chromosomal expression glyoxylate shunt genes (i.e., aceBAK) followed by directed evolution and 
reactivation of phosphophenolpyruvate (PEP) carboxylase (encoded by ppc) (Li et al. 2013b), and 
by targeting the reductive branch arm via deletion of succinate dehydrogenase subunit (encoded 
by sdh) (Zhao et al. 2016). In terms of itaconic acid production, precursor supply was increased 
by overexpression of native TCA cycle-linked enzymes, i.e,. aconitase (encoded by acnB), citrate 
synthase, and PEP carboxylase, in E. coli, leading to higher productivity of this target C5 acid 
(Chang et al. 2017). It was previously demonstrated that higher reducing power can be achieved 
in E. coli by implementing a genome-scale metabolic model to enhance anaerobic operation of 
oxidative TCA cycle for more effective production of 1,4-BDO (Yim et al. 2011). Therefore, as 
TCA cycle is responsible for production of multiple valuable precursors and potential building 
block compounds, careful rewiring and channeling of carbon flux using strain engineering 








2.8 Relevant heterologous pathways  
2.8.1 Sleeping beauty mutase pathway 
A well-documented approach to generating non-native propionyl-CoA in E. coli for the subsequent 
production of value-added fuels and chemicals is by reactivating a dormant Sleeping beauty 
mutase (Sbm) operon (i.e., sbm-ygfD-ygfG-ygfH) (Srirangan et al. 2013; Srirangan et al. 2016a; 
Srirangan et al. 2014). While the metabolic role of Sbm-related pathways (i.e., the methylmanoyl-
CoA pathway) has been studied extensively in propionate-producing bacteria (e.g., Gram positive 
prokaryotes), the exact role it plays in E. coli is still rather ambiguous. Interestingly, E. coli 
contains an intact four-gene cluster operon on the genome but the functional expression of these 
genes are thought to be silent due to an inactive native promoter-operator system (Leadlay 1981) 
and/or evolutionary loss of vitamin B12 dependence. Hence, by activating the Sbm operon in the 
E. coli host genome, the dissimilation of succinyl-CoA is diverted from the tricarboxylic acid 
(TCA) cycle into the Sbm pathway to form propionyl-CoA, as observed in studies outlined in 
subsequent chapters of this report (Akawi et al. 2015). While the functional activities of three of 
the four Sbm operon genes have already been identified (i.e., sbm, encoding a cobalamin-
dependent methylmalonyl-CoA mutase; ygfG, encoding a methylmalonyl-CoA decarboxylase; 
and ygfH, encoding a propionyl-CoA::succinate transferase), the role of the second gene in the 
operon (ygfD) is unknown. A major limitation in the implementation of this pathway in E. coli is 
the limitation of succinyl-CoA, an essential precursor.  
2.8.2 Heme biosynthetic pathway 
Heme biosynthesis is highly conserved across biological kingdoms (Ajioka et al. 2006; Dailey et 
al. 2017; Franken et al. 2011; Hoffman et al. 2003; Obornik and Green 2005; Schobert and Jahn 




documented (Bhagavan and Ha 2015; Layer et al. 2010a; Layer et al. 2010b). Basically, the 
common precursor for biosynthesis of most tetrapyrroles is 5-aminolevulinic acid (5-ALA), which 
can be derived via either of the two unrelated metabolic routes of the C5 and C4 pathways. Note 
that these two pathways differ in only the first 5-ALA-generating step and all subsequent reactions 
toward heme are identical. The C5 pathway, which is found in most bacteria and all archaea/plants, 
is initiated by the ligation of glutamate and tRNAGlu via glutamyl-tRNA synthase (GluTS) and 
subsequent reduction via glutamyl-tRNA reductase (GluTR) to form glutamate-1-semialdehyde 
(GSA). Then, GSA is transaminated by glutamate-1-semialdehyde-2,1-aminomutase (GSAM) to 
generate 5-ALA. On the other hand, in the Shemin pathway (also known as the C4 pathway) which 
is found in humans, animals, fungi, and certain proteobacteria, 5-ALA is synthesized in a one-step 
reaction catalyzed by 5-ALA synthase (ALAS or HemA) for molecular fusion of succinyl-CoA 
and glycine (Figure 2.2). 
 For the biosynthesis of various tetrapyrroles from 5-ALA, including heme (Figure 2.2), 
two 5-ALA molecules will be first fused to form the monopyrrole of porphobilinogen (PBG) via 
porphobiliongen synthase (PBGS or HemB). Next, an enzyme porphobiliongen deaminase (PBGD 
or HemC) catalyzes the stepwise polymerization of four molecules of PBG to form an unstable 
intermediate of the linear tetrapyrrole called hydroxymethylbilane (HMB). Furthermore, a small 
enzyme called uroporphyrinogen-III synthase (Cosynthase or HemD) catalyzes the cyclization of 
HMB with the inversion of ring D to generate the first cyclic tetrapyrrole (porphyrin) intermediate 
of the pathway, i.e., uroporphyrinogen-III (URO-III). The intermediate URO-III is a major branch 
intermediate for various sub-pathways leading to a wide range of porphyrins (Mathews et al. 
2001). Four acetate side-chains (localized at C-2, C-7, C-12, and C-18) in URO-III are sequentially 




groups in a newly formed coproporphyrinogen-III (CPP-III). Note that HemE appears to be the 
first known decarboxylating enzyme that does not require a cofactor (de Verneuil et al. 1983). The 
propionate side-chains (localized at C-3 and C-8) in CPP-III are subsequently converted to vinyl 
groups by different types of coproporphyrinogen-III oxidases (CPOs), generating 
protoporphyrinogen-IX (PPG-IX). The two different types of CPOs used for this catalysis are 
oxygen-dependent HemF and oxygen-independent HemN, respectively. Next, a 
protoporphyrinogen-IX oxidase (PPO or HemG) catalyzes the six-electron oxidation of PPG-IX 
to generate a conjugated double-system tetrapyrrole called protoporphyrin-IX (PP-IX). Lastly, an 


























3-Hydroxyacids (3-HAs) or β-hydroxyacids are a type of carboxylic acids that contain a hydroxyl 
group at the β-position of the aliphatic carbon atom (Yu and Van Scott 2004). 3-HAs are bio-
synthesized in various groups of organisms (i.e., bacteria, yeast, fungi, and microalgae) in which 
they serve as intermediates of the β-oxidation pathway (Jin et al. 1992; Matsumoto and Nagashima 
1984). In humans, 3-HAs are major urinary metabolites derived from fatty acid metabolism and 
can thus serve as indicators of certain liver disorders (Dhar et al. 2008; Natarajan and Ibdah 2018). 
Industrially, 3-HAs are part of larger group of fine chemicals that can act as building blocks for 
the synthesis of various antibiotics (i.e., carbapenem and di-O-methylelaiophylidene), vitamins, 
pheromones (Guevara-Martínez et al. 2015; Perez-Zabaleta et al. 2016; Ren et al. 2010), and are 
naturally produced as components of polyhydroxyalkanoates (PHA) biopolymers. Most common 
straight-chain 3-HAs are 3-hydroxypropionate (3-HP), 3-hydroxybutyrate (3-HB), and 3-
hydroxyvalerate (3-HV).  
3-Hydroxybutyrate (3-HB) is a four carbon, optically active 3-HA that is commonly used 
to synthesize chiral compounds such as amino acids, vitamins, pheromones, and biodegradable 
solvents (Li et al. 2013a). Medical and pharmaceutical industry use 3-HB as platform chemical for 
the production of various antibiotics and optically active drugs (Chen and Wu 2005). In addition, 
3-HB is one of the most commonly studied 3-HAs and serves as a monomeric constituent of 
biologically produced poly(3-hydroxybutyrate) (PHB), which is also the most common type of 
PHA (Tokiwa and Ugwu 2007). High yield of 3-HB is generated by natural PHA producing 
bacteria, i.e., Cupriavidus necator, by providing the cells with cultivation conditions that favour 
intracellular production of depolymerases (Tokiwa and Ugwu 2007). However, depolymerized 




microbial commercialization of 3-HB and other long-chain 3-HAs. Two methods were developed 
to overcome this natural metabolism of 3-HB, (i) extraction and chemical degradation of PHB 
homopolymer (Lee et al. 1999), and (ii) direct synthesis of 3-HB monomers using metabolic 
engineering strategies.  The use of harsh chemicals and conditions (i.e., strong acids) can induce 
subsequent derivatization of 3-HB and thus further complicate the conversion process. 
Biosynthesis of 3-HB using direct 3-hydroxyacid pathway by functionally expressing wild-type 
genes in a well-characterized E. coli host has been successful in the past (Guevara-Martínez et al. 
2015; Gulevich et al. 2017; Jarmander et al. 2015; Perez-Zabaleta et al. 2016). 3-HB producing 
pathway includes multiple metabolic reactions, i.e., (i) homo-fusion of two acetyl-CoA moieties 
via β-ketothiolase, generating acetoacetyl-CoA, (ii) reduction of acetoacetyl-CoA to (S)/(R)-3-
hydroxybutyryl-CoA (3-HB-CoA) by an (S)/(R)-specific dehydrogenase, and an additional final 
reaction in which (S)/(R)-3-HB-CoA is converted to (S)/(R)-3-HB using a CoA removing enzyme.  
3-Hydroxyvalerate (3-HV) is a five carbon, optically active 3-HA and, much like 3-HB, is 
readily used in the pharmaceutical industry as a building block for chiral drug production (i.e., 
renin inhibitors) (Williams et al. 1991). While PHB contains a high degree of crystallinity and 
melting temperature, its industrial applications are limited due to structural inflexibility which 
makes subsequent processing a challenging task (Luo et al. 2006; Matsusaki et al. 2000). Attempts 
at overcoming these physical property challenges have been made by incorporating longer-chain 
hydroxyalkanoates such as 3-hydroxyvalerate (3-HV) into PHB chain to generate poly(3-
hydroxybutyrate-co-3-hydroxyvalerate) (PHBV). PHBV is a biocopolymer that contains higher 
ductility and flexibility than the PHB homopolymer, and can thus further extend the industrial 
applications of PHAs (Matsusaki et al. 2000; Srirangan et al. 2016b). Note that the only bacteria 




Gram positive species belonging to genera Nocardia and Rhodococus (Chen et al. 2011), albeit, 
with very low 3-HV yields. Since most studies on microbial production of 3-HV have focused 
primarily on its incorporation into PHBV copolymer, few reports on biosynthesis of solely 3-HV 
have been documented thus far. Structurally, 3-HV can be synthesized using the same enzymes as 
those catalyzing production of 3-HB, as outlined in Chapter 4 and 5. However, the fusion of an 
odd-chain propionyl-CoA with acetyl-CoA is required in the Claisen condensation step in order to 
initialize 3-HV production. A major contributor of high production costs can be attributed to 
exogenous supplementation of structurally-related carbon sources (i.e., propionate, valerate, and 
levulinate) required for synthesizing intracellular propionyl-CoA moiety. Microbial synthesis of 
3-HV has first been demonstrated in Candida rugosa via β-hydroxylation of valerate (Hasegawa 
J et al. 1981). Moreover, significant improvements in 3-HV were observed in consumption of 
levulinate as a structurally-related carbon source by recombinant Pseudomonas putida (Martin and 
Prather 2009). To date, there is only one study that presents 3-HV production from structurally-
unrelated carbon source (i.e., glycerol) by activating threonine biosynthesis pathway in 
recombinant E. coli (producing a high titer of roughly 1.20 g l-1 3-HV) (Tseng et al. 2010).  
2.10 Glycerol as a feedstock  
 
As a carbon source, glycerol offers several distinctive advantages over traditional fermentable 
sugars. Due to the high degree of reduction (reductance κ = 4.67), glycolytic degradation of 
glycerol generates approximately twice the number of reducing equivalents (i.e., NADH) 
compared to xylose and glucose (κ = 4) (Murarka et al. 2008; Yazdani and Gonzalez 2007). 
Therefore, harnessing glycerol metabolism not only results in higher yields but also expands the 
repertoire of chemicals and fuels generated from microbial systems. However, microbial 




the NAD+/NADH ratio) must be properly maintained through terminal transfer of electrons to 
internally produced organic compounds as opposed to molecular oxygen (Celińska 2010; Yazdani 
and Gonzalez 2007). As a result, only select organisms (e.g., Clostridium pasteurianum and 
Klebsiella pneumoniae) are capable of fermenting glycerol anaerobically. Glycerol metabolism 
generates intermediates such as dihydroxyacetone (DHA) and 3-hydroxypropionaldehyde (3-
HPA), and reduced end-products such as ethanol, 1,2-propanediol (1,2-PDO), 1,3-propanediol 
(1,3-PDO), and 2,3-butanediol (2,3-BDO) (Clomburg and Gonzalez 2013; Murarka et al. 2008; 
Yazdani and Gonzalez 2007). 
 Due to the high reductance of glycerol, the overall redox balance within a cell is a vital 
principle that governs the nature and quantity of metabolites upon glycerol dissimilation 
(Clomburg and Gonzalez 2013), presenting a key challenge for the microbial breakdown process. 
The naturally-occurring fermentative metabolism of glycerol has been thoroughly studied in the 
Enterobacteriaceae family (Booth 2005; Murarka et al. 2008). Under fermentative conditions, 
microorganisms must be metabolically capable of consuming glycerol in the absence of external 
electron acceptors. Since glycerol has a greater degree of reduction than cell biomass (κ = 4.3), 
there is an excess of reducing equivalents that remain unbalanced (Clomburg and Gonzalez 2013). 
Specifically, for 1.1 mM of glycerol incorporated into cell mass, 0.6 mM reducing equivalents 
would be generated as a result. This issue is not present in other common carbohydrates, such as 
glucose and xylose, since their degree of reduction is lower than that of cell biomass. Furthermore, 
excess electrons cannot be consumed through the production of reduced products such as ethanol 
or succinate as their production from glycerol is already redox-balanced. Thus, to achieve redox 
poise, there must be a metabolic pathway that generates more reduced products for consuming 




1994; Schütz and Radler 1984) and 1,2-PDO (Clomburg and Gonzalez 2011) via ATP-neutral 
pathways results in successful anaerobic dissimilation of glycerol due to the highly reduced nature 
of these metabolites (κ = 5.33). See Figure 2.3 for an outline of glycerol dissimilation pathways.  
 Like other small, uncharged molecules, glycerol is known to cross the cytoplasmic 
membrane via two mechanisms, i.e., (i) passive diffusion when in high concentrations, and (ii) 
facilitated diffusion with the aid of a transport protein (i.e., GlpF) under low concentrations (da 
Silva et al. 2009; Sun et al. 2008). Intracellular glycerol is subsequently metabolized either in the 
presence of electron acceptors (i.e., respiratory branch) or in the absence of electrons acceptors 
(i.e., fermentative branch) (Gonzalez et al. 2008) (Figure 2.3). Fermentative (anaerobic) 
metabolism of glycerol has been previously reported in microbes belonging to the genera of 
Klebsiella sp. (Forage and Foster 1982; Homann et al. 1990), Citrobacter sp. (Daniel et al. 1995; 
Seifert et al. 2001), Clostridium sp. (Abbad-Andaloussi et al. 1995; Biebl 2001; Macis et al. 1998), 
Lactobacillus sp. (Talarico et al. 1990), and recently in E. coli (Dharmadi et al. 2006; Murarka et 
al. 2008). The natural fermentative bioconversion of glycerol to a more reduced metabolite, such 
as 1,3-PDO, occurs both reductively and oxidatively in Klebsiella sp., Citrobacter sp., Clostridium 
sp., and certain strains of Lactobacilli sp. (da Cunha and Foster 1992; da Silva et al. 2009). In the 
oxidative branch, NAD+-dependent glycerol dehydrogenase (GlyDH) catalyzes the transformation 
of glycerol to dihydroxyacetone (DHA), which is subsequently phosphorylated by a DHA kinase 
(DHAK) to form dihydroxyacetone phosphate (DHAP) (Shams Yazdani and Gonzalez 2008). In 
Klebsiella sp. and Citrobacter sp., the genes encoding enzymes specific to glycerol metabolism 





 E. coli can ferment glycerol anaerobically in a pH-dependent manner without external 
electron acceptors (Booth 2005; Dharmadi et al. 2006). The internal availability of CO2 generated 
by formate hydrogen lyase (FHL)-mediated oxidation of formate enables E. coli to anaerobically 
metabolize glycerol. For E. coli to synthesize small molecules and fatty acids, it requires a steady 
supply of bicarbonate/CO2 substrates. Lowering the pH of the media as well as potassium and 
phosphate concentrations under fermentative conditions activates the transcription of FHL and 
subsequently achieves the cellular requirement for CO2 upon formate accumulation (Murarka et 
al. 2008). In addition, formate oxidation produces hydrogen which can contribute to reducing 
equivalent accumulation that other redox-balanced pathways, such as succinate and ethanol-
generating pathways, are unable relieve (Dharmadi et al. 2006). Also, under fermentative 
conditions, E. coli can recycle the excess hydrogen formed via FHL complex by functional 
expression of native hydrogenase isoenzymes Hyd-1 and Hyd-2 (Murarka et al. 2008; Sawers et 
al. 1985; Sawers and Boxer 1986).   
 Under respiratory conditions, glycerol dissimilation to DHAP can advance through two 
different two-step routes, (i) the aerobic GlpK-GlpD pathway, or (ii) the anaerobic GlpK-GlpABC 
pathway (Blankschien et al. 2010; Durnin et al. 2009). In either case, G3P is first synthesized via 
phosphorylation of glycerol by GlpK (encoded by glpK) at the expense of ATP (Murarka et al. 
2008). Through the aerobic pathway, GlpD (encoded by glpD), a plasma membrane-associated 
homodimer, generates DHAP via oxidation of G3P. On the other hand, DHAP is synthesized from 
G3P by GlpABC (encoded by glpABC) in an anaerobic fashion. In addition to being a precursor 
to DHAP, G3P also serves as a precursor for lipid biosynthesis or production of other metabolites 






















Figure 2.3: Schematic representation of the major glycerol catabolism pathways in bacteria. 
Blue arrows represent reactions in the fermentative branch, displaying both reductive and oxidative 
routes; green arrows represent reactions in the respiratory branch; red arrows represent reactions 
in the 1,2-PDO pathway; and gold arrows represent reactions in the 2,3-BDO pathway. Solid line: 
direct bioconversion step; dashed line: multi-step bioconversion. Enzyme abbreviations: ACK, 
acetate kinase; ADH, bifunctional aldehyde/alcohol dehydrogenase; ae-G3PDH, aerobic glycerol-
3-phosphate dehydrogenase; AKR, aldo-keto reductase; ALDH, aldehyde dehydrogenase; ALDC, 
α-acetolactate decarboxylase; ALS, α-acetolactate synthase; an-G3PDH, anaerobic glycerol-3-
phosphate dehydrogenase; AR, acetoin reductase; DODHt, diol dehydratase; DHAK, 
dihydroxyacetone kinase; FHL, formate hydrogen lyase; FRD, fumarate reductase; GDHt, 
glycerol dehydratase; GK, glycerol kinase; GlpF, glycerol diffusion facilitator; GlyDH, glycerol 
dehydrogenase; LDH, lactate dehydrogenase; MGR, methylglyoxal reductase; MGS, 




PduP, propionaldehyde dehydrogenase; PduW, propionate kinase; PFL, pyruvate formate-lyase; 
PTA, phosphotransacetylase; PK, pyruvate kinase; 1,2-PDOOR; 1,2-propanediol oxidoreductase; 
1,3-PDOOR, 1,3-propanediol oxidoreductase. Chemical intermediates and product abbreviations: 
α-AL, α-acetolactate; acetyl-P, acetyl phosphate; DHA, dihydroxyacetone; DHAP, 
dihydroxyacetone phosphate; G3P, glycerol-3- phosphate; MG, methylglyoxal; PEP, 
phosphoenolpyruvate; 1,2-PDO, 1,2-propanediol; 1,3-PDO, 1,3-propanediol; 3-HP, 3-
hydroxypropionate; 3-HP-CoA, 3-hydroxypropionyl-CoA; 3-HP-P, 3-hydroxypropionyl 





High-level heterologous production of propionate in engineered 




Growing socio-economic and environmental concerns over petro-based chemical products and 
their production processes have sparked a wide range of technological interests in bio-based 
production from renewable resources. With rapid biotechnological advances, particularly in 
synthetic biology, systems biology, genetic engineering, metabolic engineering, and 
bioinformatics, etc., considerable strategies have been developed over the past decades to 
customize microbial cell factories for bio-based production (Cho et al. 2015). Consequently, a 
number of bio-based commodity products (Fabbri et al. 2018) have been made on industrial scales, 
such as organic acids (Show et al. 2015), amino acids (Ikeda 2003), and biodegradable polymers 
(Chen 2009). Propionate, the anion of propionic acid, is a three-carbon carboxylic acid with a wide 
array of applications in the food (as a preservative, additive or flavoring agent) and chemical (as 
an intermediate for chemical synthesis of herbicides, pharmaceuticals, dyes, textile and rubber 
products, plastics, plasticizers, cosmetics, and perfumes) industries. While industrial production 
of propionate has long been carried out by chemical hydrocarboxylation of ethylene or oxidation 
of propionaldehyde for decades, various biotechnological production methods have been proposed 
(Ahmadi et al. 2017). Thus far, microbial production of propionate are conducted using natural 
producers of anaerobic Propionibaterium spp., such as Propionibacterium freudenreichii, 
Propionibacterium acidipropionici, and Propionibacterium shermanii. In spite of a high 
propionate-producing capacity, this genus can suffer various technological limitations, such as low 




formation complicating downstream processing (Gonzalez-Garcia et al. 2017). As a result, the use 
of genetically tractable bacterium Escherichia coli as a host for heterologous production of 
propionate has been proposed (Akawi et al. 2015). 
Natural E. coli produce neither propionate nor its precursor propionyl-CoA. Hence, we 
derived a propanologenic (i.e., 1-propanol-producing) E. coli strain by activating the genomic 
Sleeping beauty mutase (Sbm) operon (Srirangan et al. 2013; Srirangan et al. 2014). The Sbm 
operon consists of four genes, i.e., sbm-ygfD-ygfG-ygfH, and the encoding enzymes are involved 
in extended dissimilation of succinyl-CoA for fermentative production of 1-propanol and 
propionate with propionyl-CoA as a metabolic hub (Figure 3.1). Using this propanologenic E. coli 
strain, we demonstrated biosynthesis of 1-propanol (Srirangan et al. 2014) and propionate (Akawi 
et al. 2015) from “unrelated” carbons, such as glucose and glycerol. As the non-native propionyl-
CoA exists in this propanologenic E. coli strain, we further implemented relevant synthetic 
pathways for heterologous production of various propionyl-CoA-derived chemicals, including 
butanone (Srirangan et al. 2016a) and poly(3-hydroxybutyrate-co-3-hydroxyvalerate) (Srirangan 
et al. 2016b). Given successful demonstration of propionate biosynthesis in engineered E. coli 
(Akawi et al. 2015), technological limitations existed. As the Sbm pathway is not physiologically 
essential in E. coli, the intracellular level of propionyl-CoA often remains low, limiting propionate 
biosynthesis. In addition, propionate biosynthesis via the Sbm pathway in the propanologenic E. 
coli was conducted under a limited oxygen supply, such as microaerobic conditions, hindering cell 
growth and therefore culture performance. The major objective of this study is to tackle these 




















Figure 3.1: Schematic representation of engineered propionate production pathway in E. coli 
from glycerol. Metabolic pathways outlined: glycerol dissimilation, central metabolism, and 
oxidative TCA cycle (in black); reductive branch of TCA cycle (in blue); Sbm pathway (in purple); 
glyoxylate shunt (in light orange/brown). Metabolite abbreviations: DHAP, dihydroxyacetone 
phosphate; Gly, glyoxylate; G3P, glycerol-3-phosphate; PEP, phosphoenolpyruvate. Protein 
abbreviations: AceA, isocitrate lyase; AceB, malate synthase A; AceK, isocitrate dehydrogenase 
kinase/phosphatase; AckA, acetate kinase; AdhE, aldehyde-alcohol dehydrogenase; FrdABCD, 
fumarate reductase complex; FumB, fumarate hydratase class I, anaerobic; IclR, AceBAK operon 
repressor; IDH, isocitrate dehydrogenase; MDH, malate dehydrogenase; PckA, 
phosphoenolpyruvate carboxykinase; PPC, phosphoenolpyruvate carboxylase; Pta, 
phosphotransacetylase; Sbm, methylmalonyl-CoA mutase; SdhABCD, succinate dehydrogenase 
complex; SucAB,  2-oxoglutarate dehydrogenase; SucCD,  succinyl coenzyme A synthetase;  




The Sbm pathway diverts from the tricarboxylic acid (TCA) cycle at the node of succinyl-
CoA. Hence, high-level propionate biosynthesis presumably relies on effective diversion of the 
carbon flux from the TCA cycle into the Sbm pathway. Since propionate was synthesized under 
relatively anaerobic conditions, succinyl-CoA is derived from succinate via SucCD in the 
reductive (i.e., reverse) TCA direction. Hence, succinate becomes a plausible target for metabolic 
manipulation. However, since succinate is involved in the central metabolism in a complex manner 
and its formation can be mediated through multiple oxygen-dependent pathways, manipulation of 
the carbon flux around this C4-compound can be challenging. Herein, we targeted several TCA 
cycle genes encoding enzymes near the succinyl-CoA node for genetic manipulation in order to 
investigate how the TCA carbon flux gets diverted into the Sbm pathway. With such mechanistic 
understanding of the relevant metabolic flows, we developed consolidated metabolic engineering 
and bioprocessing strategies to enhance such carbon flux redirection for high-level propionate 
biosynthesis while reducing byproduct acetate accumulation, thus demonstrating a potential 
industrial applicability of the developed bioprocess.  
3.2 Materials and Methods 
3.2.1 Bacterial strains and plasmids 
Bacterial strains and deoxynucleic acid (DNA) primers used in this study are listed Table 3.1. 
Genomic DNA from bacterial cells was isolated using the Blood & Tissue DNA Isolation Kit 
(Qiagen, Hilden, Germany). Standard recombinant DNA technologies were applied for molecular 
cloning (Miller 1992). Taq DNA polymerase was obtained from New England Biolabs (Ipswich, 
MA, USA). All synthesized oligonucleotides were obtained from Integrated DNA Technologies 
(Coralville, IA, USA). DNA sequencing was conducted by the Centre for Applied Genomics at 




derivation of all mutant strains in this study and E. coli DH5α was used as a host for molecular 
cloning. 
 Activation of the genomic Sbm operon to generate propanologenic E. coli CPC-Sbm was 
described previously (Srirangan et al. 2014). Knockouts of the genes, including frdB (encoding 
fumarate reductase iron-sulfur subunit, FrdB), aceA (encoding isocitrate lyase, AceA), sucD 
(encoding succinate-CoA ligase, SucD), sdhA (encoding succinate dehydrogenase complex 
flavoprotein subunit A, SdhA), and iclR (encoding transcriptional AceBAK operon repressor, 
IclR) were introduced into CPC-Sbm by P1 phage transduction (Miller 1992) using the appropriate 
Keio Collection strains (The Coli Genetic Stock Center, Yale University, New Haven, CT, USA) 
as donors (Baba et al. 2006). To eliminate the co-transduced FRT-KnR-FRT cassette, the 
transductants were transformed with pCP20 (Cherepanov and Wackernagel 1995), a temperature 
sensitive plasmid expressing a flippase (Flp) recombinase. Upon Flp-mediated excision of the KnR 
cassette, a single Flp recognition site (FRT “scar site”) was generated. Plasmid pCP20 was then 
cured by growing cells at 42°C. The genotypes of derived knockout strains were confirmed by 
colony polymerase chain reaction (PCR) using the appropriate verification primer sets listed in 
Table 3.1.  
3.2.2 Media and bacterial cell cultivation 
All medium components were obtained from Sigma-Aldrich Co. (St Louis, MO, USA) except 
yeast extract and tryptone which were obtained from BD Diagnostic Systems (Franklin Lakes, NJ, 
USA). E. coli strains, stored as glycerol stocks at -80°C, were streaked on lysogeny broth (LB) 
agar plates and incubated at 37°C for 14-16 hours.  
 For shake-flask cultivations, single colonies were picked from LB plates to inoculate 30-




The cultures were shaken at 37°C and 280 rpm in a rotary shaker (New Brunswick Scientific, NJ, 
USA) and used as seed cultures to inoculate 220 ml LB media at 1% (v/v) in 1-L conical flasks. 
This second seed culture was shaken at 37°C and 280 rpm until an optical density of 0.80 OD600 
was reached. Cells were then harvested by centrifugation at 9,000 ×g and 20°C for 10 minutes and 
resuspended in 30-ml modified M9 production media. The suspended culture was transferred into 
a 125-ml screwed cap or vented cap plastic production flasks and incubated at 30°C at 280 rpm in 
a rotary shaker. Unless otherwise specified, the modified M9 production medium contained 30 g 
l-1 glycerol, 3.0 g l-1 succinate, 5 g l-1 yeast extract, 10 mM NaHCO3, 1 mM MgCl2, 0.2 µM 
cyanocobalamin (vitamin B12), 5th dilution of M9 salts mix (33.9 g l-1 Na2HPO4, 15 g l
-1 KH2PO4, 
5 g l-1 NH4Cl, 2.5 g l
-1 NaCl ), 1,000th dilution of Trace Metal Mix A5 (2.86 g l-1 H3BO3, 1.81 g l
-
1 MnCl2•4H2O, 0.222 g l
-1 ZnSO4•7H2O, 0.39 g l
-1 Na2MoO4•2H2O, 79 µg l
-1 CuSO4•5H2O, 49.4 
µg l-1 Co(NO3)2•6H2O), and supplemented with 0.1 mM isopropyl β-D-1-thiogalactopyranoside 
(IPTG). All shake-flask cultivation experiments were performed in triplicate. 
For bioreactor cultivations, single colonies were picked from LB plates to inoculate 30-mL 
super broth (SB) medium (32 g l-1 tryptone, 20 g l-1 yeast extract, and 5 g l-1 NaCl) in 125 mL 
conical flasks. Overnight cultures were shaken at 37°C and 280 rpm in a rotary shaker (New 
Brunswick Scientific, NJ, USA) and used as seed cultures to inoculate 220 mL SB media at 1% 
(v/v) in 1 L conical flasks. This second seed culture was shaken at 37°C and 280 rpm for 14-16 
hours. Cells were then harvested by centrifugation at 9,000×g and 20°C for 10 minutes and 
resuspended in 50 mL fresh LB media. The suspended culture was used to inoculate a 1 L stirred 
tank bioreactor (containing two Rushton radial flow disks as impellers) (CelliGen 115, Eppendorf 
AG, Hamburg, Germany) at 30°C and 430 rpm. The semi-defined production medium in the batch 
bioreactor contained 30 g l−1 glycerol, 0.23 g l−1 K2HPO4, 0.51 g l





48.1 mg l−1 K2SO4, 1.52 mg l
−1 FeSO4, 0.055 mg l
−1 CaCl2, 2.93 g l
−1 NaCl, 0.72 g l−1 tricine, 10 
g l−1 yeast extract, 10 mM NaHCO3, 0.2 μM cyanocobalamin (vitamin B12) and 1,000th dilution 
(i.e., 1 ml l−1) trace elements (2.86 g l−1 H3BO3, 1.81 g l
−1 MnCl2• 4H2O, 0.222 g l
−1 ZnSO4• 7H2O, 
0.39 g l−1 Na2MoO4• 2H2O, 79 μg l
−1 CuSO4• 5H2O, 49.4 μg l
−1 Co(NO3)2• 6H2O) (Neidhardt et 
al. 1974), and supplemented with 0.1 mM isopropyl β-D-1-thiogalactopyranoside (IPTG). For fed-
batch cultivation, the production strain was first cultivated in a batch mode, as described above, 
followed by three feeding phases, in each of which ~15 g l-1 glycerol was supplemented for 
extended cultivation until complete glycerol dissimilation. Microaerobic and semiaerobic 
conditions were maintained by purging air into the headspace and bulk culture, respectively, at 0.1 
vvm, designated as aeration level I (AL-I) and AL-II. Aerobic conditions were maintained by 
sparging air into the bulk culture at 1 vvm (AL-III) or 2-4 vvm (AL-IV). The pH of the production 
culture was maintained at 7.0 ± 0.1 with 30% (v/v) NH4OH and 15% (v/v) H3PO4.  
3.2.3 Analysis  
Culture samples were appropriately diluted with 0.15 M saline solution for measuring cell density 
in OD600 using a spectrophotometer (DU520, Beckman Coulter, Fullerton, CA). Cell-free medium 
was prepared by centrifugation of the culture sample at 9,000×g for 5 minutes, followed by filter 
sterilization using a 0.2 µM syringe filter. Extracellular metabolites and glycerol were quantified 
using high-performance liquid chromatography (HPLC) (LC-10AT, Shimadzu, Kyoto, Japan) 
with a refractive index detector (RID; RID-10A, Shimadzu, Kyoto, Japan) and a chromatographic 
column (Aminex HPX-87H, Bio-Rad Laboratories, CA, USA). The HPLC column temperature 
was maintained at 35°C and the mobile phase was 5 mM H2SO4 (pH 2) running at 0.6 mL min
-1. 
The RID signal was acquired and processed by a data processing unit (Clarity Lite, DataApex, 




Table 3.1: E. coli strains and oligonucleotides used in this study 
 
Name Description, relevant genotype or  primer sequence (5’  3’) Source 
E. coli host strains   
     DH5α F−, endA1, glnV44, thi-1, recA1, relA1, gyrA96, deoR, nupG φ80d lacZ∆acZd ladlacZYA – 
argF) U169, hsdR17(rK-mK +), λ- 
Lab stock 
     BW25141 F-, ∆(araD-araB)567, ∆lacZ4787(::rrnB-3), ∆(phoB-phoR)580, λ-, galU95, ∆uidA3::pir + , 
recA1, endA9 (del-ins)::FRT, rph-1, ∆(rhaD-rhaB)568, hsdR514 
(Datsenko and Wanner 2000) 
     BW25113 F-, ∆(araD-araB)567, ∆lacZ4787(::rrnB-3), λ-, rph-1, ∆(rhaD-rhaB)568, hsdR514 (Datsenko and Wanner 2000) 
     BW∆ldhA-CTRL BW25113 ldhA null mutant (Srirangan et al. 2016a; 
Srirangan et al. 2014) 
     CPC-Sbm BW∆ldhA, Ptrc::sbm (i.e., with the FRT-Ptrc cassette replacing the 204-bp upstream of the 
Sbm operon) 
(Akawi et al. 2015) 
     CPC-Sbm∆frdB frdB null mutant of CPC-Sbm This study 
     CPC-Sbm∆aceA aceA null mutant of CPC-Sbm This study 
     CPC-Sbm∆sucD sucD null mutant of CPC-Sbm This study 
     CPC-Sbm∆sdhA sdhA null mutant of CPC-Sbm This study 
     CPC-Sbm∆iclR iclR null mutant of CPC-Sbm This study 
     CPC-Sbm∆frdB∆aceA frdB and aceA null mutant of CPC-Sbm This study 
     CPC-Sbm∆sdhA∆iclR sdhA and iclR null mutant of CPC-Sbm This study 
Primers   
     v-ldhA GATAACGGAGATCGGGAATGATTAA;  
GGTTTAAAAGCGTCGATGTCCAGTA 
(Akawi et al. 2015) 
     v-sdhA CTCTGCGTTCACCAAAGTGT;  
ACACACCTTCACGGCAGGAG 
This study 
     v-iclR GGTGGAATGAGATCTTGCGA;  
CCGACACGCTCAACCCAGAT 
This study 
     c-frt AGATTGCAGCATTACACGTCTTGAG;  
CCAGCTGCATTAATGAATCGGGCCATGGTCCATATGAATATCCTCC 
(Srirangan et al. 2014) 








3.3 Results  
3.3.1 Effects of succinate supplementation and oxygenic condition on propionate biosynthesis 
Using CPC-Sbm with the activated Sbm operon (Srirangan et al. 2014) as the control strain, we 
first investigated the effects of succinate supplementation and oxygenic condition on propionate 
biosynthesis (Figure 3.2). Two types of shake-flasks with either a screw-cap (i.e., being more 
anaerobic) or vent-cap (i.e., being more aerobic) were used to modulate the oxygenic condition of 
bacterial cultures. The screw-cap shake-flask culture of CPC-Sbm with no succinate 
supplementation produced 1.1 g l-1 propionate with a C3 yield of 7.13%. Supplementing the screw-
cap shake-flask culture of CPC-Sbm with 3 g l-1 succinate resulted in a significant increase in 
propionate titer (2.86 g l-1) with a nearly 2-fold of the C3 yield (13.3%) in comparison to the un-
supplemented CPC-Sbm culture, suggesting that the metabolic activity of the Sbm pathway can 
be limited by succinate availability. On the other hand, C3 metabolites were hardly produced under 
more aerobic conditions in the vent-cap shake-flask culture of CPC-Sbm, indicating that the 
metabolic activity of the Sbm pathway in the control strain CPC-Sbm was favored by anaerobic 
conditions. Interestingly, the effects of succinate supplementation were still observable under more 
aerobic culture conditions, with a trace amount of propionate (0.57 g l-1) being detected in the vent-
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Figure 3.2: Physiological effects of succinate supplementation and oxygenic conditions on 
propionate formation in shake-flasks cultivation of CPC-Sbm. Top panel represents cell 
growth (OD600), glycerol/succinate consumption, and C3 yield (%) while bottom panel represents 
titers of acetate and propionate after 48h shake-flask cultivations. Unlabeled columns represent 




a Measured cell density after 48h cultivation using spectrophotometer (OD600), time 0h cell density was kept at ~5.00 
b Concentration of glycerol and succinate at time 0h was ~30 g l-1 and 3 g l-1, respectively 
c Defined as the percentage of the total C3 products (i.e., propionate and 1-propanol) theoretical yield based on the consumed glycerol/succinate 
   NA not applicable 
   ND not detected 






3.3.2 Metabolic routes in the TCA cycle leading to propionate biosynthesis 
As the Sbm pathway diverts out of the TCA cycle via the succinyl-CoA node, it is critical to 
understand how the carbon flux gets redirected into the Sbm pathway for propionate biosynthesis. 
To do this, we knocked out several genes encoding enzymes near the succinyl-CoA node to 
observe their genetic effects on propionate biosynthesis (Figure 3.3; Note that all cultivations were 
conducted in screw-cap shake-flasks except the last one.). These selective enzymes catalyze 
various critical reactions in the three major TCA routes toward succinate, i.e., oxidative TCA 
cycle, reductive TCA branch, and glyoxylate shunt. Compared to the control strain CPC-Sbm, 
inactivation of the reductive TCA branch by mutating frdB in CPC-Sbm∆frdB resulted in notable 
reduction of propionate titer (0.79 g l-1) and C3 yield (4.88%). On the other hand, inactivation of 
the glyoxylate shunt by mutating aceA in CPC-Sbm∆aceA minimally affected propionate 
biosynthesis, with 1.18 g l-1 propionate and 7.95% C3 yield, compared to the control strain CPC-
Sbm. Simultaneous inactivation of both the reductive TCA branch and glyoxylate shunt by 
mutating frdB and aceA in the double mutant CPC-Sbm∆frdB∆aceA further deteriorate, but 
insignificantly, propionate biosynthesis, compared to CPC-Sbm∆frdB. Furthermore, inactivation 
of the oxidative TCA cycle by mutating sdhA in CPC-Sbm∆sdhA significantly improved 
propionate biosynthesis, with both the propionate titer (2.38 g l-1) and C3 yield (15.17%) being 
approximately doubled in comparison to the control strain CPC-Sbm. Interestingly, the 
succinate/succinyl-CoA interconversion in the TCA cycle was determined essential for an 
operational Sbm pathway as mutating sucD in CPC-Sbm∆sucD completely abolished propionate 
biosynthesis with a 0% C3 yield. These results suggest that, under the cultivation conditions in the 
screw-cap shake-flask, the reductive TCA branch contributed a major portion of the carbon flux 














































































































































Figure 3.3: Manipulation of TCA carbon flux by targeting several genes encoding enzymes 
near succinate node. Top panel represents cell growth (OD600), glycerol consumption, and C3 
yield (%) while bottom panel represents titers of acetate and propionate reached after 48h shake-
flask cultivations. Unlabeled columns represent screw-cap shake-flask cultivations. All values 
are reported as means ± SD (n = 3).   
 
 
a Measured cell density after 48h cultivation using spectrophotometer (OD600), time 0h cell density was kept at ~5.00 
b Concentration of glycerol at time 0h was ~30 g l-1  
c Defined as the percentage of the total C3 products (i.e., propionate and 1-propanol) theoretical yield based on the consumed glycerol 
   ND not detected 






3.3.3 Carbon flux redirection from the TCA cycle into the Sbm pathway 
Normally, the glyoxylate shunt would be inactive as expression of the key enzymes in this 
pathway, i.e., AceBAK, is negatively regulated by the IclR regulator. Deregulating the glyoxylate 
shunt by mutating iclR in CPC-Sbm∆iclR significantly improved propionate biosynthesis to 3.33 
g l-1, which was approximately 3-fold that of the control strain CPC-Sbm, with a much increased 
C3 yield to 17.1% and reduced acetate accumulation. Considering the two single mutants with 
significantly improved propionate biosynthesis, i.e., CPC-Sbm∆sdhA and CPC-Sbm∆iclR, we 
derived a double mutant CPC-Sbm∆sdhA∆iclR leading to a further increased propionate titer to 
3.68 g l-1 and C3 yield to 19.7% in screw-cap shake-flask cultures. Interestingly, cultivating CPC-
Sbm∆sdhA∆iclR under a more aerobic condition in vent-cap shake-flasks not only further 
improved propionate biosynthesis (4.79 g l-1 propionate and 21.3% C3 yield) but also drastically 
reduced acetate accumulation to 1.04 g l-1, compared to 6.19 g l-1 acetate for the control strain 
CPC-Sbm in screw-cap shake-flask cultures. The results suggest successful carbon flux redirection 
from the TCA cycle to the Sbm pathway for enhanced propionate biosynthesis in Sbm∆sdhA∆iclR 
under cultivation conditions in the vent-cap shake-flask. 
3.3.4 Batch cultivation in bioreactor for propionate biosynthesis 
As the oxygenic condition of the cultivation appeared to critically affect propionate biosynthesis 
and the oxygenic condition of a shake-flask culture could only be trivially modulated using either 
screw-cap or vent-cap, we further cultivated selective strains in a bioreactor with more defined 
aerobic/anaerobic levels. Using the control strain CPC-Sbm, bioreactor cultivation in a batch mode 
under three levels of aeration, i.e., AL-I, AL-II, and AL-III from low to high, was first used to 
characterize propionate biosynthesis (Figure 3.4). In general, the aeration level affected bacterial 




under AL-I, AL-II, and AL-III, respectively), cell growth (final cell density reaching 17.4, 21.9, 
and 22.1 OD600 under AL-I, AL-II, and AL-III, respectively), and acetate accumulation [final 
acetate titer reaching 9.32 g l-1 (45.3% acetate yield), 5.95 g l-1 (30.2% acetate yield), and 6.95 g l-
1 (35.9% acetate yield) under AL-I, AL-II, and AL-III, respectively]. In contrast, propionate 
biosynthesis was highly dependent on the oxygenic condition with the final propionate titer 
reaching 3.67 g l-1 (14.4% propionate yield), 1.81 g l-1 (7.43% propionate yield), 0 g l-1 (0% 
propionate yield) under AL-I, AL-II, and AL-III, respectively. These results were consistent with 
our shake-flask study and suggest that propionate biosynthesis in the control strain CPC-Sbm was 
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a Measured cell density (OD600) throughout cultivation period using spectrophotometer, time 0h cell density was kept in the range of 1.5-2.0 
b Defined as the percentage of acetate/propionate theoretical yield based on the consumed glycerol   






Figure 3.4: Investigating the effects of varying aeration levels on propionate production in 
bioreactor cultivation of CPC-Sbm. Aeration conditions (from left to right): Aeration level I 
(AL-I), aeration level II (AL-II), and aeration level III (AL-III). Time profiles of (a) cell growth 
(OD600), (b) glycerol consumption and metabolite production, and (c) percentage of 
acetate/propionate metabolites theoretical yield based on consumed glycerol. All values are 
reported as means ± SD (n = 2). 
In contrast, our shake-flask study showed that propionate biosynthesis in the double mutant 
CPC-Sbm∆sdhA∆iclR was rather effective under a high oxygenic condition. Hence, we conducted 
three batches of bioreactor aerobic cultivation of CPC-Sbm∆sdhA, CPC-Sbm ∆iclR, and CPC-
Sbm∆sdhA∆iclR under AL-III (Figure 3.5). Compared to the control strain CPC-Sbm which 
produced no propionate under AL-III, mutating sdhA in CPC-Sbm∆sdhA led to defective carbon 
utilization (consuming only 19.8 g l-1 glycerol after 23 h cultivation), poor cell growth (final cell 
density reaching only 13.8 OD600), no propionate biosynthesis, and a high acetate accumulation 
(final acetate titer reaching 9.71 g l-1 accounting for 76.4% acetate yield) under AL-III. On the 
other hand, compared to the control strain CPC-Sbm under AL-III, inactivation of iclR in CPC-
Sbm∆iclR hardly affected glycerol dissimilation, cell growth, and acetate accumulation of the 
culture, with an exception of producing 4.11 g l-1 propionate (17.0% propionate yield). The results 
suggest that activation of the glyoxylate shunt via the iclR mutation resulted in more carbon flux 
redirection toward succinate and subsequently into the Sbm pathway, particularly under a high 
oxygenic condition. Propionate biosynthesis was significantly enhanced to 11.7 g l-1 (48.3% 
propionate yield) with a much reduced acetate accumulation upon aerobic cultivation of the double 
mutant CPC-Sbm∆sdhA∆iclR under AL-III, suggesting more effective carbon flux redirection into 
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 a Measured cell density (OD600) throughout cultivation period using spectrophotometer, time 0h cell density was kept in the range of 1.5-2.0 
b Defined as the percentage of acetate/propionate theoretical yield based on the consumed glycerol   
NA not applicable  






Figure 3.5: Manipulation of TCA cycle for propionate production under AL-III conditions. 
Strains tested (from left to right): CPC-Sbm∆sdhA, CPC-Sbm∆iclR, and CPC-Sbm∆sdhA∆iclR. 
Time profiles of (a) cell growth (OD600), (b) glycerol consumption and metabolite production, 
and (c) percentage of acetate/propionate metabolites theoretical yield based on consumed 
glycerol. All values are reported as means ± SD (n = 2).   
3.3.5 Fed-batch cultivation for enhanced propionate biosynthesis 
Using CPC-Sbm∆sdhA∆iclR, we further conducted fed-batch cultivation by extending the existing 
batch with three pulse feedings, each at 15 g l-1 glycerol, under AL-III (Figure 3.6). In Feeding 1, 
cells continued to grow and the fed glycerol was effectively utilized for propionate biosynthesis 
with a high propionate yield of 60.2% and no acetate accumulation. In subsequent Feeding 2 and 
Feeding 3, the biosynthetic capacity of propionate steadily declined with propionate yields being 
reduced to 32.7% and 19.0%, respectively. The deteriorated propionate biosynthesis occurred with 
acetate over-accumulation to a final titer of 11.0 g l-1 which could be associated with a limited 
oxygenic condition. Nevertheless, the AL-III fed-batch culture achieved a high final propionate 
titer of 26.8 g l-1. To potentially minimize acetate accumulation, we conducted another fed-batch 
cultivation of CPC-Sbm∆sdhA∆iclR under AL-IV by increasing the air purging rate to 2 vvm 
during the batch phase and to 4 vvm during the three feeding phases (Figure 3.7). In comparison 
to the AL-III fed-batch culture, the rates of cell growth and glycerol dissimilation for the AL-IV 
fed-batch culture slightly increased with a marginally reduced acetate accumulation, leading to a 
better propionate biosynthesis. A very high level of propionate biosynthesis with 73.1% propionate 
yield was also observed in Feeding 1 of the AL-IV fed-batch culture, whereas the subsequent 
Feeding 2 and Feeding 3 still showed a steady decline in propionate biosynthesis with propionate 
yields of 49.5% and 31.2%, respectively. Note that the reduced acetate accumulation may have 
contributed to the enhanced propionate biosynthesis for the AL-IV fed-batch culture which 



















































































































Figure 3.6: Fed-batch cultivation of CPC-Sbm∆sdhA∆iclR under extended AL-III 
conditions. Time profiles of (a) cell growth (OD600), (b) glycerol consumption and metabolite 
production, and (c) percentage of acetate/propionate metabolites theoretical yield based on 
consumed glycerol during each feeding phase. Dotted vertical lines in panels A and B separate 
batch, feeding 1, feeding 2, and feeding 3 stages of fermentation. All values are reported as means 
± SD (n = 2).   
 
a Measured cell density (OD600) throughout cultivation period using spectrophotometer, time 0h cell density was kept in the range of 1.5-2.0 
b Defined as the percentage of acetate/propionate theoretical yield based on the consumed glycerol   

































































































































Figure 3.7: Fed-batch cultivation of CPC-Sbm∆sdhA∆iclR under AL-IV conditions. Time 
profiles of (a) cell growth (OD600), (b) glycerol consumption and metabolite production, and (c) 
percentage of acetate/propionate metabolites theoretical yield based on consumed glycerol during 
each feeding phase. Dotted vertical lines in panels A and B separate batch, feeding 1, feeding 2, 
and feeding 3 stages of fermentation. Black arrow indicates the point of airflow switch from 2 to 
4 vvm. All values are reported as means ± SD (n = 2).  
 
a Measured cell density (OD600) throughout cultivation period using spectrophotometer, time 0h cell density was kept in the range of 1.5-2.0 
b Defined as the percentage of acetate/propionate theoretical yield based on the consumed glycerol   








As the results of succinate supplementation for the CPC-Sbm culture (Figure 3.2) suggest that 
propionate biosynthesis could be potentially limited by succinate availability, we derived several 
mutants by targeting selective TCA genes encoding enzymes near the succinyl-CoA node for 
manipulation in order to further understand how the carbon flux was diverted from the TCA cycle 
to the Sbm pathway. SucCD are TCA enzymes catalyzing the interconversion of succinate and 
succinyl-CoA. Though mutating sucCD (encoding SucCD) can potentially disrupt the TCA cycle 
in both oxidative and reductive directions, sucCD are not essential genes since the physiologically 
required succinyl-CoA can still be derived via SucAB (Yu et al. 2006). However, succinyl-CoA 
derived from this half oxidative TCA branch cannot be funneled into the Sbm pathway since CPC-
Sbm∆sucD produced no propionate with 0% C3 yield, suggesting that not only succinate 
availability but also the conversion from succinate to succinyl-CoA in the reductive TCA branch 
were critical for carbon flux diversion into the Sbm pathway for propionate biosynthesis. 
 In E. coli, succinate is synthesized via three oxygen-dependent pathways in the TCA cycle, 
i.e., (i) reductive TCA branch, (ii) oxidative TCA cycle, and (iii) glyoxylate shunt. Under 
anaerobic conditions, the dissimilated carbon from glycolysis enters the TCA cycle in the form of 
phosphoenolpyruvate (PEP) and subject to carboxylation to form oxaloacetate, and then proceeds 
with reactions in the reductive TCA branch to generate succinate as a final product (Cheng et al. 
2013). Although the reductive TCA branch can potentially yield high-level succinate, this pathway 
is generally unfavorable as it is limited by the availability of reducing equivalents (i.e., NADH) 
(Skorokhodova et al. 2015). On the other hand, under aerobic conditions, acetyl-CoA derived from 
glycolysis enters the oxidative TCA cycle to generate succinate as a cycle intermediate  (Thakker 




generated alternatively via the glyoxylate shunt (Thakker et al. 2012), which is stimulated upon 
transcriptional activation of the aceBAK operon and negatively regulated by the IclR repressor 
(Nègre et al. 1992; Sunnarborg et al. 1990). Hence, the glyoxylate shunt can be deregulated by 
mutating the repressor-encoded gene iclR. Note that, in E. coli, the glyoxylate shunt is operational 
under aerobic conditions (generating oxidative stresses) while consuming acetate or fatty acids 
(Cheng et al. 2013). Both the shake-flask (Figure 3.2) and bioreactor (Figure 3.4) results clearly 
show that propionate biosynthesis via the Sbm pathway in the control strain CPC-Sbm was favored 
by anaerobic conditions and was minimal under aerobic conditions, suggesting that the reductive 
TCA branch was the main carbon flux contributor toward the Sbm pathway. This claim was further 
corroborated by (i) minimally affected propionate biosynthesis and C3 yield upon inactivation of 
the glyoxylate shunt in CPC-Sbm∆aceA, (ii) reduced propionate biosynthesis and C3 yield upon 
inactivation of the reductive TCA branch in CPC-Sbm∆frdB and (iii) significantly reduced 
propionate biosynthesis and C3 yield upon inactivation of both the reductive TCA branch and 
glyoxylate shunt in CPC-Sbm∆frdB∆aceA (Figure 3.3). Finally, mutating sucD blocked the carbon 
flux toward succinyl-CoA via both the reductive TCA branch and glyoxylate shunt, and 
completely abolished propionate biosynthesis in CPC-Sbm∆sucD, further suggesting the critical 
role that SucD and its associated succinate-succinyl-CoA interconversion step played in the carbon 
flux redirection into the Sbm pathway. 
Interestingly but rather unexpectedly, inactivation of the oxidative TCA cycle significantly 
enhanced propionate biosynthesis and C3 yield in CPC-Sbm∆sdhA (Figure 3.3), presumably due 
to more active reductive TCA branch since the glyoxylate shunt was likely inactive under this 
genetic background and shake-flask culture conditions. The results of CPC-Sbm∆sdhA, along with 




strain CPC-Sbm (Figure 3.2 and 3.4), suggest that the carbon flux contribution from the oxidative 
TCA cycle toward propionate biosynthesis was minimal. On the other hand, mutating iclR to 
deregulate glyoxylate shunt significantly enhanced propionate biosynthesis in CPC-Sbm∆iclR 
(Figure 3.3), suggesting that the glyoxylate shunt could be an alternative metabolic route 
contributing carbon flux toward the Sbm pathway. Combining the two mutations of ∆sdhA and 
∆iclR could further drive the entire carbon flux arising from the glyoxylate shunt toward the Sbm 
pathway via the reductive TCA branch rather than the oxidative TCA cycle, further enhancing 
propionate biosynthesis in CPC-Sbm∆sdhA∆iclR (Figure 3.3). The enhancement was even more 
pronounced when this double mutant was cultivated under higher aerobic conditions which 
stimulate the glyoxylate shunt.  
While propionate biosynthesis in CPC-Sbm was favored by anaerobiosis under AL-I in a 
bioreactor, the low oxygenic level seriously retarded cell growth, resulting in acetate accumulation 
(Figure 3.4). The accumulation of acetate, derived from acetyl-CoA, could potentially limit 
dissimilated carbon flux from glycolysis toward the reductive TCA branch (at the PEP node) and 
then into the Sbm pathway (Figure 3.1). While the retarded cell growth and acetate accumulation 
could be resolved upon marginally increasing the oxygenic level through cultivation of CPC-Sbm 
under AL-II (Figure 3.4), the resolution was at the expense of reduced propionate biosynthesis. 
Further increasing the oxygenic level to cultivate CPC-Sbm under AL-III completely abolished 
propionate biosynthesis though cell growth was effective (Figure 3.4), implying that more 
dissimilated carbon flux upon glycolysis was directed toward the acetyl-CoA node to form acetate, 
rather than toward the PEP node into the reductive TCA branch and Sbm pathway.  
The mutant strain CPC-Sbm∆sdhA with an inactivated TCA oxidative cycle had retarded 




Previous studies also showed that substantial inhibition of the TCA cycle under a high oxygen 
exposure upon disruption of the succinate dehydrogenase complex (encoded by sdhABCD) in E. 
coli, resulting in reduced cell growth and metabolic activity (Guest 1981; Steinsiek et al. 2011). 
On the other hand, glyoxylate shunt could serve as an alternative route to drive the TCA cycle 
under aerobic conditions, and mutating iclR enhanced the metabolic activity of glyoxylate shunt, 
resulting in not only vigorous cell growth but also decent propionate biosynthesis in CPC-
Sbm∆iclR under AL-III (Figure 3.5). The relatively low propionate yield was primarily associated 
with the still active TCA oxidative cycle in CPC-Sbm∆iclR, resulting in diversion of the carbon 
flux arising from glyoxylate shunt at the succinate node to both oxidative and reductive TCA 
branches. Importantly, the flux diversion could be prevented by further blocking the oxidative 
TCA cycle such that the carbon flux was effectively redirected toward succinyl-CoA and then into 
the Sbm pathway in CPC-SbmsdhAiclR under AL-III (Figure 3.5). Such carbon flux redirection 
was ineffective when the oxidative TCA cycle was functional, resulting in reduced and even no 
propionate biosynthesis under AL-III in CPC-SbmiclR (Figure 3.5) and CPC-Sbm (Figure 3.4), 
respectively. Also, note that the severely retarded glycerol dissimilation and cell growth for CPC-
SbmsdhA could be complemented by the iclR mutation, suggesting that both the oxidative TCA 
cycle and glyoxylate shunt contributed to active TCA operation for sustained cell growth under 
aerobic conditions. Finally, note that the issue of acetate accumulation was less severe for CPC-
SbmiclR and much improved for CPC-SbmsdhAiclR, suggesting that the enhanced glyoxylate 
shunt and disrupted oxidative TCA cycle could not only facilitate the carbon flux redirection 
described above but also acetyl-CoA utilization, thereby reducing acetate formation. As the Sbm 




biosynthesis in CPC-Sbm under AL-III was primarily associated with the shortage of succinate 
precursor for propionate biosynthesis. 
Using the double mutant CPC-Sbm∆sdhA∆iclR, we further demonstrated its excellent 
propionate-producing capacity through fed-batch cultivation under aerobic conditions of AL-III 
(Figure 3.6) and AL-IV (Figure 3.7). In particular, during certain feeding stages, such as Feeding 
1 under AL-III and AL-IV, in which propionate biosynthesis was effective with high propionate 
yields of 60.2% and 73.1%, respectively, which are even comparable to those reached by natural 
producers (Gonzalez-Garcia et al. 2017). Note that propionate biosynthesis was active throughout 
the three feeding phases of both fed-batch cultures. Nevertheless, the overall propionate production 
was limited by acetate accumulation, particularly during the Feeding 2 and 3 phases in the AL-III 
fed-batch culture. Such carbon spill issue was shown to be associated with oxygen limitation since 
increasing the aeration rate in the AL-IV fed-batch culture could moderately reduce acetate 
accumulation with further enhanced propionate biosynthesis, achieving a high final propionate 
titer at 30.9 g l-1, which is the highest reported for E. coli thus far, with an overall propionate yield 
of 49.7%. Note that increasing the culture aerobicity can potentially enable cells to recycle the 
accumulated acetyl-CoA (thereby reduce acetate accumulation) for biosynthesis through enhanced 
glyoxylate shunt, which involves acetyl-CoA as a co-substrate and is typically active under aerobic 
conditions (Ahn et al. 2016; Renilla et al. 2012). Hence, our results suggest that the Sbm pathway 
can be metabolically active under both anaerobic and aerobic conditions. The molecular and 
metabolic engineering approaches presented in this study are potentially applicable to bio-based 







Heterologous production of 3-hydroxyvalerate in engineered 




3-Hydroxyacids are a group of valuable fine chemicals as potential building blocks for the 
production of various antibiotics, vitamins, pheromones, and aromatic derivatives (Fonseca et al. 
2019; Mori 1981; Nahar et al. 2009; Toshiyuki and Takeshi 1987), due to their structural nature 
containing two reactive functional groups, i.e., hydroxyl and carboxyl groups, and the reactivity 
of introducing an extra chiral carbon. Currently, industrial production of 3-hydroxyacids are 
primarily conducted via two chemical processes: i.e., (i) selective oxidation through Sharpless’ 
asymmetric epoxidation and subsequent hydroxylation (Ren et al. 2010; Spengler and Albericio 
2014) and (ii) reduction of 3-ketoesters (Noyori et al. 2004). Additionally, chemical degradation 
of polyhydroxyalkanoates (PHAs), which are biopolymers naturally made in select 
microorganisms, via acid methanolysis, fractional distillation, and saponification, has been 
reported for the preparation of 3-hydroxyacids (de Roo et al. 2002). However, bio-based 
production of 3-hydroxyacids has recently gained attention due to the development of biocatalysts 
that can potentially enhance the structural variety, yield, and enantioselectivity of the product. 
Basically, bio-based production of 3-hydroxyacids is carried out in two ways: i.e., (i) 
depolymerization of PHAs in natural producing hosts (Anis et al. 2017; Biernacki et al. 2017) and 
(ii) direct biosynthesis in natural or engineered microorganisms (Tseng et al. 2010; Tseng et al. 
2009). Since biological depolymerization of PHAs is a complex and expensive approach, direct 
biosynthesis of 3-hydroxyacids is regarded as a more feasible option for industrial application. 3-




common 3-hydroxyacid. Structurally, 3-HB can be directly biosynthesized via Claisen 
condensation of two acetyl-CoA moieties to form acetoacetyl-CoA followed by subsequent 
reduction and CoA removal (Figure 4.1 and Figure 4.2), and the associated key enzymes, e.g., 
acetoacetyl-CoA thiolase (PhaA) and acetoacetyl-CoA dehydrogenase (PhaB), exist in several 
natural PHA-producing microorganisms (Table 4.1) (Taroncher-Oldenburg et al. 2000).  
While it is generally perceived that longer-chain 3-hydroxyacids are more biologically 
active than shorter-chain ones, their biosynthesis faces various technological and economic 
challenges that ultimately limit their industrial applications. In particular, 3-hydroxyvalerate (3-
HV), a C5-counterpart of 3-HB, serves as a potential building block for the production of 
pharmaceuticals, such as renin inhibitors (Williams et al. 1991). It is also desirable to include 3-
HV monomers into the PHB chain to form poly(3-hydroxybutyrate-co-3-hydroxyvalerate) 
(PHBV), a biocopolymer more ductile, flexible, and tougher than the PHB homopolymer (Lau et 
al. 2014; Snell and Peoples 2009). Structurally, 3-HV can be derived based on a biosynthetic 
pathway similar to that of 3-HB (Figure 4.1 and Figure 4.2) except one acetyl-CoA precursor 
moiety is replaced with propionyl-CoA. However, propionyl-CoA is an uncommon metabolic 
intermediate for the vast majority of microorganisms. As a result, biosynthesis of 3-HV or 3-HV-
containing biocopolymers requires supplementation of related, but often expensive, carbons such 
as propionate, valerate, 3-hydroxynitrile, and levulinate (Martin and Prather 2009), significantly 
increasing the production cost. To date, only one metabolic study reported microbial production 
of 3-HV using unrelated carbon sources by extending the threonine biosynthetic pathway to form 
propionyl-CoA in bacterium Escherichia coli (Tseng et al. 2010).  
Herein, we report an alternative approach to engineer E. coli strains for heterologous 




propanologenic (i.e., 1-propanol-producing) E. coli strain with its genomic Sleeping beauty mutase 
(Sbm) operon being activated was used as the production host (Srirangan et al. 2013; Srirangan et 
al. 2014). The Sbm operon consists of four genes, i.e., sbm-ygfD-ygfG-ygfH, whose encoding 
enzymes are involved in extended dissimilation of succinate for fermentative production of 1-
propanol or propionate with propionyl-CoA as a metabolic hub (Figure 4.1) (Froese et al. 2009; 
Haller et al. 2000). Note that propionyl-CoA is a key precursor to 3-HV and does not normally 
exist in natural microorganisms. Biosynthesis of 3-HV involves three major enzymatic reactions 
(Figure 4.2), i.e., (i) hetero-fusion of acetyl-CoA and propionyl-CoA molecules (i.e., Claisen 
condensation) via β-ketothiolase, generating 3-ketovaleryl-CoA, (ii) reduction of 3-ketovaleryl-
CoA to chiral 3-hydroxyvaleryl-CoA (3-HV-CoA) by an enantiomer-specific dehydrogenase 
(ESD), and (iii) conversion of 3-HV-CoA to 3-HV via a CoA-removing enzyme. To enhance 3-
HV production, we first targeted 3-hydroxyacid biosynthesis pathway by identifying and cloning 
relevant genes for functional expression. Then, we identified potential genetic, metabolic, and 
bioprocessing factors limiting 3-HV biosynthesis in E. coli. Finally, we developed metabolic 
engineering strategies by redirecting more carbon flux toward the Sbm pathway and various key 
E. coli host genes involved in the tricarboxylic acid (TCA) cycle were manipulated for the carbon 






























Figure 4.1: Schematic representation of natural and engineered pathways in E. coli using 
glucose or glycerol as the carbon source. Proteins targeted for mutation are in red. Metabolic 
pathways outlined: glycolysis, TCA cycle, fermentative/respiratory branch of glycerol utilization 
pathway (in black); engineered 3-hydroxyacid pathways (in green); engineered Sleeping beauty 
mutase pathway (in purple). Metabolite abbreviations: 3-HB, 3-hydroxybutyrate; 3-HV, 3-
hydroxyvalerate; ACE, acetaldehyde; Acetyl-P, acetyl-phosphate; DHA, dihydroxyacetone; 
DHAP, dihydroxyacetone phosphate; Fructose-1,6-BP, fructose-1,6-bisphosphate; Fructose-6-P; 
fructose-6-phosphate; G3P, glycerol-3-phosphate; Glucose-6-P; glucose-6-phosphate; PEP, 
phosphoenolpyruvate. Protein abbreviations: AceA, isocitrate lyase; AceB, malate synthase A; 
AceK, isocitrate dehydrogenase kinase/phosphatase; AckA, acetate kinase; AdhE, aldehyde-
alcohol dehydrogenase; ACN, aconitase; DhaKLM, dihydroxyacetone kinase; FrdABCD, 
fumarate reductase complex; FumA, fumarate hydratase class I (aerobic); FumB, fumarate 
hydratase class I (anaerobic); FumC, fumarate hydratase class II; GldA, glycerol dehydrogenase; 
GlK, glucose kinase; GlpABC, anaerobic glycerol-3-phosphate dehydrogenase; GlpD, aerobic 
glycerol-3-phosphate dehydrogenase; GlpK, glycerol kinase; GltA, citrate synthase; GPI, glucose-
6-phosphate isomerase; Hpr, phosphocarrier protein;  ICD, isocitrate dehydrogenase; IclR, 
AceBAK operon repressor; IDH, isocitrate dehydrogenase; IDH-P, isocitrate dehydrogenase-
phosphate; Ipd, lipoamide dehydrogenase; MDH, malate dehydrogenase; PckA, 
phosphoenolpyruvate carboxykinase; PDH, pyruvate dehydrogenase; PFK, phosphofructokinase; 
PFL, pyruvate formate lyase; PK, pyruvate kinase; PPC, phosphoenolpyruvate carboxylase; Pta, 
phosphotransacetylase; PtsI, PTS enzyme I;  Sbm, methylmalonyl-CoA mutase; SdhABCD, 
succinate dehydrogenase complex; SucAB,  2-oxoglutarate dehydrogenase; SucCD,  succinyl 

























Figure 4.2: Schematic representation of engineered three-step 3-hydroxyacid pathways. 
Origin and function of enzymes involved in the 3-hydroxyacid producing pathways can be found 
in Table 4.1. Protein abbreviations: BktB, beta-ketothiolase; BktBαβ, PHA-specific beta-
ketothiolase – alpha and beta subunits; Buk, butyrate kinase; Hbd, beta-hydroxybutyryl-CoA 
dehydrogenase; Pct, acetate/propionate CoA-transferase; PhaA, acetoacetyl-CoA thiolase; PhaB, 







Table 4.1: List of relative enzymes, their origin, and enzymatic functions in 3-hydroxyacid biosynthetic pathway 
 
3-HA pathway Enzyme(s) Gene(s) 
(locus_tag)a 
Source organism Function(s) 
3-HB production               3-HV production 
Step 1:  
Claisen condensation 




Homofusion of 2 acetyl-
CoA moieties                                                                          







Homofusion of 2 acetyl-
CoA moieties                                                                          












Homofusion of 2 acetyl-
CoA moieties                                                                          
Heterofusion of acetyl-CoA and 
propionyl-CoA 
Step 2:  
Enantiomer-specific 
reduction (ESR) 








CoA to (R)-3HB-CoA  
Reduction of 3-ketovaleryl-CoA 












CoA to (S)-3HB-CoA  
Reduction of 3-ketovaleryl-CoA 
to (S)-3HV-CoA  
Step 3:  
CoA removal 
Acyl-CoA thioesterase II  tesB 
(AW869_16290) 
Escherichia coli  
BW25141 
Hydrolysis of (S) and 
(R)-3HB-CoA to racemic 
3-HB 
Hydrolysis of (S) and (R)-3HV-











Catalyze the conversion 




Catalyze the conversion of (R)-3-
HV-CoA to (R)-3-HV-P, 






Clostridum propionicum  
DSM 1682 
Removes CoA moieties 
to generate racemic  
3-HB (reversible 
reaction) 
Removes CoA moieties to 
generate racemic  
3-HV (reversible reaction) 




4.2 Materials and Methods 
4.2.1 Bacterial strains and plasmids 
A comprehensive list of all bacterial strains, plasmids, and DNA primers used in this chapter can 
be found in Table 4.2. Genomic DNA from number of bacterial strains was isolated using the 
Blood & Tissue DNA Isolation Kit (Qiagen, Hilden, Germany). Standard recombinant DNA 
technologies were applied for molecular cloning (Miller 1992). All plasmids were constructed by 
Gibson enzymatic assembly (Gibson et al. 2009). Phusion HF and Taq DNA polymerases were 
obtained from New England Biolabs (Ipswich, MA, USA). All synthesized oligonucleotides were 
obtained from Integrated DNA Technologies (Coralville, IA, USA). DNA sequencing was 
conducted by the Centre for Applied Genomics at the Hospital for Sick Children (Toronto, 
Canada). E. coli BW25113 was the parental strain for derivation of all mutant strains in this study 
and E. coli DH5α was used as a host for molecular cloning. The ldhA gene (encoding lactate 
dehydrogenase) was inactivated in BW25113, generating BW∆ldhA, with the intention of reducing 
lactate accumulation (Srirangan et al. 2014).  
Activation of the genomic Sbm operon in BW∆ldhA to generate propanologenic E. coli 
CPC-Sbm was described previously (Srirangan et al. 2014). Knockouts of the genes, including 
glpK, glpD, glpABC, gldA, ptsI, dhaKLM, frdB, aceA, sucD, sdhA, and iclR were introduced into 
CPC-Sbm by P1 phage transduction (Miller 1992) using the appropriate Keio Collection strains 
(The Coli Genetic Stock Center, Yale University, New Haven, CT, USA) as donors (Baba et al. 
2006). To eliminate the co-transduced FRT-KmR-FRT cassette, the transductants were 
transformed with pCP20 (Cherepanov and Wackernagel 1995), a temperature sensitive plasmid 
expressing a flippase (Flp) recombinase. Upon Flp-mediated excision of the KmR cassette, a single 




growing cells at 42°C. The genotypes of derived knockout strains were confirmed by colony PCR 
using the appropriate verification primer sets listed in Table 4.2. 
 The phaAB operon was amplified by polymerase chain reaction (PCR) using the primer set 
g-phaAB and the genomic DNA of wild-type Cupriavidus necator ATCC 43291 as the template. 
The amplified operon was Gibson–assembled (Note that “assembled” is used for subsequent 
appearance) with the PCR-linearized pTrc99a using the primer set g-pTrc-phaAB to generate 
pTrc-PhaAB. All genes inserted into pTrc99a vector were under the control of the Ptrc promoter. 
The DNA fragments phaA and phaB from pTrc-PhaAB were individually PCR-amplified using 
the primer sets g-phaA and g-phaB, and then assembled with the PCR-linearized pTrc99a using 
the corresponding primer sets (i.e., g-pTrc-phaA and g-pTrc-phaB), generating pTc-PhaA and 
pTrc-PhaB, respectively. Plasmid pK-BktB-Hbd-TesB was previously constructed in our lab by 
PCR-amplifying bktB from C. necator ATCC 43291, hbd from Clostridium acetobutylicum ATCC 
824, and tesB from E. coli BW25141 using the corresponding primer sets (i.e., g-bktB, g-hbd, and 
g-tesB), followed by assembling all three PCR-amplified fragments with the PCR-linearized 
pK184 using the primer set g-pK-bktB-hbd-tesB. All genes inserted into pK184 vector were under 
the control of the Plac promoter. To construct pK-TesB, the primer set g-tesB2 was used to PCR-
amplify tesB from pK-BktB-Hbd-TesB and the amplicon was subsequently assembled with the 
PCR-linearized pK184 using the primer set g-pK-tesB. The two-subunit β-ketothiolase gene 
bktBαβ was PCR-amplified from the genomic DNA of wild-type Haloferax mediterranei ATCC 
33500 using the primer set g-bktBαβ. The amplicon was then assembled with the PCR-linearized 
pK-TesB using the primer set g-pK-bktαβ-tesB, yielding pK-BktBαβ-TesB. The same approach 
was used with the primer set g-pK-bktB-tesB to generate plasmid pK-BktB-TesB harboring the 




Hbd-TesB using the primer set g-pK-bktB-hbd, followed by assembling the amplicon with the 
PCR-linearized pK-BktB using the primer set g-pK-bktB. Lastly, to generate plasmids testing CoA 
removing efficiency (i.e., pK-BktB-Hbd-Ptb-Buk and pK-BktB-Hbd-Pct), the ptb-buk operon 
from C. acetobutylicum ATCC 824 and pct from  Clostridium propionicum DSM 1682 were PCR 
amplified using corresponding primer sets (i.e., g-ptb-buk and g-pct). The ptb-buk and pct 
amplicons were then individually assembled with PCR linearized pK-BktB-Hbd using g-pK-bktB-
hbd-ptb-buk and g-pK-bktB-hbd-pct primer sets, respectively.  
4.2.2 Bacterial cultivation 
All medium components were obtained from Sigma-Aldrich Co. (St Louis, MO, USA) except 
glucose, yeast extract, and tryptone which were obtained from BD Diagnostic Systems (Franklin 
Lakes, NJ, USA). The media were supplemented with antibiotics as required: 25 µg ml-1 
kanamycin and 50 µg ml-1 ampicillin. E. coli strains, stored as glycerol stocks at -80 °C, were 
streaked on LB agar plates with appropriate antibiotics and incubated at 37°C for 14-16 hours. 
Single colonies were picked from LB plates to inoculate 30-ml LB medium (10 g l-1 tryptone, 5 g 
l-1 yeast extract, and 5 g l-1 NaCl) with appropriate antibiotics in 125-ml conical flasks. The cultures 
were shaken at 37°C and 280 rpm in a rotary shaker (New Brunswick Scientific, NJ, USA) and 
used as seed cultures to inoculate 220 ml LB media at 1% (v/v) with appropriate antibiotics in 1-
L conical flasks. This second seed culture was shaken at 37°C and 280 rpm until an optical density 
of 0.80 OD600 was reached. Cells were then harvested by centrifugation at 9,000 ×g and 20°C for 
10 minutes and resuspended in 30-ml modified M9 production media. The suspended culture was 
transferred into a 125-ml screw-cap or vent-cap plastic production flasks and incubated at either 
30 or 37°C at 280 rpm in a rotary shaker. Unless otherwise specified, the modified M9 production 




NaHCO3, 1 mM MgCl2, 0.2 µM cyanocobalamin (vitamin B12), 5
th dilution of M9 salts mix (33.9 
g l-1 Na2HPO4, 15 g l
-1 KH2PO4, 5 g l
-1 NH4Cl, 2.5 g l
-1 NaCl ), 1,000th dilution of Trace Metal Mix 
A5 (2.86 g l-1 H3BO3, 1.81 g l
-1 MnCl2•4H2O, 0.222 g l
-1 ZnSO4•7H2O, 0.39 g l
-1 Na2MoO4•2H2O, 
79 µg l-1 CuSO4•5H2O, 49.4 µg l
-1 Co(NO3)2•6H2O), and supplemented with 0.1 mM isopropyl β-
D-1-thiogalactopyranoside (IPTG). All cultivation experiments were performed in triplicate. 
4.2.3 Analytical methods 
Culture samples were appropriately diluted with 0.15 M saline solution for measuring the optical 
cell density (OD600) using a spectrophotometer (DU520, Beckman Coulter, Fullerton, CA). Cell-
free medium was collected by centrifugation of the culture sample at 9,000 ×g and filter sterilized 
for titer analysis of glucose or glycerol, and various metabolites using a high-performance liquid 
chromatography (HPLC; LC-10AT, Shimadzu, Kyoto, Japan) with a refractive index detector 
(RID; RID-10A, Shimadzu, Kyoto, Japan) and a chromatographic column (Aminex HPX-87H, 
Bio-Rad Laboratories, CA, USA). The HPLC column temperature was maintained at 35°C and the 
mobile phase was 5 mM H2SO4 (pH 2.0) running at 0.6 ml min
-1. The RID signal was acquired 








Table 4.2: Host strains, plasmids, and oligonucleotides used in this study 
Name Description, relevant genotype or  primer sequence (5’  3’)a Source(s) 
E. coli host strains   
     DH5α F−, endA1, glnV44, thi-1, recA1, relA1, gyrA96, deoR, nupG φ80d lacZ∆acZd ladlacZYA – argF) U169, 
hsdR17(rK-mK +), λ- 
Lab stock 
     BW25141 F-, ∆(araD-araB)567, ∆lacZ4787(::rrnB-3), ∆(phoB-phoR)580, λ-, galU95, ∆uidA3::pir + , recA1, endA9 
(del-ins)::FRT, rph-1, ∆(rhaD-rhaB)568, hsdR514 
(Datsenko and Wanner 
2000) 
     BW25113 F-, ∆(araD-araB)567, ∆lacZ4787(::rrnB-3), λ-, rph-1, ∆(rhaD-rhaB)568, hsdR514 (Datsenko and Wanner 
2000) 
     BW∆ldhA BW25113 ldhA null mutant (Akawi et al. 2015; 
Srirangan et al. 2016a; 
Srirangan et al. 2014) 
     BW∆ldhA-3HA11 BW∆ldhA/pTrc-PhaAB and pK-TesB This study 
     CPC-Sbm BW∆ldhA, Ptrc::sbm (i.e., with the FRT-Ptrc cassette replacing the 204-bp upstream of the Sbm operon) (Akawi et al. 2015) 
     P3HA10 CPC-Sbm/pTrc-PhaB and pK-TesB This study 
     P3HA20 CPC-Sbm/pTrc-PhaA and pK-BktB-TesB This study 
     P3HA30 CPC-Sbm/pTrc-PhaAB and pK- BktB-Hbd This study 
     P3HA11 CPC-Sbm/pTrc-PhaAB and pK-TesB This study 
     P3HA12 CPC-Sbm/pTrc-PhaB and pK-BktB-TesB This study 
     P3HA13 CPC-Sbm/pTrc-PhaB and pK- BktBαβ-TesB This study 
     P3HA21 CPC-Sbm/pTrc-PhaAB and pK-BktB-TesB This study 
     P3HA22 CPC-Sbm/pTrc-PhaA and pK-BktB-Hbd-TesB This study 
     P3HA31 CPC-Sbm/pTrc-PhaAB and pK- BktB-Hbd-TesB This study 
     P3HA32 CPC-Sbm/ pTrc-PhaAB and pK-BktB-Hbd-Ptb-Buk This study 
     P3HA33 CPC-Sbm/ pTrc-PhaAB and pK-BktB-Hbd-Pct This study 
     P3HA31∆gldA gldA null mutant of P3HA31 This study 
     P3HA31∆ptsI ptsI null mutant of P3HA31 This study 
     P3HA31∆dhaKLM dhaKLM null mutant of P3HA31 This study 
     P3HA31∆glpK glpK null mutant of P3HA31 This study 
     P3HA31∆glpD glpD null mutant of P3HA31 This study 
     P3HA31∆glpABC glpABC null mutant of P3HA31 This study 
     P3HA31∆sdhA sdhA null mutant of P3HA31 This study 
     P3HA31∆frdB frdB null mutant of P3HA31  
     P3HA31∆aceA aceA null mutant of P3HA31  
     P3HA31∆iclR iclR null mutant of P3HA31 This study 




Plasmids   
     pTrc99a ColE1 ori AmpR  Ptrc (Amann et al. 1988) 
     pK184 p15A ori, KmR, Plac::lacZ’ (Jobling and Holmes 
1990) 
     pTrc-PhaA Derived from pTrc99a, Ptrc::phaA This study 
     pTrc-PhaB Derived from pTrc99a, Ptrc::phaB This study 
     pTrc-PhaAB Derived from pTrc99a, Ptrc::phaAB This study 
     pK-TesB Derived from pK184, Plac::tesB This study 
     pK-BktB-TesB Derived from pK184, Plac::bktB:tesB This study 
     pK-BktBαβ-TesB Derived from pK184, Plac::bktBαβ:tesB This study 
     pK-BktB-Hbd-TesB Derived from pK184, Plac::bktb:hbd:tesB Lab stock 
     pK- BktB-Hbd Derived from pK184, Plac::bktb:hbd This study 
     pK-BktB-Hbd-Ptb-Buk Derived from pK184, Plac::bktB:hbd:ptb:buk Lab stock 
     pK-BktB-Hbd-Pct Derived from pK184, Plac::bktB:hbd:pct This study 
Primers   
     v-ldhA GATAACGGAGATCGGGAATGATTAA;  
GGTTTAAAAGCGTCGATGTCCAGTA 
(Akawi et al. 2015) 
     v-pta GGCATGAGCGTTGACGCAATCA;  
CAGCTGTACGCGGTGATACTCAGG 
(Akawi et al. 2015) 
     v-adhE ATCAGGTGTCCTGAACTGTGCG;  
TTGACCAGCGCAAATAACCCGATGA 
(Akawi et al. 2015) 
     v-glpK TGATTGGTCTACTGATTGCG;  
CCATATACATATCCGGCG 
This study 
     v-glpD GTCAATGCTATAGACCACATC;  
ATTATTGAAGTTTGTAATATCCTTATCAC  
This study 
     v-glpABC GATTAACAGCCTGATTCAGTGAG;   
AGCTCTATTTCTGCGGTTTC 
This study 
     v-gldA ATTACTACACTTGGCACTGCTG; 
ATATCTTCGTGAACCAGTTTCTG 
This study 
     v-dhaKLM ATCGAGGATAAACAGCGCA;  
TCTGATAAAGCTCTTCCAGTGT  
This study 
     v-ptsI GGTTCAATTCTTCCTTTAGCG;  
CAGTTTGATCAGTTCTTTGATT 
This study 






     g-phaB TTCACACAGGAAACAGACATGACTCAGCGCATTGCGT; 
GGTACCGAGCTCGAATTCCATGTCAGCCCATATGCAGGCC 
This study 
     g-phaAB CCGGCTCGTATAATGTGTGGATGACTGACGTTGTCATCGTATCC; 
ATTGTTATCCGCTCACAATTTCAGCCCATATGCAGGCCGC 
This study 
     g-tesB ACAGGAAACAGCTATGACATGAGTCAGGCGCTAAA 
GAGCTCGAATTCGTAATCATTAATTGTGATTACGCATCAC 
Lab stock 
     g-bktb CACAGGAAACAGCTATGACCATGACGCGTGAAGTGGTAGT; Lab stock 
 TAAACAGACCTCCCTTAAATTTAATTCAGATACGCTCGAAGATGG  




Lab stock  





     g-ptb-buk TAAAAGGGAGTGTACGACCAGTGATTAAGAGTTTTAATGAAATTATCAT; 
GAGCTCGAATTCGTAATCATTATTTGTATTCCTTAGCTTTTTCT 
This study 
     g-pct TGATTAAGGAGGATTTTCGACAATGAGAAAGGTTCCCATTATTACC; 
GTACCGAGCTCGAATTCGTCAGGACTTCATTTCCTTCA 
This study 
     g-bktBαβ CACAGGAAACAGCTATGACCATGGAAGTCGCAGTGATTGGC; 
AGACCTCCCTTAAATTTAATCTACACAGGGTCCCAGCGATAG 
This study 
     g-bktB-tesB CACAGGAAACAGCTATGACCATGACGCGTGAAGTGGTAGT; 
CCTGACTCATATAACTCTCCTCAGATACGCTCGAAGATGG 
This study 
     g-bktB-hbd ACAGGAAACAGCTATGACCATGACGCGTGAAGTGGTAG; 
TAACAAAGCTGCCGCAGTTATTTTGAATAATCGTAGAAAC 
This study 
     g-bktB-hbd-pct CGAGGAGGATTTTCGACAATGAGAAAGGTTCCCATTATTAC; 
CGGGTACCGAGCTCGTCAGGACTTCATTTCCTTCAG 
This study 
     g-pTrc-phaA CTGGCAGTCGAGCGCAAATAAAATTGTGAGCGGATAACAATTTCACA; 
TTATTTGCGCTCGACTGCCAGTGTGAAATTGTTATCCGCTCACAATT 
This study 
     g-pTrc-phaB GCGGCCTGCATATGGGCTGATGGAATTCGAGCTCGGTACC; This study 
 TACGCAATGCGCTGAGTCATCCACACATTATACGAGCCGGA  
     g-pTrc-phaAB GCGGCCTGCATATGGGCTGATGGAATTCGAGCTCGGTACC;  This study 
 ACGATGACAACGTCAGTCATGTCTGTTTCCTGTGTGAAATTGTTATCCG  
     g-pK-bktB GCCATCTTCGAGCGTATCTGATGATTACGAATTCGAGCTCGGTA; 
TCAGATACGCTCGAAGATGGCGAGCTCGAATTCGTAATCA 
This study 
     g-pK-tesB GGTGATGCGTAATCACAATTAATGATTACGAATTCGAGCTCGG; This study 
 TTTTTAGCGCCTGACTCATGGTCATAGCTGTTTCCTGTGT  
     g-pK-bktB-tesB AAATTTAAGGGAGGTCTGTTTATGAGTCAGGCGCTAAAAA; This study 








     g-pK-bktBαβ-tesB GCTGGGACCCTGTGTAGATGAGTCAGGCGCTAAAAA; This study 
 CAATCACTGCGACTTCCATGGTCATAGCTGTTTCCTGTG  
     g-pK-bktB-hbd ACAGGAAACAGCTATGACCATGACGCGTGAAGTGGTAG; This study 
 CGAGCTCGAATTCGTAATCATTATTTTGAATAATCGTAGAAACCTTTT  
      g-pK-bktB-hbd-ptb-buk AGAAAAAGCTAAGGAATACAAATAATGATTACGAATTCGAGCTCGGTAC; This study 
 GTCGTACACTCCCTTTTACTTATTTTGAATAATCGTAGAAACCTTT  





     g-pK-bktB-hbd-tesB GGTGATGCGTAATCACAATTAATGATTACGAATTCGAGCTCGG; 
TACCACTTCACGCGTCATGGTCATAGCTGTTTCCTGTGTGAA 
Lab stock 
a bktB, beta-ketothiolase; bktBαβ, PHA-specific beta-ketothiolase – alpha and beta subunits; buk, butyrate kinase; dhaKLM, dihydroxyacetone kinase; frdB, fumarate reductase (subunit B); gldA, glycerol 
dehydrogenase; glpABC, anaerobic glycerol-3-phosphate dehydrogenase; glpD, aerobic glycerol-3-phosphate dehydrogenase; glpK, glycerol kinase; hbd, beta-hydroxybutyryl-CoA dehydrogenase; iclR, 
AceBAK operon repressor; lacZ, β-galactosidase (E. coli); ldhA, lactate dehydrogenase; pct, acetate/propionate CoA-transferase; phaA, acetoacetyl-CoA thiolase; phaB, acetoacetyl-CoA dehydrogenase; 
ptb, phosphotransbutyrylase; ptsI, PTS enzyme I; sdhA, succinate dehydrogenase complex (subunit A); sucD,  succinyl coenzyme A synthetase (subunit D); tesB, acyl-CoA thioesterase II. AmpR, 
amplicillin resistance cassette; KmR, kanamycin resistance cassette.  
 






4.3.1 Pathway implementation for heterologous 3-HV biosynthesis 
An essential precursor for 3-HV biosynthesis is propionyl-CoA, which is non-native to E. coli. By 
activating the Sbm operon in the E. coli host genome, the dissimilation of succinyl-CoA can be 
diverted from the TCA cycle into the Sbm pathway to form propionyl-CoA (Figure 4.1). To 
evaluate the feasibility of 3-HV biosynthesis using this propanologenic host strain, a double 
plasmid system was employed in strain P3HA11 (Figure 4.3). In the first step, hetero-fusion of 
propionyl-CoA and acetyl-CoA to 3-ketovaleryl-CoA was carried out by PhaA (encoded by phaA) 
(Figure 4.2). Subsequently in the second step, the enantiomer-specific reduction (ESR) of 3-
ketovaleryl-CoA into (R)-3-HV-CoA is catalyzed by NADPH-dependent PhaB (encoded by 
phaB). In the final step, (R)-3-HV is synthesized via hydrolysis of (R)-3-HV-CoA, catalyzed by 
acyl-CoA thioesterase II (i.e., TesB encoded by tesB). Note that these (R)-3-HV-producing 
enzymes also have the capacity to generate the C4 counterparts in all steps of the engineered 
pathway, resulting in the co-production of 3-HV and 3-HB (Figure 4.2). To validate the proposed 
3-hydroxyacid pathway, P3HA11 was cultivated in a 37°C shake-flask using 30 g l-1 glucose 
(Figure 4.3), producing 0.27 g l-1 3-HB and 0.03 g l-1 3-HV. On the other hand, the control strain 
CPC-Sbm without the 3-hydroxyacid biosynthetic pathway produced no 3-hydroxyacids, 
indicating that the implemented pathway was functional. Also, the loss of either one of the 3-
hydroxyacid pathway genes resulted in no 3-HV production (see later sections and Figure 4.4), 
suggesting that all these 3-hydroxyacid biosynthetic pathway genes were required for 3-HV 
production. Furthermore, another control strain BW∆ldhA-3HA11 with the native (i.e., non-
activated) Sbm operon produced 0.94 g l-1 3-HB but no 3HV, suggesting that propionyl-CoA acted 
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Figure 4.3: Construction of 3-HV-producing strain from unrelated carbon source by 
engineering Sbm and 3-hydroxyacid biosynthetic pathways. Strains compared are BW∆ldhA, 
BW∆ldhA-3HA11, CPC-Sbm, and P3HA11. Top panel represents cell growth (OD600), glucose 
consumption, and 3-HV yield (%) while bottom panel represents titers of 3-HB, 3-HV, even and 
odd-chain acids (i.e., acetate and propionate) and ethanol reached after 48h shake-flask cultivation. 
All values are reported as means ± SD (n = 3).   
 
a Measured cell density after 48h cultivation using spectrophotometer (OD600), time 0h cell density was kept at ~5.00 
b Defined as the percentage of the 3-HV theoretical yield based on the consumed glucose 
   3-HA 3-hydroxyacid 
   ESR enantiomer specific reduction 
   n/a not applicable 






4.3.2 Manipulation of genes involved in 3-HV biosynthetic pathway 
As multiple enzymes have been identified to catalyze each of the three steps in the 3-HV 
biosynthetic pathway (Table 4.1), the effects of heterologous expression of these enzyme genes, 
either individually or in combination, on 3-HV production were investigated. For the first step of 
Claisen condensation, in addition to PhaA which primarily targets short-chain CoA molecules, 
BktB (encoded by bktB) is another β-ketothiolase with a specificity toward long-chain CoA 
molecules (Slater et al. 1998). While the control strain P3HA10 produced no 3-hydroxyacids, 
heterologous expression of either phaA in P3HA11 or bktB in P3HA12 mediated both 3-HV and 
3-HB production (Figure 4.4), suggesting the catalytic activity of the two β-ketothiolases for the 
Claisen condensation. Heterologous expression of another PHA-specific β-ketothiolase (i.e., 
BktBαβ encoded by bktBαβ) in P3HA13 mediated the production of 3-HB only, but not 3-HV. 
Note that BktB appeared to be more effective than PhaA in terms of 3-HV production, potentially 
due to the promiscuous activity of BktB toward different acyl-CoA moieties (Slater et al. 1998). 
Interestingly, compared to P3HA11 and P3HA12, coexpression of both β-ketothiolase genes of 
bktB and phaA in P3HA21 significantly enhanced 3-hydroxacid production up to 0.77 g l-1 3-HB 
and 0.11 g l-1 3-HV. Due to this synergistic effect, the engineered strains used in all subsequent 
experiments contained both bktB and phaA genes. 
 For the second step of ESR, in addition to PhaB, we also evaluated another NADH-
dependent dehydrogenase, i.e., β-hydroxybutyryl-CoA dehydrogenase (also known as (S)-3-HB-
CoA dehydrogenase or Hbd encoded by hbd) and their effects on 3-HV production are summarized 
in Figure 4.4. PhaB and Hbd mediate the formation of (R)- and (S)-form hydroxyacid-CoA, 
respectively. The control strain P3HA20 without a heterologous dehydrogenase produced no 3-




specific dehydrogenases in E. coli. The overall synthesis of (R)-3-HB/HV from PhaB in P3HA21 
was approximately 3-fold that of (S)-3-HB/HV from Hbd in P3HA22. Coexpression of phaB and 
hbd further improved the production of 3-hydroxyacids and, interestingly, the total 3-hydroxyacid 
titers of P3HA31 (1.07 g l-1 3-HB and 0.19 g l-1 3-HV) were approximately equivalent to the sum 
of the 3-hydroxyacid titers of P3HA21 (0.77 g l-1 3-HB and 0.11 g l-1 3-HV) and P3HA22 (0.24 g 
l-1 3-HB and 0.04 g l-1 3-HV), implying the potentially independent enzymatic mechanisms for the 
two dehydrogenases. Due to the improved 3-HV production in P3HA31, this dehydrogenase duo 
was used in all subsequent experiments.  
 For the last step, in addition to the native TesB, we also evaluated two other CoA-removing 
enzymes, including phosphotransbutyrylase (i.e., Ptb encoded by ptb) and butyrate kinase (i.e., 
Buk encoded by buk) and acetate/propionate CoA-transferase (i.e., Pct encoded by pct), and their 
effects on 3-HV production are summarized in Figure 4.4. The Ptb-Buk system is a two-step CoA 
removal scheme generating a phosphorylated intermediate and has been successfully used for 
butyrate and 3-HB production (Fischer et al. 2010; Gao et al. 2002). On the other hand, Pct has a 
broad substrate specificity toward CoA molecules and is capable of converting both (R) and (S) 
forms of 3-HB-CoA into respective 3-HB (Matsumoto et al. 2013). The control strain P3HA30 
without a CoA-removing enzyme produced no 3-hydroxyacids. In comparison to P3HA31, 
expression of ptb-buk in P3HA32 or pct in P3HA33 did not further improve 3-HV biosynthesis. 
Given the superior CoA removing nature of TesB in comparison to Ptb-Buk and Pct, we chose not 
to conduct further enzyme co-expression for this step and thus only TesB was used for CoA 
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Figure 4.4: Modular construction of 3-HV biosynthetic pathway by establishing efficient 
Claisen condensation, reduction reaction, and CoA removing capabilities. Strains compared 
are P3HA10, P3HA11, P3HA12, P3HA13, P3HA20, P3HA21, P3HA22, P3HA30, P3HA31, 
P3HA32, and P3HA33. Panel represents titers of 3-HB and 3-HV. Cells labeled with an asterisk 
represent overexpressed genes. All values are reported as means ± SD (n = 3).   
 
4.3.3 Bacterial cultivation for 3-HV production 
As the metabolic activities of various pathways involved for 3-HV biosynthesis (Figure 4.1) can 
potentially depend on culture environment, we examined the effects of cultivation conditions, 
specifically temperature and carbon source (Figure 4.5), on 3-HV production. While the formation 
of propionyl-CoA in the fermentative Sbm pathway is favored by anaerobic conditions (Akawi et 
al. 2015; Srirangan et al. 2014), the hydroxyacid biosynthetic pathway is energetically intensive 
and presumably favored by aerobic conditions. However, precise control of the oxygenic condition 
for shaker flask cultivation was difficult though the shaking speed could be adjusted. For consistent 
operation in this study, the shaking speed was fixed to 280 rpm throughout the entire cultivation. 
Under both 30°C and 37°C, the control strain CPC-Sbm lacking a 3-hydroxyacid biosynthetic 
pathway produced neither 3-HB nor 3HV (data not shown). However, the overall yield of odd-
chain metabolites, including 3-HV, propionate, and 1-propanol, based on the consumed glucose 
was significantly higher under a low temperature, i.e., 4.42% under 30°C vs. 1.34% under 37°C. 
Note that the overall yield of odd-chain metabolites potentially correlates with the level of 
intracellular propionyl-CoA during cultivation. For P3HA31 with an optimal 3-hydroxyacid 
biosynthetic pathway, both 3-HB and 3-HV titers of the 30°C culture were significantly higher 
than those of the 37°C culture. In addition, the overall yield of odd-chain metabolites based on the 
consumed glucose was favored by a low cultivation temperature, i.e., 6.84% under 30°C vs. 3.74% 
under 37°C. Notably, for both strains, the low cultivation temperature under 30°C appeared to 




availability of acetyl-CoA for 3-hydroxyacid production. Furthermore, the overall glucose 
consumption and cell growth were also more effective under a low temperature of 30°C.   
 Given the abundance as a byproduct of biodiesel production, glycerol has become a 
promising feedstock for bio-based production (Gonzalez et al. 2008; Yazdani and Gonzalez 2007). 
Since glycerol possesses a high degree of reductance (κ = 4.67), its glycolytic degradation 
generates approximately twice the number of reducing equivalents compared to xylose and glucose 
(κ = 4.00) (Murarka et al. 2008). Cultivation of P3HA31 with glycerol at 30°C resulted in a high 
3-HV titer of 2.29 g l-1, which is approximately 2-fold that of the corresponding glucose culture. 
Similarly, cultivation of P3HA31 with glycerol at 37°C resulted in a 3-HV titer of 1.71 g l-1, which 
is approximately 9-fold that of the corresponding glucose culture, further confirming both the 
temperature and carbon source effects on 3-HV production. Importantly, the overall yield of odd-
chain metabolites was slightly elevated with glycerol as the carbon source, i.e., 16.31% under 30°C 
and 15.63% under 37°C. These results are consistent with our previous reports that glycerol is a 
more efficient carbon source in stimulating the Sbm pathway (Akawi et al. 2015; Srirangan et al. 
2016a). Hence, cultivation with glycerol as the sole carbon source under 30°C was adopted for all 
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Figure 4.5: Effects of cultivation temperature and carbon source on 3-HV production in 
P3HA31. Top panel represents cell growth (OD600), glucose/glycerol consumption, 3-HV yield 
(%), and total odd-chain (i.e., 3-HV, propionate, and 1-propanol) yield (%) while bottom panel 
represents titers of 3-HB, 3-HV, even and odd-chain acids (i.e., acetate and propionate) and ethanol 
reached after 48h shake-flask cultivation. All values are reported as means ± SD (n = 3).   
 
 
a Measured cell density after 48h cultivation using spectrophotometer (OD600), time 0h cell density was kept at ~5.00 
b Defined as the percentage of the 3-HV theoretical yield based on the consumed glucose 







4.3.4 Metabolic engineering to enhance 3-HV production 
To enhance 3-HV biosynthesis, we developed various metabolic strategies by manipulating a 
selection of TCA genes to increase such carbon flux redirection and the results are summarized in 
Figure 4.6. We first supplemented the culture of P3HA31 with succinate and observed that 
propionate and 3-HV titers were increased upon succinate supplementation, suggesting that the 
carbon flux redirection into the Sbm pathway could be limited by succinate availability. We then 
targeted several TCA genes encoding enzymes near the succinate note (designated in red in Figure 
4.1) for manipulation. Consequently, we derived various mutants by individually blocking the 
three major TCA routes, i.e. oxidative TCA cycle, reductive TCA branch, and glyoxylate shunt. 
Compared to the control strain P3HA31, inactivation of the reductive TCA branch gene of frdB in 
P3HA31∆frdB significantly reduced 3-HV titer and yield, whereas 3-HV production was slightly 
reduced upon the inactivation of the glyoxylate shunt gene of aceA in P3HA31∆aceA or the 
oxidative TCA cycle gene of sdhA in P3HA31∆sdhA. The results suggest that the carbon flux 
redirected toward the Sbm pathway was primarily derived from the reductive TCA branch. 
Simultaneous inactivation of the reductive TCA branch and glyoxylate shunt in the double mutant 
P3HA31∆frdB∆aceA further reduced 3-HV production with an 8-fold reduction in the total odd-
chain yield compared to the control P3HA31, further suggesting a minimal contribution from the 
oxidative TCA cycle for the carbon flux redirection. Importantly, disruption of sucD caused a 
complete abolishment in biosynthesis of all odd-chain metabolites, including 3-HV, 1-propanol, 
and propionate, suggesting the key role that this succinate-succinyl-CoA interconversion step 
played for the carbon flux redirection into the Sbm pathway. Given that succinate appears to be 
critically limiting the carbon flux redirection, glyoxylate shunt was deregulated by mutating iclR 




though 3-HV production was not improved compared to the control strain P3HA31. Note that these 
TCA-gene mutations appeared to minimally affect metabolic activity of the 3-hydroxyacid 
biosynthetic pathway since, compared to the control strain P3HA31, 3-HB titer and yield were 
slightly increased by all single mutations (ranging from 2.41 g l-1 to 2.76 g l-1 and from 14.6% to 
19.8%, respectively) except ∆sdhA (which slightly reduced 3-HB titer and yield). As a potential 
reason limiting 3-HV production in P3HA31∆iclR was the carbon flux diversion (toward both 
oxidative and reductive TCA directions) at the succinate node, we further blocked the oxidative 
TCA cycle by deriving a double mutant P3HA31∆sdhA∆iclR such that the entire carbon flux 
would be redirected into the Sbm pathway via the reductive TCA branch. While 3-hydroxyacid 
titers for this particular double mutant were increased moderately compared to the control strain 
P3HA31 (23.7% for 3-HB and 27.9% for 3-HV), the corresponding yields were increased 
significantly (~100% for both 3-HB and 3-HV), suggesting a much higher 3-hydroxyacid 
producing capacity and successful carbon flux redirection into the Sbm pathway under this genetic 
background. However, the culture performance was limited by deteriorated glycerol dissimilation 
and cell growth for P3HA31∆sdhA∆iclR cultivated in the standard screw-cap shake-flasks, which 
were rather anaerobic. Such limitation was partially resolved by conducting the same cultivation 
under a more aerobic condition in the vent-cap shake-flasks, resulting in the highest titers for both 
3-HV (3.71 g l-1) and propionate (2.97 g l-1), a nearly 150% increase in the odd-chain yield 
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Figure 4.6: Consolidating genetic and bioprocessing strategies for enhanced carbon flux 
toward succinate in TCA cycle. Top panel represents cell growth (OD600), glycerol consumption, 
3-HV yield (%), and total odd-chain (i.e., 3-HV, and propionate) yield (%) while bottom panel 
represents titers of 3-HB, 3-HV, even and odd-chain acids (i.e., acetate and propionate) and ethanol 




a Measured cell density after 48h cultivation using spectrophotometer (OD600), time 0h cell density was kept at ~5.00 
b Defined as the percentage of the 3-HV theoretical yield based on the consumed glycerol/succinate 
c Defined as the percentage of the total odd-chain metabolites (i.e., propionate and 3-HV) theoretical yield based on the consumed 
  ND not detected 








Among the three steps in the 3-hydroxyacid biosynthetic pathway, the Claisen condensation, 
generating acetoacetyl-CoA and 3-ketovaleryl-CoA, has to confront a thermodynamic hurdle 
caused by an energetically unfavorable fusion of two acyl-CoA molecules (Weber 1991), and 
therefore can represent a rate-limiting step. While three individual β-ketothiolases of PhaA, BktB, 
and BktBαβ mediated homofusion of acetyl-CoA for 3-HB production, only PhaA and BktB 
mediated heterofusion of acetyl-CoA and propionyl-CoA for 3-HV production. BktB appeared to 
have a higher specificity than PhaA toward propionyl-CoA. Also, the catalytic effects of PhaA and 
BktB appeared to be synergistic when the two enzymes were coexpressed. Nevertheless, both 
PhaA and BktB had a significantly higher specificity toward acetyl-CoA than propionyl-CoA, 
limiting the 3-HV yield.  
PhaB and Hbd mediate ESR of the 3-hydroxyacid biosynthetic pathway, generating (R)-3-
HB/HV-CoA and (S)-3-HB/HV-CoA, respectively, and our results suggest that PhaB was 
catalytically more active than Hbd. In addition, the catalytic effects of PhaB and Hbd appeared to 
be independent and addable upon coexpression of the two enzymes. Since PhaB and Hbd are 
NADPH-dependent and NADH-dependent, respectively, our results of higher titers in (R)-3-
HB/HV than (S)-3-HB/HV might imply the physiological abundance of NADPH as a reducing 
equivalent under the shake-flask culture conditions. Cofactor engineering has been applied to 
manipulate the physiological levels of reducing equivalents to improve the biosynthesis of an 
enantiomerically pure 3-hydroxyacid (Perez-Zabaleta et al. 2016).  
Among the three evaluated CoA removing enzymes, the native TesB thioesterase 
outperformed Ptb-Buk and Pct in both 3-HB and 3-HV production. Consistent to our results, TesB 




specificity (Zheng et al. 2004). Note that the control strain P3HA30 produced no 3-hydroxyacids, 
suggesting that the expression of the native genomic tesB gene was insufficient or even inhibited. 
The low 3-hydroxyacid titers for P3HA32 might be associated with the limited substrate specificity 
toward (R)-3-hydroxyacid-CoA only. A previous study reported that strains expressing Ptb-Buk 
yielded no (S)-3-HB (Tseng et al. 2009). While, similar to TesB, Pct also has a specificity toward 
both (R)- and (S)-3-hydroxyacid-CoA (Matsumoto et al. 2013), its catalytic activity was less 
effective than TesB based on our results. Note that, in order to alleviate the competition from the 
3-HB biosynthetic pathway for enhanced 3-HV biosynthesis, protein engineering techniques to 
improve enzymatic specificity of β-ketothiolases toward odd-chain substrates could be potentially 
useful, as was successfully demonstrated for other proteins (Arabolaza et al. 2010; Sofeo et al. 
2019). To the best of our knowledge, there are no reports demonstrating higher enzymatic 
preference for odd-chain precursors associated with the last two 3-HV reaction steps (i.e., 
reduction and CoA removal). 
Culture conditions critically affected 3-HV production. The positive effects of the lower 
cultivation temperature were presumably associated with increased levels of intracellular 
propionyl-CoA. The temperature change could potentially affect the metabolic activity of the Sbm 
pathway. On the other hand, the specific 3-HB yields based on consumed glycerol were 
approximately the same under both 30°C and 37°C, suggesting that the metabolic activity of the 
3-hydroxyacid biosynthetic pathway was minimally affected by temperature. Previously, glycerol 
was shown to outperform glucose as the carbon source in terms of stimulating the metabolic 
activity of the Sbm pathway in propanologenic E. coli strains (Akawi et al. 2015; Srirangan et al. 




glycerol than glucose could generate more reducing equivalents for their subsequent use in the 3-
hydroxyacid biosynthetic pathway.  
In E. coli, glycerol dissimilation proceeds through either respiratory or fermentative 
pathways depending on the nature and availability of the electron acceptors (Gonzalez et al. 2008). 
In the presence of external electron acceptors, glycerol is first converted to glycerol-3-phosphate 
(G3P) via GlpK in the respiratory branch. For aerobic respiration with oxygen as the external 
electron acceptor, G3P is oxidized by GlpD to DHAP (Murarka et al. 2008). Alternatively, for 
anaerobic respiration in the presence of other non-oxygen external electron acceptors, such as 
fumarate or succinate, an enzyme complex GlpABC converts G3P to DHAP (Murarka et al. 2008). 
Our supplementary results (Appendix B) suggest that glycerol dissimilation for metabolite 
production in P3HA31 under the shake-flask culture conditions was primarily mediated through 
the respiratory branch via GlpK and GlpD with oxygen as the electron acceptor. In addition, the 
enzyme complex GlpABC might not be involved in glycerol dissimilation under such oxygenic 
culture condition. However, supplying oxygen could potentially drive dissimilated carbon flux 
away from the Sbm pathway, limiting the supply of propionyl-CoA for 3-HV biosynthesis. On the 
other hand, in the absence of external electron acceptors, glycerol dissimilation proceeds 
fermentatively (via GldA and DhaKLM/PtsI) with intracellular NAD+ as the electron acceptor 
(Gonzalez et al. 2008). Compared to the control strain P3HA31, inactivation of any gene involved 
in the fermentative branch, i.e., gldA in P3HA31∆gldA, dhaKLM in P3HA31∆dhaKLM, and ptsI 
in P3HA31∆ptsI, significantly reduced 3-HV production, but minimally affected glycerol 
utilization, the overall metabolite profile, and even 3-HB production. The decreased 3-HV 
production for these single mutants could be associated with a reduced supply of propionyl-CoA. 




for its conversion to propionyl-CoA though the aerobic-respiratory one via GlpK-GlpD was 
identified to be the major route. On the other hand, the overall 3-HV production was not limited 
by the aerobic-respiratory route for glycerol dissimilation since episomal overexpression of GlpD 
in P3HA31 did not improve 3-HV production (data not shown).  
As propionyl-CoA is a key precursor for 3-HV biosynthesis, metabolic engineering 
strategies in this study were primarily developed to enhance carbon flux redirection from the TCA 
cycle to the Sbm pathway, and succinate appeared to play a key role mediating the carbon flux 
redirection. In E. coli, succinate is formed via three oxygen-dependent pathways, i.e. (i) reductive 
TCA branch, (ii) oxidative TCA cycle, and (iii) glyoxylate shunt. Under anaerobic conditions, the 
dissimilated carbon enters the TCA cycle in the form of phosphoenolpyruvate (PEP) via 
carboxylation to form oxaloacetate, and then proceeds with reactions in the reductive TCA branch 
to generate succinate as a final product (Cheng et al. 2013). On the other hand, under aerobic 
conditions, acetyl-CoA derived from glycolysis enters the oxidative TCA cycle to generate 
succinate as a cycle intermediate (Thakker et al. 2012). We previously observed that the production 
of 1-propanol and propionate via the Sbm pathway was favored by anaerobic conditions and was 
minimal under aerobic conditions (Akawi et al. 2015; Srirangan et al. 2013), suggesting that the 
reversed TCA branch was the main flux contributor toward the Sbm pathway. Hence, we targeted 
several TCA genes encoding enzymes near the succinyl-CoA node for manipulation. The 
cultivation results of the single mutants, i.e., P3HA31∆sdhA, P3HA31∆aceA, and P3HA31∆frdB, 
further confirm the main contribution from the reverse TCA branch for the carbon flux redirection 
into the Sbm pathway under the standard shake-flask culture conditions. Though knocking out 
sucCD can potentially disrupt the TCA cycle in both oxidative and reductive directions, sucCD 




SucAB (Yu et al. 2006). However, succinyl-CoA derived from this half oxidative TCA branch 
cannot be funneled into the Sbm pathway since P3HA31∆sucD produced no 3-HV or odd-chain 
metabolites. On the other hand, 3-HV biosynthesis was observed, though in a small quantity, for 
the double mutant P3HA31∆frdB∆aceA, in which only the oxidative TCA cycle was functional to 
generate succinate. These results suggest that succinate could be an essential precursor for carbon 
flux redirection into the Sbm pathway. Knocking out sucD can also block the carbon flux toward 
succinyl-CoA from both the reductive TCA branch and glyoxylate shunt, further suggesting the 
critical role that SucD and its associated succinate-succinyl-CoA interconversion step played in 
the carbon flux redirection. 
Under aerobic conditions, succinate can be generated alternatively via glyoxylate shunt 
(Thakker et al. 2012), which is stimulated upon transcriptional activation of the aceBAK operon 
and negatively regulated by the IclR repressor (Nègre et al. 1992; Sunnarborg et al. 1990). 
Compared to the control strain P3HA31, the 3-HV yield was slightly increased by the iclR 
knockout. Such minimal improvement could be associated with rather anaerobic culture conditions 
in shake-flasks as well as carbon flux diversion (to both oxidative and reductive directions) at the 
succinate node. Hence, we further prevented this flux diversion by deriving a double mutant 
P3HA31∆sdhA∆iclR such that the carbon flux from glyoxylate shunt could be completely 
redirected to succinyl-CoA and into the Sbm pathway. Compared to the control strain P3HA31, 
P3HA31∆sdhA∆iclR cultivated in the standard screw-cap shake-flasks had a significant increase 
in the yield of both 3-HV and odd-chain metabolites, suggesting successful carbon flux redirection 
into the Sbm pathway. Such production enhancement was even more pronounced with a reduced 
acetate accumulation when P3HA31∆sdhA∆iclR was cultivated under more aerobic conditions in 




carbon spill via acetogenesis can significantly limit 3-HV production. Hence, conducting 
cultivation in a bioreactor under regulated oxygenic conditions would further enhance mechanistic 
understanding of carbon flux redirection for developing better metabolic engineering and 
bioprocessing strategies toward 3-HV production. Note that glyoxylate shunt essentially provides 
anaplerotic reactions and is only active under aerobic conditions when cells adapt to growth on C2 
compounds (e.g., acetate) (Gottschalk 1986; Kornberg and Madsen 1957). Our results also suggest 






















High-level bio-based production of 3-hydroxyvalerate 




Mounting concerns over finite fossil fuels and their environmental impacts have created growing 
needs to use renewable and clean carbon sources for the production of chemical compounds. An 
emerging technology for manufacturing of chemicals involves the use of biological cell factories, 
such as microorganisms, as biocatalysts for transformation, so called bio-based production or 
biomanufacturing. While whole-cell biocatalysts have many benefits over conventional chemical 
catalysts, natural organisms often have a limited metabolic capacity to meet the increasing 
demands in chemical product variety and quantity. Recent biotechnological advances in synthetic 
biology, genetic engineering, and metabolic engineering can substantially improve bio-based 
production (Yaguchi et al. 2018). To date, successful bio-based production includes not only fine 
chemicals but also commodity chemicals, such as succinate (Mao et al. 2018), lactate (Zhou et al. 
2013), lysine (Xu et al. 2014), and polyhydroxyalkanoates (PHAs) (Kaur and Roy 2015). A major 
issue limiting bio-based production is the high feedstock cost; therefore, cheap renewable 
feedstocks are under constant exploration. As a byproduct associated with biodiesel production, 
refined glycerol can be obtained inexpensively these days (Ciriminna et al. 2014). Moreover, 
glycerol has been regarded as an effective carbon source for microbial cultivation due to its highly 
reduced nature, generating approximately twice the number of reducing equivalents upon its 
degradation compared to traditional fermentable sugars (Murarka et al. 2008; Yazdani and 




several chemicals, such as succinate, 1,3-propanediol, 2,3-butanediol, and PHAs (Zhu et al. 
2013a). 
As discussed in Chapter 4, 3-hydroxyacids are a group of fine chemicals to be used as 
precursors for making a selection of antibiotics, vitamins, pheromones, and aromatic derivatives 
(Fonseca et al. 2019; Mori 1981; Nahar et al. 2009; Toshiyuki and Takeshi 1987). Currently, most 
3-hydroxyacids are still produced via chemical reactions (Noyori et al. 2004; Spengler and 
Albericio 2014) or chemical degradation of PHAs (de Roo et al. 2002). Being more 
environmentally friendly and sustainable, bio-based production has a potential to replace these 
chemical processes for 3-hydroxyacid production. 3-Hydroxyvalerate (3-HV) is a C5-counterpart 
of 3-HB and serves as a precursor for several pharmaceutical molecules (Huang et al. 1998). Also, 
3-HV can be introduced into the PHB polymeric chain to form a biocopolymer, poly(3-
hydroxybutyrate-co-3-hydroxyvalerate) (PHBV), which is structurally more ductile, flexible, and 
tougher than the PHB homopolymer (Lau et al. 2014; Snell and Peoples 2009). While being more 
bioactive and valuable than 3-HB, 3-HV has various technological and economic challenges in 
biosynthesis, ultimately limiting its industrial applications.  
In this chapter, we report a bioprocess development based on engineered E. coli strains 
derived for 3-HV production in Chapter 4 from glycerol (Miscevic et al. 2020). To review, a 
propanologenic (i.e., 1-propanol-producing) E. coli strain with an activated Sleeping beauty 
mutase (Sbm) operon (i.e., sbm-ygfD-ygfG-ygfH) was used as a host. The encoding enzymes (i.e., 
Sbm, YgfD, YgfG, and YgfH) of the Sbm operon are involved in a metabolic pathway for extended 
dissimilation of succinate to form propionyl-CoA, and subsequently 1-propanol and propionate as 
fermentative metabolites (Figure 5.1) (Srirangan et al. 2013; Srirangan et al. 2014). Structurally, 




acetyl-CoA moiety being replaced by propionyl-CoA. Note that the use of our propanologenic E. 
coli strains (with the presence of non-native propionyl-CoA) as the production host can eliminate 
a common but expensive bioprocess requirement, i.e., supplementation of structurally related 
carbons such as propionate, valerate, 3-hydroxynitrile, and levulinate (Martin and Prather 2009), 
significantly reducing the 3-HV production cost.  
Based on the 3-HV biosynthetic pathway, high-level 3-HV production potentially relies on 
the intracellular availability of propionyl-CoA as a key precursor. Though the Sbm pathway was 
activated in our original propanologenic E. coli strain, the intracellular propionyl-CoA level might 
remain low since the Sbm pathway is not physiologically essential, limiting the biosynthesis of 
propionyl-CoA-derived compounds. The major objective of this chapter is to tackle such metabolic 
limitation. As succinyl-CoA serves as a precursor toward the Sbm pathway, the tricarboxylic acid 
(TCA) cycle becomes a plausible target for metabolic manipulation. However, since succinyl-CoA 
is involved in the central metabolism in a complex manner and its formation can be mediated 
through multiple pathways, manipulation of the carbon flux around this C4-compound can be 
challenging. In addition, carbon flux channelling from the TCA cycle to the Sbm pathway in E. 
coli appears to be highly sensitive to the oxygenic condition of the culture. Herein, we developed 
consolidated strain engineering (i.e., manipulation of TCA cycle) and bioprocessing (i.e., 
regulation of culture aeration) strategies for effective carbon flux direction and, therefore, 




























Figure 5.1: Schematic representation of natural and engineered pathways in E. coli using 
glycerol as the carbon source. Metabolic pathways outlined: glycerol dissimilation, central 
metabolism, and oxidative TCA cycle (in black); glyoxylate shunt of TCA cycle (in dark yellow); 
reductive branch of TCA cycle (in blue); Sbm pathway (in purple); 3-hydroxyacid biosynthetic 
pathway (in green). Metabolite abbreviations: 3-HB, 3-hydroxybutyrate; 3-HV, 3-
hydroxyvalerate; DHAP, dihydroxyacetone phosphate; PEP, phosphoenolpyruvate; (S)/(R)-3-HB-
CoA, (S)/(R)-3-hydroxybutyryl-CoA; (S)/(R)-3-HV-CoA, (S)/(R)-3-hydroxyvaleryl-CoA. Protein 
abbreviations: AceA, isocitrate lyase; AceB, malate synthase A; AceK, isocitrate dehydrogenase 
kinase/phosphatase; AckA, acetate kinase; AdhE, aldehyde-alcohol dehydrogenase; BktB, beta-
ketothiolase; Hbd, beta-hydroxybutyryl-CoA dehydrogenase; IclR, AceBAK operon repressor; 
IDH, isocitrate dehydrogenase; IDH-P, isocitrate dehydrogenase-phosphate; LdhA, lactate 
dehydrogenase A; PckA, phosphoenolpyruvate carboxykinase; PDH, pyruvate dehydrogenase; 
PFL, pyruvate formate-lyase; PhaA, acetoacetyl-CoA thiolase; PhaB, acetoacetyl-CoA reductase; 
PK, pyruvate kinase; PPC, phosphoenolpyruvate carboxylase; Pta, phosphotransacetylase; Sbm, 
methylmalonyl-CoA mutase; SdhABCD, succinate dehydrogenase complex; TesB, acyl-CoA 
thioesterase II; YgfG, (R)-methyl-malonyl-CoA carboxylase; YgfH, propionyl-CoA: succinate 
CoA-transferase.  
5.2 Materials and Methods 
5.2.1 Bacterial strains and plasmids 
List of bacterial strains, plasmids, and deoxynucleic acid (DNA) primers used in this chapter can 
be seen in Table 5.1. Genomic DNA from bacterial cells was isolated using the Blood & Tissue 
DNA Isolation Kit (Qiagen, Hilden, Germany). Standard recombinant DNA technologies were 
applied for molecular cloning (Miller 1992). All plasmids were constructed by Gibson enzymatic 
assembly (Gibson et al. 2009). Phusion HF and Taq DNA polymerases were obtained from New 
England Biolabs (Ipswich, MA, USA). All synthesized oligonucleotides were obtained from 
Integrated DNA Technologies (Coralville, IA, USA). DNA sequencing was conducted by the 
Centre for Applied Genomics at the Hospital for Sick Children (Toronto, Canada). E. coli 
BW25113 was the parental strain for derivation of all mutant strains in this study and E. coli DH5α 
was used as a host for molecular cloning. It should be emphasized that the ldhA gene (encoding 




et al. 2014). Activation of the genomic Sbm operon in BW∆ldhA to generate propanologenic E. 
coli CPC-Sbm was described previously (Srirangan et al. 2014). 
Implementation of 3-hydroxyacid biosynthetic pathway in propanologenic E. coli to form 
3-HV-producing strains was recently reported (Miscevic et al. 2020) (and as outlined in previous 
chapter). Briefly, the phaAB operon was PCR-amplified using the primer set g-phaAB and the 
genomic DNA of wild-type Cupriavidus necator ATCC 43291 as the template. The amplified 
operon was Gibson–assembled (Note that “assembled” is used for subsequent appearance) with 
the PCR-linearized pTrc99a using the primer set g-pTrc-phaAB to generate pTrc-PhaAB. All 
genes inserted into pTrc99a vector were under the control of the Ptrc promoter. Plasmid pK-BktB-
Hbd-TesB was previously constructed in our lab by PCR-amplifying bktB from C. necator ATCC 
43291, hbd from Clostridium acetobutylicum ATCC 824, and tesB from E. coli BW 25141 using 
the corresponding primer sets (i.e., g-bktB, g-hbd, and g-tesB), followed by assembling all three 
PCR-amplified fragments with the PCR-linearized pK184 using the primer set g-pK-bktB-hbd-
tesB. All genes inserted into pK184 vector were under the control of the Plac promoter.  
Gene knockouts were introduced into E. coli recipient strains by P1 phage transduction 
(Miller 1992) using the appropriate Keio Collection strains (The Coli Genetic Stock Center, Yale 
University, New Haven, CT, USA) as donors (Baba et al. 2006). To eliminate the co-transduced 
FRT-KnR-FRT cassette, the transductants were transformed with pCP20 (Cherepanov and 
Wackernagel 1995), a temperature sensitive plasmid expressing a flippase (Flp) recombinase. 
Upon Flp-mediated excision of the KnR cassette, a single Flp recognition site (FRT “scar site”) 
was generated. Plasmid pCP20 was then cured by growing cells at 42°C. The genotypes of derived 
knockout strains were confirmed by colony polymerase chain reaction (PCR) using the appropriate 




5.2.2 Media and bacterial cell cultivation 
All medium ingredients were obtained from Sigma-Aldrich Co. (St Louis, MO, USA) except yeast 
extract, and tryptone which were obtained from BD Diagnostic Systems (Franklin Lakes, NJ, 
USA). The media were supplemented with antibiotics as required: 25 µg mL-1 kanamycin and 50 
µg mL-1 ampicillin. E. coli strains, stored as glycerol stocks at -80°C, were streaked on lysogeny 
broth (LB) agar plates with appropriate antibiotics and incubated at 37°C for 14-16 hours. Single 
colonies were picked from LB plates to inoculate 30-mL super broth (SB) medium (32 g l-1 
tryptone, 20 g l-1 yeast extract, and 5 g l-1 NaCl) with appropriate antibiotics in 125 mL conical 
flasks. Overnight cultures were shaken at 37°C and 280 rpm in a rotary shaker (New Brunswick 
Scientific, NJ, USA) and used as seed cultures to inoculate 220 mL SB media at 1% (v/v) with 
appropriate antibiotics in 1 L conical flasks. This second seed culture was shaken at 37°C and 280 
rpm for 14-16 hours. Cells were then harvested by centrifugation at 9,000×g and 20°C for 10 
minutes and resuspended in 50 mL fresh LB media. The suspended culture was used to inoculate 
a 1 L stirred tank bioreactor (containing two Rushton radial flow disks as impellers) (CelliGen 
115, Eppendorf AG, Hamburg, Germany) at 30°C and 430 rpm. The semi-defined production 
medium in the batch bioreactor contained 30 g l−1 glycerol, 0.23 g l−1 K2HPO4, 0.51 g l
−1 NH4Cl, 
49.8 mg l−1 MgCl2, 48.1 mg l
−1 K2SO4, 1.52 mg l
−1 FeSO4, 0.055 mg l
−1 CaCl2, 2.93 g l
−1 NaCl, 
0.72 g l−1 tricine, 10 g l−1 yeast extract, 10 mM NaHCO3, 0.2 μM cyanocobalamin (vitamin B12) 
and 1,000th dilution (i.e., 1 ml l−1) trace elements (2.86 g l−1 H3BO3, 1.81 g l
−1 MnCl2• 4H2O, 
0.222 g l−1 ZnSO4• 7H2O, 0.39 g l
−1 Na2MoO4• 2H2O, 79 μg l
−1 CuSO4• 5H2O, 49.4 μg l
−1 
Co(NO3)2• 6H2O) (Neidhardt et al. 1974), appropriate antibiotics, and supplemented with 0.1 mM 
isopropyl β-D-1-thiogalactopyranoside (IPTG). For fed-batch cultivation, the production strain 




of which ~15 g l-1 glycerol was supplemented for extended cultivation until complete glycerol 
dissimilation. Microaerobic and semiaerobic conditions were maintained by purging air into the 
headspace and bulk culture, respectively, at 0.1 vvm, designated as aeration level I (AL-I) and AL-
II. Aerobic conditions were maintained by sparging air into the bulk culture at 1 vvm (AL-III) or 
2-4 vvm (AL-IV). The pH of the production culture was maintained at 7.0 ± 0.1 with 30% (v/v) 
NH4OH and 15% (v/v) H3PO4.  
5.2.3 Analysis  
Culture samples were appropriately diluted with 0.15 M saline solution for measuring cell density 
in OD600 using a spectrophotometer (DU520, Beckman Coulter, Fullerton, CA). Cell-free medium 
was prepared by centrifugation of the culture sample at 9,000×g for 5 minutes, followed by filter 
sterilization using a 0.2 µm syringe filter. Extracellular metabolites and glycerol were quantified 
using high-performance liquid chromatography (HPLC) (LC-10AT, Shimadzu, Kyoto, Japan) 
with a refractive index detector (RID; RID-10A, Shimadzu, Kyoto, Japan) and a chromatographic 
column (Aminex HPX-87H, Bio-Rad Laboratories, CA, USA). The HPLC column temperature 
was maintained at 35°C and the mobile phase was 5 mM H2SO4 (pH 2) running at 0.6 mL min
-1. 
The RID signal was acquired and processed by a data processing unit (Clarity Lite, DataApex, 







Name Description, relevant genotype or  primer sequence (5’  3’) Source 
E. coli host strains   
     DH5α F−, endA1, glnV44, thi-1, recA1, relA1, gyrA96, deoR, nupG φ80d lacZ∆acZd ladlacZYA – 
argF) U169, hsdR17(rK-mK +), λ- 
Lab stock 
     BW25113 F-, ∆(araD-araB)567, ∆lacZ4787(::rrnB-3), λ-, rph-1, ∆(rhaD-rhaB)568, hsdR514 (Datsenko and Wanner 
2000) 
     BW∆ldhA BW25113 ldhA null mutant (Akawi et al. 2015; 
Srirangan et al. 2016a; 
Srirangan et al. 2014) 
     CPC-Sbm BW∆ldhA, Ptrc::sbm (i.e., with the FRT-Ptrc cassette replacing the 204-bp upstream of the 
Sbm operon) 
(Akawi et al. 2015) 
     P3HA31 CPC-Sbm/pTrc-PhaAB and pK- BktB-Hbd-TesB (Miscevic et al. 2020) 
     P3HA31∆sdhA sdhA null mutant of P3HA31 (Miscevic et al. 2020) 
     P3HA31∆iclR iclR null mutant of P3HA31 (Miscevic et al. 2020) 
     P3HA31∆sdhA∆iclR sdhA and iclR null mutant of P3HA31 (Miscevic et al. 2020) 
Plasmids   
     pTrc99a ColE1 ori Apr Ptrc (Amann et al. 1988) 
     pK184 p15A ori, KmR, Plac::lacZ’ (Jobling and Holmes 
1990) 
     pTrc-PhaAB Derived from pTrc99a, Ptrc::phaAB Lab stock 
     pK-BktB-Hbd-TesB Derived from pK184, Plac::bktb:hbd:tesB Lab stock 
Primers   
     v-ldhA GATAACGGAGATCGGGAATGATTAA;  
GGTTTAAAAGCGTCGATGTCCAGTA 
(Akawi et al. 2015) 
     v-sdhA CTCTGCGTTCACCAAAGTGT;  
ACACACCTTCACGGCAGGAG 
(Miscevic et al. 2020) 
     v-iclR GGTGGAATGAGATCTTGCGA;  
CCGACACGCTCAACCCAGAT 
(Miscevic et al. 2020) 
     c-frt AGATTGCAGCATTACACGTCTTGAG;  
CCAGCTGCATTAATGAATCGGGCCATGGTCCATATGAATATCCTCC 
(Srirangan et al. 2014) 




(Srirangan et al. 2016a) 










     g-phaAB CCGGCTCGTATAATGTGTGGATGACTGACGTTGTCATCGTATCC; 
ATTGTTATCCGCTCACAATTTCAGCCCATATGCAGGCCGC 
Lab stock 
     g-tesB ACAGGAAACAGCTATGACATGAGTCAGGCGCTAAA 
GAGCTCGAATTCGTAATCATTAATTGTGATTACGCATCAC 
Lab stock 
     g-bktb CACAGGAAACAGCTATGACCATGACGCGTGAAGTGGTAGT; Lab stock 
 TAAACAGACCTCCCTTAAATTTAATTCAGATACGCTCGAAGATGG  





     g-pTrc-phaAB GCGGCCTGCATATGGGCTGATGGAATTCGAGCTCGGTACC;  Lab stock 
 ACGATGACAACGTCAGTCATGTCTGTTTCCTGTGTGAAATTGTTATCCG  







5.3.1 Effects of oxygenic conditions on 3-HV biosynthesis 
The propanologenic E. coli with an activated Sbm operon, i.e., CPC-Sbm, was used as a host and 
a double plasmid system was employed to express key enzymes in the 3-HV biosynthetic pathway 
(Figure 5.1), including (1) PhaA (encoded by phaA) and BktB (encoded by bktB) for hetero-fusion 
of propionyl-CoA and acetyl-CoA moieties to 3-ketovaerlyl-CoA, (2) Hbd (encoded by hbd) and 
PhaB (encoded by phaB) for reduction of 3-ketovaleryl-CoA to 3-hydroxyvaleryl-CoA (3-HV-
CoA), and (3) TesB (encoded by tesB) for conversion of 3-HV-CoA to 3-HV. The resulting 
engineered strain P3HA31 was used as the control strain for bioreactor cultivation for 3-HV 
production. Note that these enzymes also have the activity toward their C4 counterpart species in 
all steps of the engineered pathway (Figure 5.1), resulting in the co-production of 3-HB and 3-HV. 
Several major metabolic pathways are involved for 3-HV biosynthesis in E. coli, including those 
for glycerol dissimilation, TCA cycle, Sbm fermentation, and 3-hydroxyacid biosynthesis (Figure 
5.1). These metabolic pathways, along with cell growth, can be sensitive to cultivation conditions 
in different levels. Specifically, the oxygenic condition could critically affect direction of the 
dissimilated carbon flux from the TCA cycle to the Sbm pathway for 3-HV biosynthesis. To 
investigate such oxygenic effects, batch cultivation of the control strain P3HA31 in a bioreactor 
was subject to three levels of aeration, i.e., AL-I, AL-II, and AL-III (from low to high) (Figure 
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a Measured cell density (OD600) throughout cultivation period using spectrophotometer, time 0h cell density (i.e., at the induction of IPTG) was in the range of 1.5-2.0 
b Defined as the percentage of the 3-HB/3-HV/odd-chain metabolites theoretical yield based on the consumed glycerol 
   Odd-chain metabolites include 3-HV, propionate, and 1-propanol 
  NA not applicable  






Figure 5.2: Physiological effects of varying aeration levels on 3-HV production in P3HA31. 
Time profiles of (a) cell growth (OD600), (b) glycerol consumption and metabolite production, and 
(c) percentage of 3-HB/3-HV/odd-chain metabolites theoretical yield based on consumed glycerol. 
AL-I, aeration level I; AL-II, aeration level II; and AL-III, aeration level III. Error bars represent 
± SD from the mean of two replicates.  
The aeration level had major physiological and metabolic effects on P3HA31. Under AL-
I, glycerol consumption and cell growth were significantly retarded with only 15.8 g l-1 glycerol 
being dissimilated after 39 h and the maximal cell density reaching only 8.0 OD600. On the other 
hand, glycerol dissimilation was rather effective and complete under both AL-II and AL-III, with 
the final cell density reaching 17.6 and 18.4 OD600, respectively. The enhanced cell growth 
appeared to be in line with 3-HB production, i.e., 1.68 g l-1 (18.7% yield) under AL-I, 4.92 g l-1 
(26.1% yield) under AL-II, and 5.21 g l-1 (28.1 % yield) under AL-III. However, the time profiles 
of acetate formation, which could potentially reflect cell physiology, were different under these 
three aeration conditions. There was a significant acetate accumulation toward the end of P3HA31 
cultivation under AL-I, suggesting a potential carbon spill at the acetyl-CoA node upon the growth 
arrest; whereas the secreted acetate was subsequently dissimilated for P3HA31 cultivation under 
AL-II. However, acetate accumulation reappeared for P3HA31 cultivation under AL-III even 
though there was no growth arrest. On the other hand, it appears that the level of Sbm fermentation 
was highly dependent on the oxygenic condition as the production of 3-HV and odd-chain 
metabolites (i.e., 1-propanol, propionate, and 3-HV) in P3HA31 increased with a reduced oxygen 
availability. Note that trace amounts of 1-propanol and succinate were even present under AL-I. 
While the 3-HV titers were rather similar for P3HA31 cultivations under AL-I and AL-II, the 3-
HV yield of the cultivation under AL-I was 2.3-fold that under AL-II. In addition, the yield of odd-
chain metabolites was 28.4% and 7.92% under AL-I and AL-II, respectively. Interestingly, no 3-
HV or any odd-chain metabolite was detected under AL-III, implying that the Sbm pathway 




Sbm fermentation was favored by anaerobiosis, the associated poor glycerol dissimilation and cell 
growth could limit the overall cultivation performance for 3-HV production.  
5.3.2 Strain engineering for 3-HV biosynthesis under microaerobic conditions 
To alleviate ineffective glycerol dissimilation and cell growth in P3HA31 under AL-I, we derived 
a single-knockout mutant P3HA31∆sdhA in which the oxidative TCA cycle was inactivated 
(Figure 5.3), achieving faster glycerol consumption (31.2 g l-1 glycerol dissimilated in 36 h) and 
higher cell density (12.2 OD600). With these physiological improvements, P3HA31∆sdhA 
produced nearly 2-fold 3-HV titer with an overall 3-HV yield comparable to P3HA31 under AL-
I. Interestingly, cultivation of P3HA31∆sdhA under AL-III led to seriously defective carbon 
dissimilation (consuming only 6.24 g l-1 glycerol after 23 h cultivation), cell growth (final cell 
density of 7.61 OD600), and metabolite production (no 3-HV and other odd-chain metabolites). The 
secreted acetate in P3HA31∆sdhA under AL-III accounted for 87% of dissimilated glycerol, which 
is more than 5-fold that in P3HA31 under the same aeration condition, implying a serious carbon 
spill associated with the stressful cell physiology. These results suggest that the dissimilated 
carbon flux was directed from the TCA cycle to the Sbm pathway for 3-HV biosynthesis via the 
reductive TCA branch under microaerobic conditions, and such carbon flux channeling became 























Figure 5.3: Disruption of sdhA in P3HA31 for 3-HV production under AL-I and AL-III. Time 
profiles of (a) cell growth (OD600), (b) glycerol consumption and metabolite production, and (c) 
percentage of 3-HB/3-HV/odd-chain metabolites theoretical yield based on consumed glycerol. 
Error bars represent ± SD from the mean of two replicates.  
 
 

































































































































a Measured cell density (OD600) throughout cultivation period using spectrophotometer, time 0h cell density (i.e., at the induction of IPTG) was in the range of 1.5-2.0 
b Defined as the percentage of the 3-HB/3-HV/odd-chain metabolites theoretical yield based on the consumed glycerol 
    Odd-chain metabolites include 3-HV, propionate, and 1-propanol     
   NA not applicable 
 






We further explored the 3-HV biosynthetic capacity in P3HA31∆sdhA under AL-I by 
extending the existing batch culture with three pulse glycerol feedings (i.e., Feeding 1-3), each at 
15 g l-1 (Figure 5.4). While there was no cell growth during the three feeding phases, cells 
continued to consume glycerol to form various metabolites. The 3-HV and odd-chain yields (i.e., 
combined yields of 3-HV, propionate, and 1-propanol) remained relatively constant (around 5-
7%), whereas the 3-HB yield continuously increased (from 10.4% to 31.5%) throughout the entire 
fed-batch cultivation, achieving final titers of 3.08 g l-1 3-HV and 7.19 g l-1 3-HB. Note that, in 
addition to a significant carbon spill in terms of acetate accumulation (15.0 g l-1), there was an 
uncommon and relatively high-level formation of succinate and malate (up to 3.22 and 7.5 g l-1, 































































































































a Measured cell density (OD600) throughout cultivation period using spectrophotometer, time 0h cell density (i.e., at the induction of IPTG) was in the range of 1.5-2.0 
b Defined as the percentage of the 3-HB/3-HV/odd-chain metabolites theoretical yield based on the consumed glycerol   
    Odd-chain metabolites include 3-HV, propionate, and 1-propanol  






Figure 5.4: Fed-batch cultivation of P3HA31∆sdhA under extended AL-I conditions. Time 
profiles of (a) cell growth (OD600), (b) glycerol consumption and metabolite production, and (c) 
percentage of 3-HB/3-HV/odd-chain metabolites theoretical yield based on consumed glycerol 
during each feeding phase. Dotted vertical lines in panels A and B separate batch, feeding 1, 
feeding 2, and feeding 3 stages of fermentation. Error bars represent ± SD from the mean of two 
replicates.  
5.3.3 Strain engineering for 3-HV biosynthesis under aerobic conditions 
While it is desirable to cultivate E. coli aerobically for effective carbon utilization and cell growth, 
3-HV biosynthesis was retarded in P3HA31 under AL-III likely due to insufficient carbon 
diversion from succinyl-CoA node, leading to shortage of propionyl-CoA. Hence, we explored 
metabolic direction of dissimilated carbon flux from the TCA cycle to the Sbm pathway via the 
glyoxylate shunt, which is metabolically active under aerobic conditions upon consumption of 
acetate/fatty acids (Cheng et al. 2013). To do this, we mutated iclR (encoding a repressor regulating 
the glyoxylate shunt) to derive P3HA31∆iclR with a deregulated glyoxylate shunt (Figure 5.5). 
Compared to the control strain P3HA31, P3HA31∆iclR had slightly improved glycerol 
dissimilation and cell growth under AL-III with the production of various metabolites, including 
4.44 g l-1 3-HB, 0.61 g l-1 3-HV, and 0.89 g l-1 propionate. In addition, the yield of odd-chain 
metabolites was approximately 7%, suggesting that the glyoxylate shunt was functional to supply 
succinate/succinyl-CoA as the precursor into the Sbm pathway. Interestingly, much more 
dissimilated carbon flux could be directed from the TCA cycle to the Sbm pathway upon 
combining the two mutations in the double mutant P3HA31∆sdhA∆iclR, significant enhancing the 
production of 3-HV (1.83 g l-1) and propionate (6.52 g l-1) under AL-III. Note that the yield of odd-
chain metabolites for P3HA31∆sdhA∆iclR was approximately 5-fold that for P3HA31∆iclR. Also, 
there was hardly any carbon spill in terms of acetate secretion, implying effective carbon utilization 
and minimal physiological stress upon aerobic cultivation of P3HA31∆sdhA∆iclR. Compared to 




production for P3HA31∆sdhA∆iclR under AL-III, suggesting that the significant carbon flux 
direction was associated with not only the operational glyoxylate shunt but also disrupted oxidative 

















































































































































a Measured cell density (OD600) throughout cultivation period using spectrophotometer, time 0h cell density (i.e., at the induction of IPTG) was in the range of 1.5-2.0 
b Defined as the percentage of the 3-HB/3-HV/odd-chain metabolites theoretical yield based on the consumed glycerol  
    Odd-chain metabolites include 3-HV and propionate 






Figure 5.5: Comparing the effects of P3HA31∆iclR and P3HA31∆sdhA∆iclR for 3-HV 
production under AL-III conditions. Time profiles of (a) cell growth (OD600), (b) glycerol 
consumption and metabolite production, and (c) percentage of 3-HB/3-HV/odd-chain metabolites 
theoretical yield based on consumed glycerol. Error bars represent ± SD from the mean of two 
replicates. 
5.3.4 Fed-batch cultivation for high-level 3-HV production under aerobic conditions 
To explore the full capacity of P3HA31∆sdhA∆iclR for 3-HV production, we conducted fed-batch 
cultivation under AL-III (Figure 5.6). Basically, there was no further cell growth and most cells 
remained viable and metabolically active in all the three feeding phases. In the Feeding 1 phase, 
the additional glycerol was effectively utilized for metabolite production with the overall yields 
for 3-HB, 3-HV, and odd-chain metabolites reaching 56.7%, 23.3%, and 45.5%, respectively. 
Interestingly, the sum of 3-HB and odd-chain metabolite yields achieved ~100%, suggesting that 
metabolite production was extremely effective with no carbon spill. The subsequent Feeding 2 and 
3 phases displayed a steady decrease in 3-HV (as well as 3-HB and propionate) production, 
reflected by monotonically decreasing 3-HV (and 3-HB and odd-chain metabolite) yields. The 
decreasing capacity for metabolite production occurred simultaneously with persistent acetate 
secretion, which started at the end of Feeding 1 and reached a high level of 12.3 g l-1 at the end of 
Feeding 3. Such drastic carbon spill suggested that cells experienced deteriorated physiology, 
limiting the overall cultivation performance. Nevertheless, the final 3-HV, 3-HB, and propionate 
titers of the fed-batch cultivation under AL-III reached 7.3 g l-1, 11.3 g l-1, and 11.9 g l-1, 
respectively. To reduce acetate secretion, we conducted another similar fed-batch cultivation by 
increasing the air flowrate into the bulk culture to 2 vvm during the initial batch stage and then to 
4 vvm during the three feeding phases (AL-IV) (Figure 5.7). The initial batch stages for the two 
fed-batch cultures under AL-III and AL-IV behaved similarly in cell growth and metabolite 




the Feeding 1 phase under a higher aeration rate of AL-IV. The glycerol dissimilation rate during 
the three feeding phases also increased under AL-IV, reducing the overall cultivation time from 
118 h to 98 h. Most importantly, the production of key metabolites significantly improved with a 
much reduced carbon spill. The most effective metabolite production period occurred in the 
Feeding 2 phase, with the overall yields for 3-HB, 3-HV, and odd-chain metabolites reaching 
43.4%, 36.5%, and 54.7%, respectively. Note that the sum of 3-HB and odd-chain metabolite 
yields also achieved ~100%. Compared to the AL-III fed-batch culture, the onset of acetate 
secretion of the AL-IV fed-batch culture was delayed to the early Feeding 2 phase and acetate 
reached a lower level of 8.1 g l-1 at the end of Feeding 3. The final 3-HV, 3-HB, and propionate 
titers of the AL-IV fed-batch culture reached high levels of 10.6 g l-1, 11.3 g l-1, and 12.7 g l-1, 
equivalent to overall yields of 18.8%, 22.8%, and 18.1%, respectively. To the best of our 
knowledge, the current report represents the most effective bio-based production of 3-HV to date 






























































































































Figure 5.6: Fed-batch cultivation of P3HA31∆sdhA∆iclR under extended AL-III conditions. 
Time profiles of (a) cell growth (OD600), (b) glycerol consumption and metabolite production, and 
(c) percentage of 3-HB/3-HV/odd-chain metabolites theoretical yield based on consumed glycerol 
during each feeding phase. Dotted vertical lines in panels A and B separate batch, feeding 1, 
feeding 2, and feeding 3 stages of fermentation. Error bars represent ± SD from the mean of two 
replicates. 
 
a Measured cell density (OD600) throughout cultivation period using spectrophotometer, time 0h cell density (i.e., at the induction of IPTG) was in the range of 1.5-2.0 
b Defined as the percentage of the 3-HB/3-HV/odd-chain metabolites theoretical yield based on the consumed glycerol 





























































































































Figure 5.7: Fed-batch cultivation of P3HA31∆sdhA∆iclR under AL-IV conditions. Time 
profiles of (a) cell growth (OD600), (b) glycerol consumption and metabolite production, and (c) 
percentage of 3-HB/3-HV/odd-chain metabolites theoretical yield based on consumed glycerol 
during each feeding phase. Dotted vertical lines in panels A and B separate batch, feeding 1, 
feeding 2, and feeding 3 stages of fermentation. Black arrow indicates the point of airflow switch 
from 2 vvm to 4 vvm. Error bars represent ± SD from the mean of two replicates. 
 
a Measured cell density (OD600) throughout cultivation period using spectrophotometer, time 0h cell density (i.e., at the induction of IPTG) was in the range of 1.5-2.0 
b Defined as the percentage of the 3-HB/3-HV/odd-chain metabolites theoretical yield based on the consumed glycerol   








Several physiological and metabolic factors can potentially affect 3-HV production, including cell 
growth (and glycerol dissimilation), intracellular abundance of propionyl-CoA as a key precursor, 
and metabolic activity of the hydroxyacid biosynthetic pathway. Our results suggest that the first 
two, but not the third one, were highly sensitive to the oxygenic condition of the culture. While 
the Sbm fermentation was favored by anaerobiosis, reflected by a higher odd-chain yield for 
P3HA31 under AL-I than that under AL-II or AL-III, the low oxygenic level retarded cell growth, 
resulting in a high carbon spill. The acetate accumulation could also limit carbon flux toward the 
reductive TCA branch at the PEP node (Figure 5.1), which was identified as the major route for 
dissimilated carbon being directed toward the Sbm pathway (Srirangan et al. 2016a). The two 
issues of retarded cell growth and high acetate secretion were simultaneously resolved upon 
marginally increasing the oxygenic level through cultivation of P3HA31 under AL-II. However, 
the resolution was at the expense of a reduced propionyl-CoA level, reflected by significantly 
lower 3-HV and odd-chain yields for the AL-II culture, compared to the AL-I culture. Further 
increasing the oxygenic level upon cultivation of P3HA31 under AL-III abolished the production 
of 3-HV and other odd-chain metabolites though cell growth was effective, implying that more 
dissimilated carbon flux upon glycolysis was directed toward the acetyl-CoA node rather than the 
PEP node into the reductive TCA branch. Consistently, acetate accumulated more under AL-III 
potentially due to an increased level of acetyl-CoA. On the other hand, the metabolic activity of 3-
hydroxyacid biosynthetic pathway was minimally affected by the oxygenic condition as the sums 
of the overall 3-HV and 3-HB yields were approximately the same for the three P3HA31 cultures, 
i.e., 27.0%, 29.5%, 28.1% for AL-I, AL-II, and AL-III, respectively (Figure 5.2), suggesting that 




As succinate (and, therefore, succinyl-CoA) is a key precursor predating the Sbm pathway, 
the level of the Sbm fermentation can depend on the supply of succinate. Intracellular formation 
of succinate can be achieved via three oxygen-dependent pathways, i.e., (i) reductive TCA branch 
(i.e., reverse TCA cycle), (ii) oxidative TCA cycle, and (iii) glyoxylate shunt (Cheng et al. 2013). 
Normally, succinate accumulates as an end-product of mixed acid fermentation in E. coli via the 
reductive TCA branch which is activated under anaerobic conditions (Cheng et al. 2013; Thakker 
et al. 2012). Although the reductive TCA branch can potentially yield high-level succinate, its 
metabolic activity for biosynthesis is often limited by the availability of reducing equivalents (i.e., 
NADH) (Skorokhodova et al. 2015). Under aerobic conditions, succinate is normally used up as 
an intermediate of the oxidative TCA cycle without accumulation, except for the conditions of 
oxidative stress and/or acetate/fatty-acid consumption under which succinate can be aerobically 
derived via an operational glyoxylate shunt (Cheng et al. 2013; Thakker et al. 2012). Glyoxylate 
shunt can provide anaplerotic reactions and bypass the CO2-producing steps in the oxidative TCA 
cycle, thereby conserving carbon atoms for the cell (Gottschalk 1986; Kornberg and Madsen 
1957). Given that succinate is involved in the central metabolism, manipulation of carbon flux 
around this C4-dicarboxylate can be challenging due to high oxygen sensitivity for its production. 
Therefore, proper operation of the TCA cycle can effectively direct dissimilated carbon flux 
toward the Sbm pathway to form propionyl-CoA. 
By inactivating the oxidative TCA cycle in P3HA31∆sdhA under microaerobic conditions, 
more dissimilated carbon flux could be channeled to the Sbm pathway via the reductive TCA 
branch to form propionyl-CoA. While cell growth and 3-HV biosynthesis under microaerobic 
conditions were enhanced compared to the control strain P3HA31, significant carbon spill still 




conditions even resulted in uncommon and significant accumulation of TCA metabolites of malate 
and succinate, potentially associated with reduced enzyme activities of FumB and SucCD in the 
reductive TCA branch and consequently, limited the carbon flux channeling to the Sbm pathway.  
Under aerobic conditions such as AL-III, the control strain P3HA31 primarily operated the 
oxidative TCA cycle for respiration. Thus, inactivating the TCA oxidative cycle in P3HA31∆sdhA 
under AL-III significantly retarded cell growth with limited glycerol dissimilation and metabolite 
production. Substantial inhibition of the TCA cycle under a high oxygen exposure was previously 
observed upon disruption of the succinate dehydrogenase complex in E. coli, resulting in reduced 
supply of NADH to the aerobic respiratory chain, and thus diminished cell growth/metabolic 
activity (Guest 1981; Steinsiek et al. 2011). Glyoxylate shunt could serve as an alternative route 
to drive the TCA cycle under aerobic conditions (Nègre et al. 1992; Sunnarborg et al. 1990), and 
deregulation of the glyoxylate shunt via the iclR mutation in P3HA31 could potentially enhance 
the metabolic activity of this pathway, resulting in not only vigorous cell growth but also 
metabolite biosynthesis. Note that the final 3-HB and 3-HV titers for P3HA31∆iclR went up to 
4.44 and 0.61 g l-1, respectively, equivalent to 26.3% and 3.2% yields, suggesting that 3-
hydroxyacid biosynthesis was quite active under AL-III. The production of propionate and 3-HV, 
though with a decent overall odd-chain yield of 6.9%, suggested that the Sbm pathway was active 
in P3HA31∆iclR under AL-III. In comparison to higher odd-chain yields obtained under more 
anaerobic conditions, the relatively low odd-chain yield for P3HA31∆iclR under AL-III was 
primarily associated with the active TCA oxidative cycle, which caused a carbon flux diversion at 
the succinate node. Importantly, the flux diversion could be prevented with enhanced production 
of the odd-chain metabolites by simultaneous knockout of sdhA and iclR in P3HA31. Up to 6.52 




produced in P3HA31sdhAiclR under AL-III, suggesting that more dissimilated carbon flux was 
successfully directed from the TCA cycle to the Sbm pathway. Such carbon flux channeling hardly 
occurred when the oxidative TCA branch was functional, resulting in no production of odd-chain 
metabolites in the control strain P3HA31 under AL-III. The severely retarded glycerol 
dissimilation and cell growth for P3HA31sdhA could be complemented by the iclR mutation, 
suggesting that both the oxidative TCA cycle and glyoxylate shunt contributed to active TCA 
operation for sustained cell growth under AL-III. Our results also suggested that the dissimilated 
carbon flux was directed from the TCA cycle to the Sbm pathway via glyoxylate shunt and 
reductive TCA branch rather than oxidative TCA branch. Furthermore, the sum of 3-HB and 3-
HV yields was somewhat lower in P3HA31sdhAiclR (21.3%) than P3HA31iclR (29.5%); and 
such reduction was primarily associated with an effective propionate production in 
P3HA31sdhAiclR than reduced 3-hydroxyacid biosynthesis. Finally, it is noteworthy that the 
secreted acetate could be dissimilated in P3HA31iclR toward the end of batch cultivation and 
acetate was not even secreted in P3HA31sdhAiclR, suggesting that the enhanced glyoxylate 
shunt with a disrupted oxidative TCA cycle could facilitate not only acetyl-CoA utilization, 
thereby reducing carbon spill, but also carbon direction from the TCA cycle to the Sbm pathway 
for biosynthesis of odd-chain metabolites. As the Sbm fermentation still occurred under AL-III for 
P3HA31sdhAiclR, the lack of 3-HV production in the control strain P3HA31 under AL-III was 
primarily associated with the shortage of succinate precursor and inactive glyoxylate shunt for the 
carbon flux direction. 
Using the engineered strain P3HA31∆sdhA∆iclR, we further demonstrated its high 
capacity for producing both 3-HV and 3-HB through fed-batch cultivation under aerobic 




under AL-III and Feeding 2 under AL-IV, metabolite production was extremely effective with no 
carbon spill, and a total 3-hydroxyacid yield of ~80% was achieved. It is worth highlighting that 
the metabolite-producing capacity was actively maintained throughout most of the three feeding 
phases of both fed-batch cultures. Nevertheless, 3-hydroxyacid production was limited by carbon 
spill toward acetogenesis particularly during the Feeding 2 and 3 phases in the AL-III fed-batch 
culture, resulting in high-level acetate secretion. Such carbon spill was shown to be associated 
with oxygen limitation since increasing the aeration rate in the AL-IV fed-batch culture could 
significantly reduce acetate secretion with enhanced 3-HV production. It was previously reported 
that increasing the culture aerobicity can potentially enable cells to recycle accumulated acetyl-
CoA (thereby reduce acetate formation) for biosynthesis through enhanced glyoxylate shunt, 
which involves acetyl-CoA as a co-substrate and is typically active under aerobic conditions (Ahn 
et al. 2016; Renilla et al. 2012). Nevertheless, complete elimination of acetate during aerobic 
growth of E. coli can be a rather difficult task due to physiological challenges of overflow 
metabolism (data not shown).   
In summary, our results suggest that the Sbm pathway can be metabolically active under 
both anaerobic and aerobic conditions for 3-HV to be produced. In addition, the production of 3-
HV (and other odd-chain metabolites derived from propionyl-CoA) can be critically limited by the 
level of the dissimilated carbon flux directed from the TCA cycle to the Sbm pathway, and such 
carbon flux direction can be enhanced by manipulation of key TCA genes (i.e., sdhA and iclR) in 








Strain engineering for high-level 5-aminolevulinic acid 





5-Aminolevulinic acid (5-ALA) is a non-proteinogenic amino acid existing in most living 
organisms as a metabolic intermediate toward biosynthesis of essential tetrapyrrole/porphyrin 
pigment compounds, such as heme (Schlicke et al. 2015) (Figure 6.1). Practically, 5-ALA has 
broad applications in many fields, such as medicine (Inoue 2017; Juzeniene et al. 2002), agriculture 
(Hotta et al. 1997), and food preservation (Li et al. 2016). In nature, there are two major metabolic 
routes for 5-ALA biosynthesis, i.e., (i) C4 (also known as Shemin) pathway (mainly existing in 
mammals, fungi, and purple sulphur bacteria), in which succinyl-CoA and glycine are structurally 
fused by 5-aminolevulinate synthase (ALAS or HemA) to form 5-ALA (Kang et al. 2004), and (ii) 
C5 pathway (existing in most bacteria, all archaea and plants), in which glutamate is converted to 
5-ALA via three enzymatic reactions of ligation, reduction, and transamination catalyzed by 
glutamyl-tRNA synthase (GluTS), glutamyl-tRNA reductase (GluTR), and glutamate-1-
semialdehyde-2,1-aminomutase (GSAM), respectively (Woodard and Dailey 1995).  
While 5-ALA can be chemically derived from various precursors, such as levulinic acid 
(MacDonald 1974), tetrahydrofurfurylamine (Kawakami et al. 1991), 5-bromo esters (Ha et al. 
1994), and N-furfurylphthalimide (Takeya et al. 1996), these synthetic approaches are deemed 
uneconomical and the production processes are often complicated for implementation with low 
yields (Kang et al. 2017). As a result, bio-based production of 5-ALA using either multi-enzyme 




particular photosynthetic microorganisms, such as Rhodobacter sphaeroides, Rhodopseudomonas 
palustris, and Chlorella sp. (Sasaki et al. 1995), Streptomyces coelicolor (Tran et al. 2019), 
Corynebacterium glutamicum (Zhang and Ye 2018), as well as genetically tractable Escherichia 
coli (Ding et al. 2017; Zhang et al. 2015; Zhang et al. 2019).  
By initializing the formation of essential porphyrin compounds, 5-ALA is among the most 
conserved metabolites across all biological kingdoms (Petříčková et al. 2015; Yu et al. 2015). 
However, 5-ALA normally acts as a metabolic intermediate toward porphyrin biosynthesis with 
minimal accumulation, limiting its overproduction. In virtually all biological systems, porphyrins, 
such as heme, serve as a prosthetic group in many essential proteins (i.e., cytochromes and heme-
containing globins) (Asakura and Yonetani 1969; Li et al. 1993), and also operate as regulatory 
molecules in numerous cellular roles/processes (i.e.,  transcription, translation, protein stability, 
and differentiation) (Padmanaban et al. 1989; Ponka 1999). Given the imperative physiological 
role of porphyrin compounds, attempting to accumulate 5-ALA by inactivation of the immediate 
post-5-ALA conversion catalyzed by 5-ALA dehydratase (HemB, encoded by hemB) would 
abolish porphyrin biosynthesis (Figure 6.1) and, therefore, be detrimental to the cells. Previous 
attempts at hemB repression in E. coli through direct engineering of the hemB open reading frame 
(ORF) (Kang et al. 2011) and start codon (Ding et al. 2017) were not particularly effective in 
accumulating 5-ALA. While Clustered Regularly Interspersed Short Palindromic Repeats 
interference (CRISPRi) was recently applied to repress hemB expression in E. coli (Su et al. 2019), 
5-ALA production could be metabolically limited by the use of the native C5 pathway. The C5 
metabolic route is considered mechanistically complex and energetically demanding, particularly 
upon high-level 5-ALA biosynthesis, as it requires multiple tightly regulated enzymes (Wang et 




for high-level biosynthesis of a target metabolite, it is critical to ensure intracellular abundance of 
the corresponding precursors, i.e., glutamate for the C5 pathway or succinyl-CoA/glycine for the 
Shemin pathway in the 5-ALA case. This is normally achieved by metabolic direction of the 
dissimilated carbon flux into key pathways, otherwise exogenous supplementation of structurally 
related carbons, which are often expensive, might be necessary. 
Considering the above technical aspects/limitations, we chose to implement the Shemin 
pathway into E. coli for heterologous 5-ALA biosynthesis with metabolic direction of the 
dissimilated carbon flux toward the oxygen-sensitive formation of succinyl-CoA in the 
tricarboxylic acid (TCA) cycle. In E. coli, succinate (and, therefore, succinyl-CoA) can be derived 
via three oxygen-dependent pathways, i.e., (i) reductive TCA branch, (ii) oxidative TCA cycle, 
and (iii) glyoxylate shunt (Figure 6.1) (Cheng et al. 2013). Under anaerobic conditions, succinate 
serves as an electron acceptor (instead of oxygen) and accumulates as an end-product of mixed 
acid fermentation via the reductive TCA branch (Thakker et al. 2012). Although the reductive 
TCA branch can potentially yield high-level succinate, this pathway is generally unfavorable due 
to the limited availability of reducing equivalents (Skorokhodova et al. 2015). Under aerobic 
conditions, succinate is normally used up as a metabolic intermediate of the oxidative TCA cycle 
without accumulation, except for the conditions of oxidative stress and/or acetate/fatty-acid 
consumption under which succinate can be aerobically derived via the operational glyoxylate shunt 
(Thakker et al. 2012). Moreover, without supplementation of structurally-related carbons, glycerol 
can be used as the sole carbon source for cultivation of engineered E. coli strains due to its low 
cost (Ciriminna et al. 2014) and highly reduced nature, generating approximately twice the number 
of reducing equivalents upon its degradation compared to traditional fermentable sugars (Murarka 




In this study, we explored strain engineering strategies for high-level 5-ALA production in 
E. coli using Shemin pathway. We applied CRISPRi by targeting sequences in the promoter and 
ORF to repress hemB expression and, therefore, increase 5-ALA accumulation without imposing 
physiological impacts to the 5-ALA-producing cells. Using various engineered E. coli strains for 
bioreactor cultivation, we demonstrated high-level 5-ALA biosynthesis under both microaerobic 































Figure 6.1: Schematic representation of the natural metabolism and the implemented 
Shemin pathway for 5-ALA and porphyrin biosynthesis in E. coli from glycerol. Metabolic 
pathways outlined: glycolysis, glycine biosynthesis, pyruvate carboxylation, and oxidative TCA 
cycle (in black); glyoxylate shunt in the TCA cycle (in light brown); reductive branch of TCA 
cycle (in blue); Shemin pathway (in green); porphyrin biosynthesis (in red). Colored proteins: 
mutations (in red); overexpression (in purple). Metabolite abbreviations: 5,10-MTH, 5,10-
methenyltetrahydrofolic acid; 5-ALA, 5-aminolevulinic acid; 3-PG, 3-phosphoglycerate; 3-PP, 3-
phosphooxypyruvate; O-P-Serine, O-phospho-L-serine; PBG, porphobilinogen; PEP, 
phosphoenolpyruvate. The number of carbon atoms for each metabolite is specified in orange. 
Protein abbreviations: AceA, isocitrate lyase; AceB, malate synthase A; AceK, isocitrate 
dehydrogenase kinase/phosphatase; AckA, acetate kinase; AdhE, aldehyde-alcohol 
dehydrogenase; FHL, formate hydrogenlyase; HemA, 5-aminolevulinate synthase; HemB, 5-
aminolevulinate dehydratase; IclR, AceBAK operon repressor; IDH, isocitrate dehydrogenase; 
IDH-P, isocitrate dehydrogenase-phosphate; LdhA, lactate dehydrogenase A; PC, pyruvate 
carboxylase; PckA, phosphoenolpyruvate carboxykinase; PDH, pyruvate dehydrogenase; PFL, 
pyruvate formate-lyase; PK, pyruvate kinase; PPC, phosphoenolpyruvate carboxylase; Pta, 
phosphotransacetylase; SdhA, succinate dehydrogenase complex (subunit A). 
6.2 Materials and Methods 
6.2.1 Bacterial strains and plasmids 
Bacterial strains, plasmids, and oligonucleotide sequences used in this study are listed in Table 
6.1. Genomic DNA from bacterial cells was isolated using the Blood & Tissue DNA Isolation Kit 
(Qiagen, Hilden, Germany). Standard recombinant DNA technologies were applied for molecular 
cloning (Miller 1992). Taq DNA polymerase was obtained from New England Biolabs (Ipswich, 
MA, USA). All synthesized oligonucleotides were obtained from Integrated DNA Technologies 
(Coralville, IA, USA). DNA sequencing was conducted by the Centre for Applied Genomics at 
the Hospital for Sick Children (Toronto, Canada). E. coli BW25113 was the parental strain for 
derivation of all engineered strains in this study and E. coli DH5α was used as a host for molecular 
cloning. Note that the ldhA gene (encoding lactate dehydrogenase) was previously inactivated in 
BW25113, generating BW∆ldhA (Srirangan et al. 2014), a strain with higher metabolic potential 




For genetic implementation of the Shemin pathway in E. coli, the hemA gene was first 
amplified by polymerase chain reaction (PCR) using the primer set g-hemA and the genomic DNA 
of wild-type Rhodobacter sphaeroides DSM 158 as the template. The amplified hemA gene was 
Gibson–assembled with the PCR-linearized pK184 using the primer set g-pK-hemA to generate 
pK-hemA. The expression of the cloned hemA gene in the pK184 vector was under the control of 
the Plac promoter.   
Knockouts of the genes, including sdhA (encoding succinate dehydrogenase (SDH) 
complex flavoprotein subunit A, SdhA) and iclR (encoding transcriptional AceBAK operon 
repressor, IclR), were introduced into BW∆ldhA by P1 phage transduction (Miller 1992) using the 
appropriate Keio Collection strains (The Coli Genetic Stock Center, Yale University, New Haven, 
CT, USA) as donors (Baba et al. 2006). To eliminate the co-transduced FRT-KnR-FRT cassette, 
the transductants were transformed with pCP20 (Cherepanov and Wackernagel 1995), a 
temperature sensitive plasmid expressing a flippase (Flp) recombinase. Upon Flp-mediated 
excision of the KnR cassette, a single Flp recognition site (FRT “scar site”) was generated. Plasmid 
pCP20 was then cured by growing cells at 42°C. The genotypes of derived knockout strains were 
confirmed by colony PCR using the appropriate verification primer sets listed in Table 6.1. 
The expression of hemB was repressed by CRISPRi using various derived plasmids from 
pdcas9-bacteria (Addgene plasmid # 44249) and pgRNA-bacteria (Addgene plasmid # 44251). All 
synthesized oligonucleotide pairs have 60 nucleotides (nt), which includes 20 nt hemB-targeting 
sequence, 20 nt upstream and 20 nt downstream sequences of pgRNA-bacteria vector (Figure 6.2). 
They were ordered from Integrated DNA Technologies (Coralville, IA, USA) and annealed as 
described previously (Pengpumkiat et al. 2016), generating four double-stranded DNA fragments 




four DNA fragments were individually Gibson-assembled with the PCR-linearized pgRNA-
bacteria using the primer set g-pgRNA to generate pgRNA-L1, pgRNA-L2, pgRNA-L3, and 
pgRNA-L4, respectively (Table 6.1). The four hemB-repressed strains, i.e., DMH-L1, DMH-L2, 
DMH-L3, and DMH-L4, were developed by creating a triple-plasmid system (Figure 6.2) 
containing pK-hemA, pdcas9-bacteria, and the gRNA-containing plasmid (i.e., pgRNA-L1, 
pgRNA-L2, pgRNA-L3, or pgRNA-L4). For the control strain DMH-CT, the original pgRNA-
bacteria plasmid without any hemB-targeting sequence was used as the third plasmid.  
6.2.2 Media and bacterial cell cultivation 
All medium components were obtained from Sigma-Aldrich Co. (St Louis, MO, USA) except 
yeast extract and tryptone which were obtained from BD Diagnostic Systems (Franklin Lakes, NJ, 
USA). E. coli strains, stored as glycerol stocks at -80°C, were streaked on lysogeny broth (LB; 10 
g l-1 tryptone, 5 g l-1 yeast extract, and 5 g l-1 NaCl) agar plates and incubated at 37°C for 14-16 
hours.  
For shake-flask cultivations, single colonies were picked from LB plates to inoculate 30 
ml LB medium in 125 ml conical flasks. The cultures were shaken at 37°C and 280 rpm in a rotary 
shaker (New Brunswick Scientific, NJ, USA) and used as seed cultures to inoculate 220 ml LB 
media at 1% (v/v) in 1 L conical flasks. This second seed culture was shaken at 37°C and 280 rpm 
until a cell density of 0.80 OD600 was reached. Cells were then harvested by centrifugation at 9,000 
×g and 20°C for 10 minutes and resuspended in 30 ml modified M9 production media. The 
suspended culture was transferred into a 125 ml screwed cap plastic production flasks and 
incubated at 37°C at 280 rpm in a rotary shaker. Unless otherwise specified, the modified M9 
production medium contained 20 g l-1 glycerol, 5 g l-1 yeast extract, 10 mM NaHCO3, 1 mM MgCl2, 
200 ml l-1 of M9 salts mix (33.9 g l-1 Na2HPO4, 15 g l
-1 KH2PO4, 5 g l
-1 NH4Cl, 2.5 g l




ml l-1 dilution of Trace Metal Mix A5 (2.86 g l-1 H3BO3, 1.81 g l
-1 MnCl2•4H2O, 0.222 g l
-1 
ZnSO4•7H2O, 0.39 g l
-1 Na2MoO4•2H2O, 79 µg l
-1 CuSO4•5H2O, 49.4 µg l
-1 Co(NO3)2•6H2O), and 
was supplemented with 0.1 mM isopropyl β-D-1-thiogalactopyranoside (IPTG). All shake-flask 
cultivation experiments were performed in triplicate. 
For bioreactor cultivations, single colonies were picked from LB plates to inoculate 30 mL 
super broth (SB) medium (32 g l-1 tryptone, 20 g l-1 yeast extract, and 5 g l-1 NaCl) in 125 mL 
conical flasks. The overnight cultures were shaken at 37°C and 280 rpm in a rotary shaker (New 
Brunswick Scientific, NJ, USA) and used as seed cultures to inoculate 220 mL SB media at 1% 
(v/v) in 1 L conical flasks. This second seed culture was shaken at 37°C and 280 rpm for 14-16 
hours. Cells were then harvested by centrifugation at 9,000×g and 20°C for 10 minutes and 
resuspended in 50 mL fresh LB media. The suspended culture was used to inoculate a 1 L stirred 
tank bioreactor (containing two Rushton radial flow disks as impellers) (CelliGen 115, Eppendorf 
AG, Hamburg, Germany) at 37°C and 430 rpm. The semi-defined production medium in the batch 
bioreactor contained 30 g l−1 glycerol, 0.23 g l−1 K2HPO4, 0.51 g l
−1 NH4Cl, 49.8 mg l
−1 MgCl2, 
48.1 mg l−1 K2SO4, 1.52 mg l
−1 FeSO4, 0.055 mg l
−1 CaCl2, 2.93 g l
−1 NaCl, 0.72 g l−1 tricine, 10 
g l−1 yeast extract, 10 mM NaHCO3, and 1 ml l
−1 trace elements (2.86 g l−1 H3BO3, 1.81 g l
−1 
MnCl2• 4H2O, 0.222 g l
−1 ZnSO4• 7H2O, 0.39 g l
−1 Na2MoO4• 2H2O, 79 μg l
−1 CuSO4• 5H2O, 49.4 
μg l−1 Co(NO3)2• 6H2O) (Neidhardt et al. 1974), and was supplemented with 0.1 mM isopropyl β-
D-1-thiogalactopyranoside (IPTG). Microaerobic and semiaerobic conditions were maintained by 
purging air into the headspace and bulk culture, respectively, at 0.1 vvm, designated as aeration 
level I (AL-I) and II (AL-II). Aerobic conditions were maintained by purging air into the bulk 
culture at 1 vvm (AL-III). The pH of the production culture was maintained at 7.0 ± 0.1 with 30% 





Culture samples were appropriately diluted with 0.15 M saline solution for measuring cell density 
in OD600 using a spectrophotometer (DU520, Beckman Coulter, Fullerton, CA). Cell-free medium 
was prepared by centrifugation of the culture sample at 9,000×g for 5 minutes, followed by filter 
sterilization using a 0.2 µM syringe filter. Extracellular metabolites and glycerol were quantified 
using high-performance liquid chromatography (HPLC) (LC-10AT, Shimadzu, Kyoto, Japan) 
with a refractive index detector (RID; RID-10A, Shimadzu, Kyoto, Japan) and a chromatographic 
column (Aminex HPX-87H, Bio-Rad Laboratories, CA, USA). The HPLC column temperature 
was maintained at 35°C and the mobile phase was 5 mM H2SO4 (pH 2) running at 0.6 mL min
-1. 
The RID signal was acquired and processed by a data processing unit (Clarity Lite, DataApex, 
Prague, Czech Republic). 
The 5-ALA titer in the cell-free medium was measured using a modified Ehrlich’s reagent 
(Mauzerall and Granick 1956). The percentage yield of 5-ALA was defined as the mole (or mass) 
ratio of the produced 5-ALA to the theoretically maximal 5-ALA produced based on the consumed 
glycerol with a molar ratio of one-to-three (i.e., one mole 5-ALA produced per three moles glycerol 
consumed). Note that one-mole succinyl-CoA (derived from two-mole glycerol) and one-mole 
glycine (derived from one-mole glycerol) are required to generate one-mole 5-ALA. The bulk level 
of secreted porphyrin compounds in the cell-free medium was estimated using a spectrophotometer 
at two specific wavelengths, i.e., OD405 (measuring Soret band) and OD495 (measuring Q-band).   
6.2.4 Real-time quantitative reverse transcription PCR (qRT-PCR) 
Cells used for RNA extraction were cultivated in 30 mL liquid LB medium at 37°C and harvested 
in the exponential growth phase. Total RNA of E. coli was extracted using the High Pure RNA 




Complementary DNAs (cDNAs) were synthesized using the High-Capacity cDNA Reverse 
Transcription Kit (ThermoFisher Scientific, MA). Sequence specific primers were used for reverse 
transcription of hemB mRNA (i.e., q-hemB) and internal control rrsA (encoding ribosomal RNA 
16S) mRNA (i.e., q-rrsA) (Table 6.1), at a final concentration of 1 µM. 100 ng of the total RNA 
was used in a 20 µL reaction mixture. Real-time qRT-PCR was carried out using the Power 
SYBR® Green PCR Master Mix (ThermoFisher Scientific; MA) in an Applied Biosystems 















Name  Description, relevant genotype or primer/oligo sequence (5’  3’) Source 
E. coli host strains     
     DH5α F−, endA1, glnV44, thi-1, recA1, relA1, gyrA96, deoR, nupG φ80d lacZ∆acZd ladlacZYA – argF) 
U169, hsdR17(rK-mK +), λ- 
Lab stock 
     BW25113 F-, ∆(araD-araB)567, ∆lacZ4787(::rrnB-3), λ-, rph-1, ∆(rhaD-rhaB)568, hsdR514 (Datsenko and Wanner 2000) 
     BW∆ldhA BW25113 ldhA null mutant (Srirangan et al. 2014) 
     DMH BW∆ldhA/pK-hemA This study  
     DMH∆sdhA 
     DMH∆sdhA∆iclR 
sdhA null mutant of DMH 
sdhA and iclR mutants of DMH 
This study 
This study 
     DMH-CT DMH/pK-hemA/pgRNA-bacteria/pdcas9-bacteria This study 
     DMH-L1 DMH/pK-hemA/pgRNA-L1/pdcas9-bacteria This study 
     DMH-L2 DMH/pK-hemA/pgRNA-L2/pdcas9-bacteria This study 
     DMH-L3 DMH/pK-hemA/pgRNA-L3/pdcas9-bacteria This study 
     DMH-L4 DMH/pK-hemA/pgRNA-L4/pdcas9-bacteria This study 
     DMH-L4∆sdhA sdhA null mutant of DMH-L4 This study      
     DMH-L4∆iclR iclR null mutant of DMH-L4 This study 
     DMH-L4∆sdhA∆iclR sdhA and iclR null mutants of DMH-L4 This study 
Plasmids     
     pCP20 
     pK184 
Flp+, λ cI857+, λ pR Rep(pSC101 ori)ts, ApR, CmR 
p15A ori, KmR, Plac::lacZ’ 
(Cherepanov and Wackernagel 1995) 
(Jobling and Holmes 1990) 
     pdcas9-bacteria p15A ori, PTet-dCas9 (Qi et al. 2013) 
     pgRNA-bacteria ColE1 origin, PJ23119-gRNA  (Qi et al. 2013) 
     pgRNA-L1 Derived from pgRNA-bacteria, PspeI::hemB-gRNA-L1 This study 
     pgRNA-L2 Derived from pgRNA-bacteria, PspeI::hemB-gRNA-L2 This study 
     pgRNA-L3 Derived from pgRNA-bacteria, PspeI::hemB-gRNA-L3 This study 
     pgRNA-L4 Derived from pgRNA-bacteria, PspeI::hemB-gRNA-L4 This study 
     pK-hemA Derived from pTrc99a, Ptrc::phaAB This study 
Primers/oligo name   
     v-ldhA GATAACGGAGATCGGGAATGATTAA;  
GGTTTAAAAGCGTCGATGTCCAGTA 
(Akawi et al. 2015) 
     v-sdhA CTCTGCGTTCACCAAAGTGT;  
ACACACCTTCACGGCAGGAG 
This study 
     v-iclR GGTGGAATGAGATCTTGCGA;  
CCGACACGCTCAACCCAGAT 
This study 
     c-frt AGATTGCAGCATTACACGTCTTGAG;  
CCAGCTGCATTAATGAATCGGGCCATGGTCCATATGAATATCCTCC 
(Srirangan et al. 2014) 
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     cf-gRNA 
 
     q-hemB 
 
     q-rrsA 
 
     g-hemA 
 
     g-pK-hemA 
 
     g-pgRNA 
 
     hemB-gRNA-L1 
 
     hemB-gRNA-L2 
 
     hemB-gRNA-L3 
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This study  
Notation for oligonucleotides: v-verification primer, c-cloning primer, cf- confirmation primer, q-reverse transcription primers, and g-Gibson DNA assembly 





























































































Figure 6.2: Design strategy for CRISPRi-mediated hemB repression. The three plasmids with 
their major genetic features, such as promoters, selection markers, key genes, are shown. The 
design of hemB-targeting sequences and their associated interacting spots in the hemB gene (i.e., 
L1, L2, L3, and L4) and the predicted repression efficiencies (numbers in parenthesis) are shown. 
The resulting hemB-repressed strains, i.e., DMH-CT (control), DMH-L1, DMH-L2, DMH-L3, and 
DMH-L4, were characterized for quantification of the relative hemB expression using qRT-PCR. 
All qRT-PCR values are reported as means ± SD (n = 2).  
6.3 Results 
6.3.1 Repression of hemB expression for extracellular 5-ALA accumulation  
We first implemented the Shemin pathway by episomal expression of hemA from R. sphaeroides 
in BW∆ldhA, deriving DMH. The effects of the implemented Shemin pathway were observed by 
comparing the two cultures of BW∆ldhA and DMH in screw-cap shake-flasks containing 20 g l-1 
glycerol as the sole carbon source. Note that all percentage yields of 5-ALA reported in this study 
were calculated based on the ratio of the produced 5-ALA to the theoretical maximum based on 
consumed glycerol. While BW∆ldhA generated no detectable levels of 5-ALA or porphyrin, DMH 
produced 0.44 g l-1 5-ALA (5.22% yield) with considerable porphyrin biosynthesis (Figure 6.3), 
suggesting that the Shemin pathway was active in DMH. In particular, the dark red color of the 
DMH culture (Figure 6.3) suggests that a considerable amount of glycerol was converted to 
porphyrin pigments with limited 5-ALA accumulation.  
 To prevent the above intracellular drainage of 5-ALA, we explored gene knockout of 
hemB, but failed to derive the corresponding mutant strain (data now shown), confirming that 
hemB is an essential gene. We then aimed to reduce the carbon flux toward porphyrin biosynthesis 
in DMH by repressing the expression of hemB (Figure 6.1), leading to a limited conversion of two 
5-ALA molecules into porphobiliongen (PBG) and extracellular 5-ALA accumulation. We applied 
CRISPRi by designing four hemB-targeting gRNAs with different relative expression efficiencies, 




6.3). Note that DMH-CT is the control strain without a hemB-specific gRNA for CRISPRi. While 
cell growth and glycerol consumption were minimally affected for all the triple-plasmid systems, 
suggesting that these strains had sufficient biosynthesis of essential porphyrins, all hemB-repressed 
strains showed increased extracellular 5-ALA accumulation compared to DMH-CT upon shake-
flask cultivation. In particular, DMH-L1 and DMH-L4 had both titers and yields up to 4-5 fold 
higher than the control strain DMH-CT (Figure 6.3). This substantial increase in 5-ALA 
accumulation in DMH-L1 (1.26 g l-1) and DMH-L4 (1.61 g l-1) occurred simultaneous with 
considerably reduced levels of the relative hemB expression at 67% and 40%, respectively (Figure 
6.2). Additional supporting evidence for the repressed hemB expression was reflected by the 
decrease in porphyrin biosynthesis in all four hemB-repressed strains as the degrees of 
pigmentation and the corresponding absorbances (in 405 and 495 nm) of the cell-free media were 
significantly lower than that of the control strain DMH-CT (Figure 6.3). Given the lowest relative 
hemB expression and the most superior extracellular 5-ALA accumulation in DMH-L4 among all 













































































































































































































































































































Figure 6.3: Shake-flask cultivation of hemB-repressed strains for 5-ALA accumulation. 
Strains compared include BW∆ldhA, DMH, DMH-CT, DMH-L1, DMH-L2, DMH-L3, and DMH-
L4. Results of the 48h shake-flask cultivation in (a) cell density (OD600), (b) glycerol consumption, 
(c) 5-ALA titer and percentage yield, and (d) porphyrin biosynthesis (represented by the 
absorbance readings of the Soret peak (OD405) and Q-band (OD495) and the images of cell-free 
media) are shown. All values are reported as means ± SD (n = 3).   
6.3.2 Effects of oxygenic condition on 5-ALA biosynthesis 
5-ALA biosynthesis via the Shemin pathway requires succinyl-CoA as one of the two key 
precursors. Several metabolic pathways are involved in succinyl-CoA formation in E. coli, i.e., 
reductive TCA branch, oxidative TCA cycle, and glyoxylate shunt (Figure 6.1). These metabolic 
pathways, along with cell growth and acetogenesis, can be sensitive to the oxygenic condition, 
which critically directs the dissimilated carbon flux toward succinyl-CoA for 5-ALA biosynthesis. 
To investigate such oxygenic effects, batch cultivation of the control strain DMH in a bioreactor 
containing 30 g l-1 glycerol (and 10 g l-1 yeast extract) was subject to three different levels of 
aeration, i.e., AL-I (microaerobic), AL-II (semiaerobic), and AL-III (aerobic) (Figure 6.4). While 
cell growth and glycerol consumption were favored by oxygen exposure, 5-ALA biosynthesis was 
more effective under lower aeration levels, i.e., 0.53 g l-1 (3.40% yield) under AL-I, 0.39 g l-1 
(2.44% yield) under AL-II, and 0.31 g l-1 (2.08% yield) under AL-III, presumably because more 
carbon was directed toward the succinyl-CoA node under microaerobic conditions. In addition, 
the reduced 5-ALA biosynthesis under aerobic conditions occurred with less porphyrin formation, 
reflected by a notably less pigmentation of the culture medium (Appendix A). Note that, in addition 
to low levels of 5-ALA biosynthesis in DMH under all investigated culture conditions, acetate was 
the major side metabolite with high yields up to 75.9%, implying a decent carbon spill at the acetyl-
CoA node. The results suggest that 5-ALA biosynthesis in DMH was favored by lower oxygenic 
levels and potentially limited by acetogenesis. Note that glycerol utilization and cell growth were 













Figure 6.4: Bioreactor cultivation of DMH for 5-ALA biosynthesis under different oxygenic conditions. Time profiles of cell 
density (OD600), glycerol consumption and metabolite production profiles, acetate and 5-ALA percentage yields, and porphyrin 
biosynthesis (represented by the absorbance readings of the Soret peak in OD405 and Q-band in OD495 and the images of cell-free media) 
are shown. The percentage yields of acetate/5-ALA and absorbance readings of porphyrin compounds are calculated/measured based 
on the consumed glycerol at the end of cultivation. (I) AL-I: microaerobic, (II) AL-II: semi-aerobic, and (III) AL-III: aerobic. All values 
are reported as means ± SD (n = 2). 
 
 








































































































































































































6.3.3 Metabolic engineering to enhance 5-ALA biosynthesis under microaerobic conditions 
As previously demonstrated (Arikawa et al. 1999), disruption of SDH complex can reduce acetate 
secretion under oxygen limitation. We derived a single-knockout mutant DMH∆sdhA, in which 
the oxidative TCA cycle was disrupted (Figure 6.5-I). In addition to reduced acetogenesis under 
AL-I, DMH∆sdhA produced 0.94 g l-1 5-ALA (6.61% yield) with enhanced formate, succinate, 
and ethanol secretion. With an increased carbon flux toward porphyrin biosynthesis, pigmentation 
of the DMH∆sdhA culture medium was moderately enhanced. On the other hand, while glycerol 
consumption and cell growth were substantially retarded upon cultivation of the hemB-repressed 
strain DMH-L4 under AL-I, 5-ALA biosynthesis was drastically improved with much reduced 
acetogenesis, achieving 4.73 g l-1 5-ALA with 32.0% yield (Figure 6.5-II). The improved 5-ALA 
biosynthesis was also evidenced by considerable reduction in pigmentation of the culture medium 
compared to DMH. Notably, compared to DMH∆sdhA or DMH-L4, 5-ALA biosynthesis was 
further improved upon cultivation of DMH-L4∆sdhA, in which the sdhA mutation and hemB-
repression was simultaneously introduced, under AL-I, achieving 5.95 g l-1 5-ALA with 36.9% 
yield (Figure 6.5-III). These results suggest that the dissimilated carbon flux was directed toward 
the succinyl-CoA node for 5-ALA biosynthesis primarily via the reductive TCA branch under 
microaerobic conditions, and such carbon flux direction was rather effective upon simultaneous 
disruption of the oxidative TCA cycle and hemB repression. Aside from DMH∆sdhA, higher levels 
of formate, succinate, and ethanol were also observed upon cultivation of other two engineered 
strains, i.e., DMH-L4, and DMH-L4∆sdhA, in comparison to DMH under microaerobic conditions 














Figure 6.5: Bioreactor cultivation of engineered E. coli for 5-ALA biosynthesis under microaerobic (AL-I) conditions. Strains 
compared include DMH∆sdhA, DMH-L4, and DMH-L4∆sdhA. Time profiles of cell density (OD600), glycerol consumption and 
metabolite production profiles, acetate and 5-ALA percentage yields, and porphyrin biosynthesis (represented by the absorbance 
readings of the Soret peak in OD405 and Q-band in OD495 and the images of cell-free media) are shown. The percentage yields of 
acetate/5-ALA and absorbance readings of porphyrin compounds are calculated/measured based on the consumed glycerol at the end of 
cultivation. (I) DMH∆sdhA, (II) DMH-L4, and (III) DMH-L4∆sdhA. All values are reported as means ± SD (n = 2). 
 
 








































































































































































































6.3.4 Metabolic engineering to enhance 5-ALA biosynthesis under aerobic conditions 
We also explored 5-ALA biosynthesis under aerobic conditions, which often facilitate carbon 
utilization and cell growth. While the DMH-L4 culture under AL-III showed effective glycerol 
dissimilation and cell growth, biosynthesis of 5-ALA and porphyrins was much lower than that of 
the DMH-L4 culture under AL-I (Figure 6.6-I vs. Figure 6.5-II), suggesting a potential limitation 
in succinyl-CoA precursor under aerobic conditions. Nevertheless, the enhancing effects of hemB-
repression on 5-ALA biosynthesis were still observable under aerobic conditions by comparing 
the two cultures of DMH-L4 and DMH under AL-III (Figure 6.6-I vs. Figure 6.4-III). To overcome 
the limitation in succinyl-CoA under AL-III, we derived another mutant of DMH-L4∆iclR with a 
deregulated glyoxylate shunt. Compared to the parental strain DMH-L4, DMH-L4∆iclR had a 
much higher 5-ALA biosynthesis with effective glycerol dissimilation and cell growth under AL-
III (Figure 6.6-III vs. Figure 6.6-I), suggesting successful direction of the dissimilated carbon flux 
toward succinyl-CoA for 5-ALA biosynthesis via the glyoxylate shunt under aerobic conditions. 
For more effective carbon flux direction, we derived another double mutant of DMH-
L4∆iclR∆sdhA with a disruptive oxidative TCA cycle such that the directed carbon flux at the 
succinate node via the glyoxylate shunt could be further directed toward succinyl-CoA via the 
activity of fumarate reductase (FRD) complex. Compared to the parental strain DMH-L4∆iclR, 
DMH-L4∆iclR∆sdhA had even higher 5-ALA biosynthesis under AL-III (Figure 6.7-II vs. Figure 
6.6-III), achieving 6.93 g l-1 5-ALA with 50.9% yield, though the mutation of sdhA in DMH-
L4∆sdhA appeared to be rather harmful to cell physiology and, therefore, culture performance 
(Figure 6.6-II vs. Figure 6.6-I). Note that the 5-ALA yield for DMH-L4∆sdhA∆iclR was 3.4-fold 
that for DMH-L4 and 1.3-fold that for DMH-L4∆iclR. Also, note that the enhancing effects of 




DMH-L4∆iclR∆sdhA and DMH∆iclR∆sdhA under AL-III (Figure 6.7-II vs. Figure 6.7-I). On the 
other hand, the successful carbon flux direction toward the Shemin pathway via the glyoxylate 
shunt and partial reductive TCA branch for biosynthesis of both 5-ALA and porphyrin pigments 
can be also observed by comparing the two cultures of DMH∆iclR∆sdhA and DMH under AL-III 
(Figure 6.7-I vs. Figure 6.4-III). These results successfully demonstrated the consolidated strategy 
based on carbon flux redirection in the TCA cycle toward the Shemin pathway with repressed 
hemB expression to enhance 5-ALA biosynthesis. However, the overall culture performance was 
limited by acetogenesis, particularly during extended fed-batch cultivation (data not shown). Note 
that full abolishment of acetogenesis during aerobic growth of E. coli can be highly challenging 





















Figure 6.6: Bioreactor cultivation of engineered E. coli for 5-ALA biosynthesis under aerobic (AL-III) conditions. Strains 
compared include DMH-L4, DMH-L4∆sdhA, DMH-L4∆iclR, DMH∆sdhA∆iclR, and DMH-L4∆sdhA∆iclR. Time profiles of cell 
density (OD600), glycerol consumption and metabolite production profiles, acetate and 5-ALA percentage yields, and porphyrin 
biosynthesis (represented by the absorbance readings of the Soret peak in OD405 and Q-band in OD495 and the images of cell-free media) 
are shown. The percentage yields of acetate/5-ALA and absorbance readings of porphyrin compounds are calculated/measured based 
on the consumed glycerol at the end of cultivation. (I) DMH-L4 (II) DMH-L4∆sdhA, (III) DMH-L4∆iclR. All values are reported as 
means ± SD (n = 2). 
 

















































































































































































































Figure 6.7: Bioreactor cultivation of E. coli double mutants for 5-ALA biosynthesis under aerobic (AL-III) conditions. Strains 
compared include DMH∆sdhA∆iclR and DMH-L4∆sdhA∆iclR. Time profiles of cell density (OD600), glycerol consumption and 
metabolite production profiles, acetate and 5-ALA percentage yields, and porphyrin biosynthesis (represented by the absorbance 
readings of the Soret peak in OD405 and Q-band in OD495 and the images of cell-free media) are shown. The percentage yields of 
acetate/5-ALA and absorbance readings of porphyrin compounds are calculated/measured based on the consumed glycerol at the end of 
cultivation. (I) DMH∆sdhA∆iclR, and (II) DMH-L4∆sdhA∆iclR. All values are reported as means ± SD (n = 2).

































































































































































While E. coli has the native C5 pathway for 5-ALA biosynthesis, we herein adopted the 
heterologous Shemin pathway since the intracellular level of the key precursor succinyl-CoA can 
be metabolically manipulated. Being a metabolic intermediate in the pathway for biosynthesis of 
essential porphyrins, 5-ALA hardly accumulates in E. coli. As hemB is an essential gene, CRISPRi 
was applied to repress its expression, such that 5-ALA could accumulate as a result of reduced 
conversion, with DMH-L1 and DMH-L4 demonstrating high levels of hemB repression. Our 
results further suggest that 5-ALA acts as a committed precursor for porphyrin biosynthesis. Given 
improved 5-ALA production, hemB repression also slightly impaired cell growth, presumably as 
a consequence of lower biosynthesis of essential porphyrins. However, as the overall culture 
performance was not seriously affected, the feasibility of this genetic strategy was demonstrated.  
While the effects of oxygen supply on 5-ALA biosynthesis were investigated in several 
organisms (Nishikawa et al. 1999; Yu et al. 2015), little effort on this front was made for E. coli. 
With the implemented Shemin pathway, 5-ALA biosynthesis in E. coli can critically depend on 
the availability of the key precursor succinyl-CoA, whose formation is rather oxygen-sensitive. 
Using the control strain DMH, the effects of oxygenic conditions on 5-ALA biosynthesis were 
systematically investigated for cell cultivation under microaerobic (AL-I), semiaerobic (AL-II), 
and aerobic (AL-III) conditions. Our results show that biosynthesis of 5-ALA and porphyrins was 
favored by microaerobic conditions, though the low oxygenic level triggered high-level 
acetogenesis and the associated physiological impacts. The results suggest that, in DMH, most of 
5-ALA/porphyrins have been derived via the reductive TCA branch; and the oxidative TCA cycle 




Compared to DMH, blocking the oxidative TCA cycle in DMH∆sdhA could potentially 
channel more dissimilated carbon flux toward succinyl-CoA as a result of restricted conversion of 
succinyl-CoA-to-succinate under AL-I and, therefore, improve biosynthesis of 5-ALA and 
porphyrins with much reduced acetogenesis. With more dissimilated carbon flux channeling into 
the Shemin pathway, porphyrin biosynthesis was reduced by repressing hemB expression to 
enhance 5-ALA accumulation in DMH-L4∆sdhA under AL-I, achieving 5.95 g l-1 5-ALA and with 
36.9% yield while minimizing porphyrin biosynthesis. Note that inactivating the oxidative TCA 
cycle and/or repressing hemB expression resulted in uncommon accumulation of formate with 
reduced acetogenesis, compared to the control strain DMH. Such observation suggests that, under 
these biochemical and microaerobic conditions, pyruvate formate lyase (PFL; via which formate 
is coproduced) could be more active than pyruvate dehydrogenase (PDH) for the conversion of 
pyruvate to acetyl-CoA (Durnin et al. 2009). In E. coli, PDH and PFL are responsible for 
decarboxylation of pyruvate to form acetyl-CoA under aerobic and anaerobic conditions, 
respectively (Wang et al. 2010). It was also reported that acetate and formate could induce opposite 
proteome responses in E. coli as most proteins induced by one of these two acids are repressed by 
the other (Kirkpatrick et al. 2001), further signifying antagonistic nature of these two acids.  
While the control strain DMH had a low-level biosynthesis of 5-ALA and porphyrins under 
aerobic conditions such as AL-III, implying a limited carbon flux contribution from the oxidative 
TCA cycle (and, therefore, limited succinyl-CoA precursor) into the Shemin pathway, repressing 
hemB expression could also considerably increase 5-ALA accumulation in DMH-L4. Inactivating 
the oxidative TCA cycle in DMH-L4∆sdhA substantially retarded cell growth with limited glycerol 
dissimilation, cell growth, and metabolite production under AL-III, suggesting the critical 




conditions as per previous observations (Guest 1981; Steinsiek et al. 2011). To resolve the apparent 
succinyl-CoA limitation under AL-III, we explored channeling of the dissimilated carbon flux via 
a deregulated glyoxylate shunt by mutating iclR in DMH-L4∆iclR and observed notably enhanced 
5-ALA biosynthesis. Nevertheless, with an active TCA oxidative cycle in DMH-L4∆iclR, the 
carbon flux arising from the deregulated glyoxylate shunt could divert at the succinate node to 
either the oxidative or reductive TCA direction. Importantly, the flux diversion could be prevented 
with the dissimilated carbon being effectively directed into the Shemin pathway by further 
mutating sdhA for disruption of the oxidative TCA cycle in DMH-L4∆sdhA∆iclR, achieving 6.93 
g l-1 5-ALA with 50.9% yield upon its cultivation under AL-III while minimizing porphyrin 
biosynthesis. Such carbon flux rerouting effects under AL-III could also be observed by the 
enhanced biosynthesis of 5-ALA and porphyrins (reflected by notable pigmentation of the culture 
medium in Figure 6.7-I) in DMH∆sdhA∆iclR compared to DMH. Additionally, note that the 
retarded glycerol utilization and cell growth for DMH-L4sdhA could be complemented by the 
iclR mutation, suggesting that both the oxidative TCA cycle and glyoxylate shunt contribute to 
active TCA operation for sustained cell growth and metabolic biosynthesis under aerobic 
conditions. Therefore, TCA cycle engineering proposed in this study is considered more flexible 
and efficient to enhance bio-based production under different aeration conditions, compared to a 









Original contributions and recommendations 
 
7.1 Original contributions 
7.1.1 Enhancing propionate production in Escherichia coli via TCA cycle engineering  
In Chapter 3 of this report, we targeted several TCA cycle genes encoding enzymes near the 
succinyl-CoA node for genetic manipulation in order to identify the individual contribution of the 
carbon flux into the Sbm pathway from the three TCA metabolic routes, i.e., oxidative TCA cycle, 
reductive TCA branch, and glyoxylate shunt. For the control strain CPC-Sbm in which propionate 
biosynthesis occurred under relatively anaerobic conditions, the carbon flux into the Sbm pathway 
were primarily derived from the reductive TCA branch; and both succinate availability and the 
SucCD-mediated interconversion of succinate/succinyl-CoA were critical for such carbon flux 
redirection. While the oxidative TCA cycle normally had a minimal contribution to the carbon flux 
redirection, the glyoxylate shunt could be an alternative and effective carbon flux contributor under 
aerobic conditions. With mechanistic understanding of such carbon flux redirection, metabolic 
strategies based on blocking the oxidative TCA cycle (via ∆sdhA mutation) and deregulating the 
glyoxylate shunt (via ∆iclR mutation) were developed to enhance the carbon flux redirection and, 
therefore, propionate biosynthesis, achieving a high propionate titer of 30.9 g l-1 with an overall 
propionate yield of 49.7% upon fed-batch cultivation of the double mutant strain CPC-
Sbm∆sdhA∆iclR under aerobic conditions. The results also suggest that the Sbm pathway could 
be metabolically active under both aerobic and anaerobic conditions. 
7.1.2 Establishing heterologous pathway for 3-hydroxyvalerate production in E. coli 
In Chapter 4, we report the derivation of engineered E. coli strains for the production of 3-HV 




pathway in E. coli enabled the intracellular formation of non-native propionyl-CoA. A selection 
of enzymes involved in 3-HV biosynthetic pathway from various microorganisms were explored 
for investigating their effects on 3-HV biosynthesis in E. coli. Glycerol outperformed glucose as 
the carbon source, and glycerol dissimilation for 3-HV biosynthesis was primarily mediated 
through the aerobic GlpK-GlpD route. To further enhance 3-HV production, we developed 
metabolic engineering strategies to redirect more dissimilated carbon flux from the TCA cycle to 
the Sbm pathway, resulting in an enlarged intracellular pool of propionyl-CoA. Both the presence 
of succinate/succinyl-CoA and their interconversion step in the TCA cycle were identified to 
critically limit the carbon flux redirection into the Sbm pathway and, therefore, 3-HV biosynthesis. 
A selection of E. coli host TCA genes encoding enzymes near the succinate node were targeted 
for manipulation to evaluate the contribution of the three TCA routes (i.e., oxidative TCA cycle, 
reductive TCA branch, and glyoxylate shunt) to the redirected carbon flux into the Sbm pathway. 
Finally, the carbon flux redirection into the Sbm pathway was enhanced by simultaneously 
deregulating glyoxylate shunt and blocking the oxidative TCA cycle, significantly improving 3-
HV biosynthesis. With the implementation of these biotechnological and bioprocessing strategies, 
our engineered E. coli strains can effectively produce 3-HV up to 3.71 g l-1 with a yield of 24.1% 
based on the consumed glycerol in shake-flask cultures.  
7.1.3 Bioprocess engineering toward high-level 3-hydroxyavalerate production in E. coli  
In Chapter 5, we report the development of a microbial bioprocess for high-level and potentially 
economical production of 3-HV from glycerol, which can be cheaply and renewably refined as a 
byproduct from biodiesel production. We used our previously derived 3-HV-producing E. coli 
strains (from Chapter 4) for bioreactor characterization under various culture conditions. In the 




whose formation was favored by anaerobic conditions, which often compromised cell growth. 
With appropriate strain engineering, we demonstrated that 3-HV can be effectively produced under 
both microaerobic (close to anaerobic) and aerobic conditions, which determine the direction of 
dissimilated carbon flux toward the succinate node in the TCA cycle. We first used the ∆sdhA 
single mutant strain, in which the dissimilated carbon flux was primarily directed to the Sbm 
pathway (via the reductive TCA branch, with enhanced cell growth under microaerobic conditions, 
achieving 3.08 g l-1 3-HV in a fed-batch culture. In addition, we used the ∆sdhA∆iclR double 
mutant strain, in which the dissimilated carbon flux was directed from the TCA cycle to the Sbm 
pathway via the deregulated glyoxylate shunt, for cultivation under rather aerobic conditions. In 
addition to demonstrating effective cell growth, this strain has shown impressive 3-HV 
biosynthesis (up to 10.6 g l-1), equivalent to an overall yield of 18.8% based on consumed glycerol, 
in aerobic fed-batch culture. This study not only represents one of the most effective bio-based 
production of 3-HV from structurally unrelated carbons to date, but also highlights the importance 
of integrated strain engineering and bioprocessing strategies to enhance bio-based production. 
7.1.4 Developing efficient production of 5-aminolevulinate in E. coli  
In our last chapter (Chapter 6), we report development of a microbial bioprocess for high-level 
and potentially economical production of 5-aminolevulinic acid (5-ALA), a valuable non-
proteinogenic amino acid with multiple applications in medical, agricultural, and food industries, 
using E. coli as a cell factory. We first implemented the Shemin (i.e., C4) pathway for heterologous 
5-ALA biosynthesis in E. coli. To reduce, but not to abolish, the carbon flux toward essential 
tetrapyrrole/porphyrin biosynthesis, we applied Clustered Regularly Interspersed Short 
Palindromic Repeats interference (CRISPRi) to repress hemB expression, leading to extracellular 




dissimilated carbon flux toward the key precursor of succinyl-CoA for enhanced 5-ALA 
biosynthesis. Using these engineered E. coli strains for bioreactor cultivation, we successfully 
demonstrated high-level 5-ALA biosynthesis solely from glycerol (~30 g l-1) under both 
microaerobic and aerobic conditions, achieving up to 5.95 g l-1 (36.9% of the theoretical yield) and 
6.93 g l-1 (50.9% of the theoretical yield) 5-ALA, respectively. This study represents one of the 
most effective bio-based production of 5-ALA from a structurally unrelated carbon to date, 
highlighting the importance of integrated strain engineering and bioprocessing strategies to 
enhance bio-based production.  
7.2 Recommendations and future prospects 
 
As described in this thesis, redirecting carbon flux toward succinyl-CoA node in E. coli has opened 
an avenue for novel chemical production, particularly those derived from Sbm and heme 
biosynthetic pathways. With respect to the Sbm pathway, future research efforts can implement 
our developed strategy for enhanced bio-based production of other odd-chain chemicals, i.e., 1-
propanol (Srirangan et al. 2013), poly(3-hydroxybutyrate-co-hydroxyvalerate) (PHBV) (Srirangan 
et al. 2016b), valerate (Dhande et al. 2012), and pentanol (Tseng and Prather 2012). In addition, 
similar strategy can be adopted for production of more broader range of chemicals that are also 
generated from propionyl-CoA moiety, including even-chain butanone (Srirangan et al. 2016a) 
and particular types of polyketides (e.g., erythromycin C) (Peirú et al. 2005). Future research 
focusing on Sbm-derived chemical production should consider utilization of other cheap carbon 
sources (i.e., acetate and lignocellulosic substrates), enhancing availability of reducing 
equivalents, cofactor engineering, and determining metabolic bottlenecks. Much like with Sbm 
pathway, the developed methods in this thesis can be used to improve bio-based chemicals from 




compounds (Kwon et al. 2003), and linear tetrapyrroles (e.g., biliverdin, phycocyanobillin, and 
phycoerythrobilin) (Chen et al. 2012; Mukougawa et al. 2006). Note that linear tetrapyrroles, 
collectively termed as bilins, have a potent antioxidant activity and can protect cells from oxidative 
damage (Frankenberg-Dinkel 2004; Mysliwa-Kurdziel and Solymosi 2017), suggesting their 
potential applications in therapeutics and healthcare. Various other heme-derived bacterial bilins 
have been increasingly identified (Celis and DuBois 2019; Lyles and Eichenbaum 2018). As this 
thesis outlined highest 5-ALA production in E. coli without supplementation of precursors, the 
strategies described here can be useful for economical biosynthesis of valuable 5-ALA-derived 
compounds, i.e., 2,5-piperidinedione (2,5-PDO) (Zhang et al. 2010) and 4, 5-dioxovalerate (4,5-
DOVA) (Douki et al. 1998).  
As many other metabolic pathways stem from succinyl-CoA, the combined strain and 
bioprocess engineering approach presented in our thesis can be implemented for production of 
value-added chemicals from other metabolic pathways. For instance, previous studies have 
demonstrated effective production of various chemicals from succinate semialdehdyde (SSA) 
(Choi et al. 2013; Shelp et al. 2017; Zhou et al. 2012), which is directly synthesized from succinyl-
CoA via NADPH-dependent reduction reaction by semialdehyde dehydrogenase (SSADH) 
(Söhling and Gottschalk 1993). While E. coli is unable to produce SSA naturally, successful 
biosynthesis of SSA in this strain was reported via heterologous expression of SSADH gene (i.e., 
sucD) from Clostridium kluyveri (Wang et al. 2014). Hence, integration of our TCA cycle 
engineering approach, which redirects more carbon flux toward the node of succinyl-CoA, with 
those for biosynthesis of non-native SSA in E. coli, may possibly enhance production of 
industrially valuable SSA-derived chemicals, such as 4-aminobutanoate (GABA) and 4-




butyrolactone (GBL) (Efe et al. 2008) and environmentally-friendly bioplastics, i.e., poly(4-
hydroxybutyrate) (P4HB) (Martin and Williams 2003) and poly(3-hydroxybutyrate-co-4-
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Appendix A: Supplementary tables 
 












a 5-ALA produced (g l-1) after complete consumption of glycerol, theoretical percent yield based on consumed glycerol is presented in parentheses 
  AL-I aeration level I 
  AL-III aeration level III 
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Figure S4.1: Effects of glycerol pathway knockouts on 3-HV production. Strains compared are 
P3HA31, P3HA31∆gldA, P3HA31∆ptsI, P3HA31∆dhaKLM, P3HA31∆glpK, P3HA31∆glpD, 
and P3HA31∆glpABC. Top panel represents cell growth (OD600), glycerol consumption, 3-HV 
yield (%), and total odd-chain (i.e., 3-HV, propionate, and 1-propanol) yield (%) while bottom 
panel represents titers of 3-HB, 3-HV, even and odd-chain acids (i.e., acetate and propionate) and 
alcohols (i.e., ethanol and 1-propanol) reached after 48h shake-flask cultivation. All values are 
reported as means ± SD (n = 3).   
a Measured cell density after 48h cultivation using spectrophotometer (OD600), time 0h cell density was kept at ~5.00 
b Defined as the percentage of the 3-HV theoretical yield based on the consumed glycerol 
c Defined as the percentage of the total odd-chain metabolites (i.e., propionate, 1-propanol, and 3-HV) theoretical yield based on the consumed 
  ND not detected 
 
